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SU M M A R Y
N -A c y l -L -h is t id in e  d e r iv a t iv e s ,  a n u m b e r  o f  N-  
a c y ld ip e p t id e s  c o n ta in in g  L -h is t id in e  (A), and  d ip e p tid e s  
containing 1-methyl-L-histidine (B) or 3-m ethyl-L-histidine (C) 
are thought to be present in cardiac muscle. These compounds are 
believed to play an important role in the healthy functioning of 
the heart. The work presented in this thesis investigates the 
synthesis of optically active forms of some of these L-histidine 
derivatives. The results obtained when these compounds were 
tested by the physiologists for their individual effects on cardiac 
muscle are presented.
Me
+NH-
(B)
(A ). W -A cyl-L -h is tid ine  D e r iv a t iv e s  and iV -A cyld ipep tides  
Containing L-Histidine
N -A ce ty l-L -h is t id in e  and  A -p ro p io n y l-L -h is t id in e  w ere  
successfully synthesised in good yield and high optical purity by 
the direct acylation of L-histidine with acetic or propionic  
anhydride. Two routes aimed at providing a range of N-
v  m
acyldipeptides containing L-histidine in chemically and optically  
pure form were studied. A series o f  N-acylamino acids were  
coupled to L-histidine protected on the carboxyl function. The  
first route used the benzyl ester o f  L-histidine but a number o f  
problems were encountered which made this route unattractive. 
The second route involved L-histidine protected as a metal salt. 
The mixed anhydride method o f peptide coupling was employed  
to produce the compounds in chemically pure form.
A number of methods were used in an attempt to determine 
the optical purities o f  the histidine derivatives synthesised. The 
m ost p ro m is in g  m ethod in vo lved  the coupling  of (R ) - a - 
m e th y lb e n z y la m in e  to the ca rb o x y l func tion  o f  the N- 
acyldipeptides. The diastereoisomeric mixtures formed were then 
a n a ly s e d  u s in g  r e v e r s e -p h a s e  h ig h  p e r fo rm a n c e  l iq u id  
chromatography (HPLC). The solvent mixture used to elute the 
column was adjusted to find a composition which would allow the 
separation of the diastereoisomers. The areas under the peaks 
were then used to estimate the optical purities of the compounds 
under investigation.
The L-histidine derivatives were examined by physiologists  
at Glasgow University. They discovered, using HPLC techniques, 
that W -acetyl-L-histidine, iV-acetyl-L-carnosine and N-acetyl-L- 
homocarnosine were present in cardiac muscle. The N-propionyl 
derivatives synth esised  had an adverse e ffec t  on the Ca- 
sensitising apparatus o f  cardiac muscle. jV-Acetyl-L-histidine, N- 
a c e ty l-L -a la n y l -L -h is t id in e  and N -a c e ty l-D -a la n y l-L -h is t id in e  
were weak Ca-sensitisers. iV-Acetylglycyl-L-histidine, A-acetyl-L- 
carnosine and A-acetyl-L-homocarnosine produced more positive  
action on the Ca-sensitising apparatus o f  the heart muscle.
IX
(B). 1-M ethvl-L-histid ine. 3-M ethvl-L-histid ine and Dipeptides 
Containing L-Histidine Methylated on the Imidazole Ring
Because the im idazole  function of L-histidine has two 
possib le  sites for A -a lky la tion  to take p lace , routes  were 
deve loped  to ob ta in  se le c t iv e ly  the d es ired  W -m ethylated 
histidine derivatives as pure isomers.
A syn th es is  o f  1 -m ethy l-L -h istid ine , re p o r te d  in the 
li te ra tu re , was a ttem pted . Problem s w ere encoun te red  in 
introducing the pro tecting  group onto the 3 -position  o f  the 
im idazole ring. This could not be achieved in the manner 
described in the literature, thus an alternative route was studied. 
A (a ) ,3 -b is (7 -B u to x y c a rb o n y l ) -L -h is t id in e  m e th y l  e s te r  was 
alkylated using methyl iodide. The residue obtained from the 
reaction was found to be a mixture of the desired  1-methyl 
compound and the 1,3-dimethyl compound. This mixture was 
successfully separated. The final stage was to remove the 
protecting groups. A number of different methods were used. 
Each procedure  rem oved the protecting groups without any 
difficulties but each attempt yielded 1-methylhistidine which was 
not optically active.
The synthesis  o f  3-m ethyl-L-histid ine, repo rted  in the 
literature, was attempted. The synthetic sequence was successful 
until the final deprotection stage which yielded 3-methylhistidine 
in chemically pure form, but contrary to the data published, the 
product was not optically active. An a lternative route was 
investigated. N ( a ) -r-Butoxy carbonyl- 1-benzoxy m ethyl-3-m ethyl-
L-histidinium methyl ester iodide was synthesised. 3-Methyl-L- 
histidine should then be obtained upon removal of the protecting
Xgroups. The removal of the methyl ester resulted in a racemic 
product. A ttem pts to remove the benzoxym ethyl group were 
cons is ten tly  u nsuccessfu l .  3 -M eth y lh is t id in e  could  not be 
obtained in chemically or optically pure form from this route.
A route  to d ipeptides containing 1-m ethylh is tid ine  was 
established. 1-M ethylglycylhistidine, 1-m ethylcarnosine and 1- 
m ethylhom ocarnosine were synthesised in chemically pure form. 
The interm ediates in this route all possessed some degree o f  
optical purity but the hydrolysis of the methyl esters at the end of 
the route resulted in racemic products.
The rou te  es tab lished  for the synthesis  of d ipeptides 
c o n ta in in g  3 - m e th y lg ly c y lh i s t id in e  and  3 -m e th y lc a rn o s in e  
p roduced  these  com pounds as pure isom ers. P roblem s in 
removing the methyl esters in the final stage resulted in the 
p roduc ts  be ing  racem ic . This  rou te  fa iled  to y ie ld  3- 
methylhomocarnosine, thus an alternative route to these 3-methyl 
compounds was investigated. The benzoxym ethyl group was 
introduced onto the 1-position of the imidazole ring of N(a)-  
carbobenzoxy-L-carnosine methyl ester. M ethylation of the 3- 
position was attempted but failed to produce reasonable amounts 
of  the TV-methylated product. Time did not allow further 
investigation into the routes leading to the dipeptides containing 
1- or 3-methyl-L-histidine.
1 - M e t h y  l h i s t i d i n e ,  1 - m e th y  l g ly  cy  l h i s t i d i n e ,  1- 
m ethy lcarnosine , 1-m ethylhom ocarnosine , 3 -m ethy lh is tid ine , 3- 
methylglycylhistidine and 3-methylcarnosine were all obtained as 
pure isomers but none of the compounds possessed any optical 
ac tiv ity .
1C H A PTE R  1 
I n t r o d u c t i o n
It has long been established that three main dipeptides 
containing L-histidine (1) occur in muscle.1 These are carnosine 
( P -a la n y l -L -h is t id in e )  (2 ) ,  a n s e r in e  ( (3 -a la n y l-1 -m e th y l-L -  
h istidine) (3) and balenine (f3-alanyl-3-methyl-L-histidine) (4). 
The numbering of the imidazole ring in L-histidine (1) and its 
derivatives in this thesis is carried out according to the IUPAC- 
IUB convention.2 The system according to Chemical Abstracts ,3 
numbers the nitrogens of the ring in the opposite order. It was 
decided to follow the biological convention since it would avoid 
confusion in communications with the physiologists. Furthermore, 
much of the litera ture  available  on h istid ine chem istry  also 
follows the biological convention.
CO
( 1)
co;
NHCOCHoCHoNH
(2)
Me
CO
NHCOCHoCICNH
(3)
.N.
N-
Me
II
PO; 
'"'H
NHCOCH2CH2NH3
(4)
Other histidine derivatives exist that are acylated on the 
terminal amino group or monomethylated on the imidazole ring of 
histidine. Thus, N -acetylcarnosine and A -acetylhom ocarnosine 
have been detected in muscle and brain respectively.4 Free N-
2acetylhistidine has been isolated from amphibian cardiac muscle.5 
It was found previously in the central nervous system and the 
eyes o f  frogs,6 and subsequently in those of fish .7’8 It can 
therefore be said that histidine dipeptides, the acyl forms o f  these 
d e r iv a tiv es ,  and the N -m ethy la ted  h istid ine  d e r iv a tiv es  are 
widely distributed in the animal kingdom.
The full b iological roles o f  these histidine derivatives, 
especially in muscle, is still subject to speculation. Imidazole 
d e r iv a t iv e s  occur at m il l im o la r  concen tra tions  in m usc le  
cytoplasm and undoubtedly contribute to pH buffering capacity .1’9 
Carnosine and its methylated analogues may play a role in the 
regulation of glycolysis. These compounds may also be involved 
in other reactions of energy transduction.1’ 1° Carnosine has also 
been shown to possess at least some of the properties o f  a 
neurotransm itter in the olfactory system where its release from 
synaptosomes appears to be calcium dependent.11
Caffeine (5) has long been known to induce calcium release 
from the sarcoplasmic reticu lum .12 Caffeine is a methylxanthine 
and includes an imidazole ring in its structure. Sulmazole (6), a 
cardiotonic drug, is an imidazole derivative and behaves as a more 
potent calcium sensitiser.!^»14 Previous w ork15 has shown that 
the additional lone pair on the nitrogen in the imidazole ring not 
required for aromaticity is the key feature necessary to cause 
contraction in cardiac and skeletal muscle. Dr. D. J. Miller and co­
w orkers ,  p h y s io lo g is ts  at G lasgow  U niversity , sough t an 
explanation of the enhancing effect of the compounds (5) and (6) 
on the contractile  apparatus of the heart. They considered 
whether analogous compounds containing the imidazole ring exist 
in mammalian muscle tissue in sufficient quantities. It interested
3them to find out if  (5) and (6) were mimicking the action of such 
natural compounds.
H
OCH
(6)
rMe
MeMe
(5)
P re l im in a ry  w ork  s h o w e d  th a t  c a rn o s in e  and  N-  
acety lh is tid ine  enhance the calcium  sensitivity of rat m uscle 
c o n t ra c t i le  p r o te in s .16 F u r th e r  da ta  in d ica ted  tha t N-  
acetylhistidine and its 1-methyl derivative are present in skeletal 
muscles and that these, along with N-acetyl forms o f  carnosine 
and anserine, could be significant contributors to the imidazole 
pools of cardiac muscle.*7
In order to obtain more substantial results, novel high 
p e r fo rm a n c e  liqu id  ch ro m ato g rap h y  (HPLC) m ethods w ere  
developed by O'Dowd et al . 18 to analyse extracts taken from the 
cardiac muscle of frogs. This  was intended to allow the 
iden tif ica tion  and quantifica tion  o f  the h istid ine derivatives  
present. Elution of muscle extracts with a phosphate buffer 
mobile phase from columns packed with hypersil octadecyl-silica 
(ODS) (5 pm) resulted in good separation of the h istid ine  
derivatives as shown in Figure 1. The conditions used for HPLC 
are d iscussed  in more detail in Section 4.4.1. F rac tions  
corresponding to the chromatographic peaks were collected and 
spotted onto filter paper.
4Figure 1
HPLC trace of extracts from cardiac muscle of 
frogs. See text for conditions.
6 .4 1
y . y
5Im id a z o le  c o m p o u n d s  b o th  w ith  s u b s t i tu t e d  and
unsubstitu ted  rings w ere visualised using a reac tion  between
im id a z o le  and  b r o m in e .18 A n o th e r  v is u a l is a t io n  system  
d is t in g u ish e d  w h ich  f rac tio n s  co n ta in ed  co m p o u n d s  with
unsubstitu ted  rings and ninhydrin was used to test for the 
presence of compounds with a free terminal amino group. Cardiac 
failure was induced in some hearts (collaborative work with 
scientists at the Dr Karl Thomae company in Germany) to look for 
any deviation in the composition of histidine derivatives from a
healthy heart. On HPLC analysis there were very significant 
alterations in the relative abundance and the occurrence of the
histid ine derivatives. This gave an indication that histidine 
derivatives are im portant for the healthy function o f  the heart 
and that this area warranted further investigation.
Since the beginning of this work histidine derivatives have 
been identified as constituents in brain, vascular smooth muscle, 
and plasma. The derivatives have a variety of physiological roles, 
some of which have been discussed in the preceding paragraphs. 
In the course of this work it has also been discovered that some of 
the histidine derivatives have the ability to increase the calcium 
ion sensitivity of the contractile proteins of cardiac and skeletal 
muscle. It is also now known that some of the derivatives have 
actions on tone in vascular smooth muscle.
Because of these multiple and potentially important actions,
alterations in either the concentration or variety of the histidine 
derivatives could be of very significant physiological importance 
in the cardiovascular system.
In order to identify the peaks present in the previously 
mentioned HPLC trace of cardiac muscle, it was necessary in this
6w ork  to syn thesise  a range  o f  L -histid ine  com pounds  for 
com parison. Pure com pounds in optically active form were 
required so that they could be tested to establish whether they 
behave as calcium sensitisers and to determine what other effects 
they have on heart muscle.
The physio logy invo lved  in these procedures  will be 
discussed in detail in Chapter 2. Since most of the compounds 
required are commercially unavailable, general synthetic schemes 
to a range of these compounds were developed. The synthetic 
methods employed in the peptide synthesis will be discussed in 
Chapter 3. The routes to the 7V-acylhistidine dipeptides will be 
covered in Chapter 4 and the test data for these compounds is 
discussed in Section 4.4. The routes to the 1- and 3-N-methylated 
derivatives will be discussed in Chapter 5.
7CHAPTER 2
Physiology of the Heart
The function of the heart is to generate the pressures which 
produce blood flow.19 The cardiac muscle apparatus contracts and 
relaxes rhythm ically  and w ithou t fatigue. Its pow er output 
constantly adapts to cater for the variable demands made on it. 
For example, during physical exercise various tissues and organs 
require a greater flow of blood if  they are to maintain normal 
function and hence higher card iac  output is required. The 
m echanisms involved in the contraction o f  the heart will be 
d iscussed .
2.1 Anatomy of the Heart
The human heart is divided into two halves (Figure 2).20 
Each of these halves has two chambers, namely the atrium and 
the ventricle. The atrium receives blood from the veins and 
passes it on to the ventricle in the same half. The two cavities are 
separated by the atrioventricular valves. These valves permit 
blood flow from the atrium to the ventricle but not the reverse 
process. The opening and closing of these valves is a passive 
mechanism caused by the difference in pressure across them.
Myocardium is composed o f  layers of cardiac muscle which 
are tightly bound together and completely enclose the blood filled 
ch a m b e rs .
8Figure  2.20 Diagramatic section of the heart. The arrows indicate 
the direction of blood flow.
right atrium
left atrium
left AV 
valve
right AV valve
f  left
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The individual cells of  cardiac muscle are joined end to end 
at intercalated discs within which are gap junctions. These gap 
junctions allow the spread of currents from one cardiac muscle 
cell to another via low resistance pathways which trigger action 
potentials. Contraction of cardiac muscle, like that of many other 
m uscle  types, is triggered by depolarisa tion  o f  the p lasm a 
membrane. If  the threshold of stimulation is not reached then the 
cardiac muscle will not react at all. Normally, it responds with all 
its fibres being activated or none at all.
2.2 O r ig in  o f  the  H e a r tb e a t
Certain areas of the heart contain specialised muscle fibres 
which are essential for normal excitation of the heart. These areas 
are known as the conducting system which are in contact with the
9normal muscle fibres via the gap junctions. The specialised 
conducting system allows the rapid  and coordinated spread o f  
excitation. Several areas of the conducting system of the heart are 
capable of se lf  excitation. This has the effect of causing the 
membrane potential to reach threshold through depolarisation, at 
which point an action potential is initiated. The area with the 
fastest intrinsic rhythm becomes the pacemaker. Normally the 
area known as the sinoatrial node is the pacemaker for the whole 
heart. From the sinoatrial node, the wave of excitation spreads 
through the atrium via the low resistance pathways provided by 
the gap junctions. It propagates through the atrioventricular node 
along a conducting link to the working myocardium of the 
ventric les and finally makes contact with the normal cardiac 
muscle cells through which the impulse spreads from cell to cell in 
the remaining myocardium. The rapid conduction ensures a single 
coordinated wave of contraction.
2.3 Role of Calcium in Muscle  Excitation-contraction  
C ou pl ing
The depolarisation of cardiac muscle triggers contraction. 
The importance of calcium for heart muscle contraction has been 
recognised since Ringer's discovery21 in 1883 that an isolated 
heart from a frog ceases to beat in the absence of calcium in the 
bathing solution. Indeed, the mechanism coupling excitation and 
contraction in all types of muscle is an increase in the intracellular 
concentration of ionised calcium.
A muscle fibre contains actin and myosin; these are the two 
proteins crucial to contraction. Cross-bridges extend from the
10
myosin filament. Contraction occurs when these cross-bridges 
make contact with binding sites on the actin filament and as a 
resu lt generates a force on the actin filam ents. Adenosine 
triphosphate  (ATP) is the source o f  chemical energy for the 
contraction process. Muscles are obviously not in a continuous 
sta te  of contraction; in the resting muscle fibre cross-bridge 
binding is inhibited. This inhibition is due to two regulator 
proteins, troponin and tropomyosin, which are bound to the actin 
f i lam en t.
Tropomysin molecules are arranged end to end along the 
chains of actin, so that they partially cover the myosin binding 
sites. The result o f  this relationship is that the cross-bridges 
cannot make contact with their binding sites on actin. Troponin 
holds the tropomysin molecules in place (Figure 3).22 In order for 
the cross-bridges to bind to actin, the binding sites must be 
u n c o v e re d .
troponin
^ctin com plex tropom yosin
^ 0  nm
F igure  3.22 Muscle thin filament showing the position of 
tropomysin and the troponin complex on actin.
The initial m em brane depolarisation causes voltage-gated 
calcium channels in the cardiac cell membrane to open, which 
results in a flow of  calcium ions into the cell. This results in a
11
rapid rise in the concentration of calcium ions which provokes a 
m uch la rger  am ount o f  ca lc ium  to be re leased  from  the 
sarcoplasm ic reticulum.
T n l
(TnT)
Tm:
-Tm
T n l
TnC
iTnC;
T n l
T n l
TnC
F igure  4.23 This is a cross section through the filaments seen in 
F igure 3 to indicate the spatial relationships when calcium is 
bound and when it is not.
Calcium ions bind to specific sites on troponin. As in skeletal 
muscle, cardiac troponin is composed of three polypeptide chains 
(Figure 4).23 It consists of a calcium binding subunit known as
troponin C (TnC), an inhibitory subunit (Tnl) and a tropomysin- 
binding peptide (TnT).
Within the troponin C crystal (Figure 5),22 the molecules are 
extended structures, each with two domains connected by a single
12
helical strand. Each domain has two calcium ion binding sites. At 
the carboxy terminal domain there are two high affinity sites 
which bind either calcium or magnesium ions. These high affinity 
sites are required to maintain the integrity of the troponin 
complex binding sites. The amino terminal domain contains two 
low affinity sites, specific to calcium ions. These lower affinity 
sites are the sites which are involved in the regulation of muscle 
co n trac tio n .
i
F igure 5.22 The f0ici of the Troponin C crystal.
The E-F hand model (Figure 6)24 is the model used to 
describe the common structure of intracellular calcium binding 
proteins. Six oxygen ligands are formed from the peptide chain to 
coordinate to a calcium ion. These ligands are arranged by a
13
helix:loop:helix  configuration of the polypeptide chain. The cx- 
helical segments in troponin C are labelled A-F. Each calcium 
binding site is flanked by two of these segments.
-Y<
Figure  6.24 The EF hand model for the common structure of 
intracellular calcium binding proteins.
The two helices work as lever arms, and their re lative 
orientation depends on the presence of calcium ions. In the
resting muscle ( [Ca2+] about 10‘8 to 10'7 M), the high affinity sites 
are thought to be always occupied. It is believed that the
occupation o f  the low affinity sites with calcium ions causes the
conformation of the troponin molecule to change. This change in
conformation leads to an interaction with troponin I which in turn 
leads to the binding sites on actin being uncovered. The net result 
is that cross-bridging can take place and hence contraction. The 
removal of the calcium ions reverses the process. The entire cycle 
of contraction is represented in Figure 7.2®
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Figure  7.20 Role of calcium in muscle excitation-contraction 
coupling.
2.4 A lte ra t io n s  to the  Force  of C o n tra c t io n
The force o f  contraction is in direct proportion to the 
fraction of troponin binding sites o c c u p i e d . ^  Heart muscle has a 
large contractile reserve, which means that its performance can be
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increased by a number of means. These include increasing the 
extracellu lar calcium concentration, increasing the frequency of 
beating , and the application  of com pounds w ith a positive 
inotropic action. In the majority of these cases the increase in 
force or positive inotropy is due ultimately to an increase in the 
intracellular calcium concentration reached during contraction. If 
the frequency o f  stim ulation is increased, the filling  of the 
sarcoplasmic reticulum is improved, so that each stimulus induces 
a greater re lease  o f  calcium. Due to the h igher  calcium 
concentration reached during the period when the ventricles of 
the heart are contracting, the contractile force also increases, but 
can take longer to develop fully.
The re la tio n sh ip  betw een peak  force and in trace llu la r  
calcium ion concentration is virtually the same regardless of 
whether the force has been changed by altering the frequency of 
stimulation or by altering the extracellular calcium concentration. 
Even during positive inotropic intervention, it seems that force 
developm ent is submaxim al. Results obtained by F a b ia to ^  
suggest that, even under optimal conditions, living cardiac muscle 
is never more than about half to two-thirds maximally activated. 
Force can therefore be easily varied by increasing or decreasing 
the free maximum calcium ion concentration achieved during 
activa tion .
The binding of calcium ions to troponin receptor sites 
activates contraction and the degree of occupancy of troponin 
determines the contractile force. Thus contractility may also be 
altered by changing the calcium sensitivity of the regulator 
protein, troponin, so that at a given concentration of calcium ions 
more troponin molecules are occupied. Amongst the factors
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known to alter the apparent affinity o f  the regulatory proteins to
calcium  are: the length o f  the sarcomere (i.e. the repeating
structural unit o f  a m uscle),26 intracellular pH ,19 the concentration 
o f  cy c lic  n u c le o t id e s ,19 and calcium  sensit ising , cardiotonic  
drugs. 27,28,29
The apparent affinity, Kapp, of troponin C for calcium ions
represents the ratio between 'on' and 'o ff  rates, (1-2 x 108 sec-1),
for Ca2+ binding. It is generally believed that the rate at which 
the troponin sites become occupied cannot be increased since it is
diffusion limited.30 An increase in Kapp, thus implies a slowing of
the 'o f f  rate. The removal o f  the calcium ions reverses the 
activation  process. It is this rem oval which is the rate
determining step for calcium binding. It is alterations to the 
speed of dissociation o f  the calcium ions which could cause
changes to calcium sensitivity.
The relationship  betw een the sarcomere length and the 
force produced on contraction is shown in Figure 8.31 When the 
sarcomere length is less than optimum (area 1), the thin filaments 
will overlap. This could mean that, in some way, the cross-bridges 
do not make normal contact with the binding sites on the actin 
filament. As the length of the sarcomere is increased, cross­
bridging is more efficient in producing force until an optimum 
length, (10), is reached where force production is maximal (area 2). 
At 10, therefore, all of the cross-bridges have access to binding 
sites on actin and there is no steric hindrance to tension 
development at the filament ends. If the sarcomere length is 
increased past this optimum, the thin filaments are aligned in 
such a way that some of the cross-bridges are unable to reach the 
binding sites on actin (area 3). In this situation less cross-bridges
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can form and the force produced is reduced in direct proportion to 
the amounts o f  overlap between the actin and myosin filaments.
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F igu re  8 .31 Tension-length curve from part o f  a single muscle 
fibre.
The sarcomere length in the working heart is normally less 
than the optimum. This means that even if all the cross-bridges 
are active, the cardiac muscle is only able to produce less than 
100% tension on activation. At a set sarcomere length, factors 
such as pH, temperature, and certain cardiotonic drugs can alter 
the tension produced at a given concentration of calcium ions. The 
qualitative effect of these factors on the tension is shown in Figure 
9.
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This action is to be understood as an alteration to the force 
produced by each cross-bridge or, if  cross-bridge kinetics are 
altered, by force being transmitted more successfully through the 
filaments. This means that 'stiffness' is increased as a result o f  
cross-bridges remaining attached for a longer part of  each cycle.
/
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F ig u re  9 Simple peak force enhancement.
2 .5  T e s t in g  o f  th e  S e n s i t i s in g  E f fe c ts  o f  L -H is t id in e  
D eriv a tiv es  on C a rd ia c  M uscle  F ib res
L-Histidine derivatives synthesised in the course of this 
work were tested by Dr D. J. Miller and his co-workers.32 The 
tests were carried out on muscle fibres isolated from hearts taken 
from rats. These fibres were chemically skinned with either
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T riton  X -100 or saponin. T riton  com pletely  d isrupts  the 
membrane while saponin selectively skins the cells leaving the 
sarcolemma perforated with holes large enough to permit the free 
passage of small ions and molecules such as ATP, etc. The holes 
are small enough though to retain the diffusible sarcoplasmic
enzymes. This means the mitochondrial and the sarcoplasmic 
reticulum membranes remain functional, permitting the study of 
the Ca-sensitising effects of these histid ine derivatives under
conditions of dynamic tension development. Skinned preparations 
have the advantage of having many of the complicating factors
acting in the intact cell brought under experimental control.
E xperim ents  w ere carried  out on small, free  running 
trabeculae  iso la ted  from the r igh t ventric le  of the rat and
mounted for isom etric  force measurement. The animals were 
killed by a blow to the head, the heart was rapidly excised and 
flushed with a saline solution at room temperature.
Accurate knowledge of the sarcomere length of the isolated 
muscle fibre is critical in these experiments for the following 
reasons:
(a) the well established effect of reduced Ca-sensitivity of the 
contractile proteins at shorter sarcomere length;
(b) the efficacy of Ca-sensitising by caffeine (5) and sulmazole (6) 
may be affected by sarcomere length; and
(c) the effect of  sarcomere length on the extent of calcium uptake 
and / or release by the sarcoplasmic reticulum.
In this study, the sarcomere length was set at 2.1-2.2 pm 
(equivalent to 10 in Figure 8). The fibre was fixed at one end and 
attached to a force transducer at the other. The ionic environment 
around the fibre approximates to that in the intact cell. When the
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concentration of calcium ions is altered, the muscle generates a 
force which reaches an equilibrium  level which is a simple 
function of the concentration of calcium ions. The fibre was 
exposed to buffer solutions containing a range of concentrations of 
the histidine derivative under investigation at a range o f  calcium 
concentrations and the tension produced was measured for each 
one. The results were collected as s teady-state  force and 
normalised. A relationship between the relative tension and pCa 
was plotted to show a curve similar to that in Figure 10.
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F ig u re  10. Basic calcium sensitivity
The curve plotted for each compound tested was compared 
to the control curve obtained with no test compounds present. 
The effect expected for an L-histidine derivative which sensitises 
the heart muscle is shown in Figure 11. The curve was shifted to
21
the left so that at the same concentration of calcium ions a larger 
force is produced when a sensitising derivative is present.
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F igure  11. Simple calcium sensitising.
Tw o m easurem ents  w ere  recorded . F irs tly , the Ca- 
sensitising effects of the L-histidine derivatives on cardiac muscle 
expressed as a reduction in the concentration of calcium ions 
required to produce half maximum tension was noted. The second 
m easurem ent was the effect of  these derivatives on the peak 
force expressed as the change in force produced by the compound 
under investigation in a maximally Ca-activated preparation. The 
results obtained for each L-histidine derivative will be discussed 
in Section 4.4.2.
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CHAPTER 3
L-Histidine is a trifunctional a-amino acid. As well as the oc- 
amino function and the a-carboxyl function, L-histidine has an 
imidazole side chain. This imidazole moiety has a pKa value of 6.0 
which is close to neutrality.33 This moiety therefore has the 
ability to function both as a proton donor and a proton acceptor at 
pH values found in many biological fluids. The imidazole portion 
can also behave  as a nucleophile  and as a ligand in the 
coordination of metal ions.34 L-Histidine is therefore endowed 
with a wide range of potential functions. As the free amino acid, 
L-histidine has been implicated in the mechanism of a number of 
enzyme catalysed reactions. It is known that L-histidine is part of 
the active site of many of these enzymes3^ 3** and it is thought 
that the imidazole ring plays a role in their catalytic function.
3.1 Tautomerism of L-Histidine
In aqueous solutions of pH greater than the pKa o f  the 
im idazole ring, two tautomeric structures are possible for the 
zwitterionic form of L-histidine (Figure 12).
3-H 1-H
Figure 12
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In biologically active molecules, the predominance of one or 
other of  the two forms may well have a direct effect on the mode 
of action or the activity of a given substance.
The nature of the tautomerism involved in the imidazole
ring of L-histidine is known as annular tautomerism.37 This type 
o f  tau tom erism  occurs when the hydrogen atom can move
between sites w ithin the ring system. Since the mechanism 
involves the breaking of one N-H bond and the forming o f
another, the rate o f  exchange is extremely fast. Due to the
difficu lties  in determ ining the degree of population  of each 
tautomer, for a long time there was no evidence to support the
fact that two individual species existed.
Over the past ten to fifteen years a number of papers have 
appeared concerning the determination o f  the preferred tautomer 
o f  L-histidine and its derivatives. The research published has
encom passed a range of both physical and theoretical methods
used to study the tautomerism.
Reynolds and c o - w o r k e r s 3 3  used NMR spectroscopy to
determine the dominant tautomeric form of the imidazole ring of 
L-histidine in basic solution. They studied the pH dependence of 
13C chemical shifts of L-histidine in comparison with imidazole 
itself. They discovered that while the C-4 and C-5 resonances in 
im idazole  both move to higher field upon protonation, the
equivalent C-5 resonance in L-histidine shifted to higher field but 
the C-4 resonance moved to lower field. They went on to carry
out theoretical calculations of 13c NMR chemical shifts for the two
compounds in an attempt to interpret the observed results. The 
theoretical calculations accurately predicted the observed shifts
for imidazole when the calculated chemical shifts for C-4 and C-5
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in the neutral form were averaged. On comparison, the theoretical 
values calculated for the 3-H tautom er of im idazole, without 
averaging, were close to the observed shifts for L-histidine. 
Similarly the theoretical results of the 3-H tautomer o f  L-histidine 
were closer to the observed  values than those o f  the 1-H 
tautomer. These results indicated a predominance o f  the 3-H 
tautomer in basic solution.
Due to the approxim ations involved in the calculations, 
Reynolds and c o - w o r k e r s 3 3  went on to confirm the results by 
using 1-methyl and 3-methyl-L-histidine as model compounds. 
These can be regarded as frozen forms of the tautomers. The 
NMR chemical shift titration curves for the two model compounds 
were determined. The profiles they obtained are shown in Figure 
13.33
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The titration 13C NMR chemical shifts for all o f  the imidazole 
carbons of 3-methyl-L-histidine were identical in sign and similar 
in magnitude to those for L-histidine. The shifts for C-4 and C-5 
of  1-methyl-L-histidine were quite different from those for L- 
histidine. This was viewed as conclusive proof that the 3-H
tautomer was indeed the predominant tautomer in basic solution, 
in an estimated 4:1 ratio. A number o f  L-histidine derivatives 
were also diagnosed to have the 3-H tautomer predominant.
Blomberg and co-workers3** used the pH dependence o f  *3N 
and 13C resonances of L-histidine and the various couplings 
be tw een  the d iffe ren t n u c le i  to describe  the tau to m eric  
equilibrium. The results they obtained were consistent with those 
previously described. W asylishen and Tomlinson34 estimated the
predominant tautomer in L-histidine and related compounds using 
three bond 13C, *H nuclear spin-spin coupling constants. Again the 
results were in accordance with those previously discussed. It 
would be safe to assume, therefore, that the prevalent tautomer of 
L-histidine and related compounds in basic solution is indeed the
3-H tautomer.
Madden and co-workers39 have studied the crystal structure 
o f  L-histidine. Since the crystal lattice prevents interconversion,
the crystal is composed of only one of the tautomeric species. The
results these workers obtained show that the 3-H tautomer is also 
the prevalent tautomer in the solid state form of L-histidine.
All o f  the ev idence presented  indicates that the 3-H 
tautom er is the prevalent species. For the rem ainder o f  this 
thesis, therefore, only the 3-H tautomer will be represented.
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3.2 The D if fer en t ia t io n  Betw een  N (  1)- and N (3)~  
Derivatised L-Histidine Compounds
The differentiation of L-histidine compounds derivatised on 
the 1- or the 3-position of the imidazole ring has long been a 
p ro b le m .40 By far the most com m on method o f  making 
assignm ents has been to assume that the main product in the 
reaction o f  L-histidine with an equimolar amount of electrophilic 
reagent will be that isom er arising from attack at the least 
hindered site. This leads to the assumption that the L-histidine 
will be derivatised  preferentially  at the 3-position. Various 
experim ental approaches to the problem can be found in the 
l i te ra tu re .
The structures of compounds such as anserine (3) and the N- 
methylhistidines were originally assigned by degradation to the 
corresponding 1,4- or 1 ,5-dim ethylim idazoles.41 The structural 
a ss ig n m en ts  o f  these  d eg rada tion  p ro d u c ts  w ere in tu rn  
determ ined by their conversion into acyclic compounds or on 
com parison with synthesised compounds. Differentiation using 
chemical methods imposes severe limitations for many biologically 
im portant compounds of limited availability. A method was
required which needed only small amounts of material with little
chemical manipulation involved. The desired method would need 
to be widely applicable.
M atthew s and R ap o p o r t40 ev a lu a ted  several sp ec tra l  
methods which could possibly be used to solve the problem. The 
use o f  mass spectrom etry  had prev iously  been rep o rted .4^
M atthews and Rapoport obtained the spectra of four isomeric
pairs of 1,4- and 1,5-disubstituted imidazoles. On analysis.
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differences were observed between the members o f  each pair. 
Unfortunately these differences were not significant enough to be 
o f any general diagnostic value.
These workers went on to look at the ultraviolet spectra of 
several 1,4- and 1,5-disubstituted imidazoles including N(\)~  and 
iV (3 )-m ethy lh is t id ine .  They lo o k ed  for th ree  k inds o f  
distinguishing differences between the isomers:
(a) the relative difference in the wavelength of the absorption 
maxima of the free acids and the conjugate acids;
(b) differences in curve shapes; and
(c) relative differences in shifts in the maxima upon protonation.
For non-conjugating substituents such as in the case of 
h is tid ine  derivatives, no consis tent re la tive  d ifferences were 
o b se rv e d .
It has been reported43 that 1,4- and 1 ,5-disubstitu ted  
imidazoles can sometimes be differentiated by their infrared (IR) 
spectra. Matthews and Rapoport confirmed a previous report44 
that 7V(im)-methyl- and A(im )-carboxym ethylhistid ines exhibited 
an absorption maximum at 12p in the IR spectra of the 1,5- 
disubstituted isomers. The 1,4-disubstituted isomers exhibited a 
minimum at that point. They could not find consistent differences 
between isomers of other disubstituted imidazoles. This led them 
to speculate that there could be differences in the solid state 
spectra and the solution spectra. A study of the solution spectra 
o f  the same compounds was therefore  made. There were 
differences in the solution IR spectra between members of each 
pair of isomers. These differences were not, however, sufficient to 
be of any diagnostic value.
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The a ro m atic  p ro to n s  o f  1,4- and 1 ,5 -d isu b s t i tu te d  
imidazoles are coupled to each other across the ring giving rise to 
the coupling constants 72,5 and 72,4 respectively. Matthews and 
Rapoport measured the coupling constants of several im idazole 
derivatives. On studying the results obtained, they concluded that 
under specified conditions the cross-ring coupling constants can 
be used to distinguish 1,4- and 1,5-disubstituted imidazoles. The 
differences between the coupling constants can be rationalised by 
the geometry o f  the imidazole system. At least two geometric 
factors may produce differences in the 7 values:
(a) the angles the carbon-hydrogen bonds make to each other; and
(b) the relative separations of the carbons.
Both of these factors will influence the interactions of the 
two protons involved. The cross-ring coupling constants can only 
be observed in aprotic solvents. In all protic solvents the 
aromatic protons appeared as broad singlets.
Of the several spectral methods they investigated, Matthews 
and Rapoport concluded that only the method involving the cross­
ring coupling constants is of  general applicability. This method 
proved to be highly reliable and other workers45 have since 
applied it to determine which derivatised L-histidine isomer they 
have synthesised.
A crystal structure has been reported45 for an L-histidine 
compound derivatised on the imidazole function. This is another
physical method for determining the substitution pattern. This 
method has obvious restrictions and can only therefore be of use 
when a su itab le  crystal can be obtained. Jones and his
cow orkers45 used the evidence they obtained from the crystal 
s truc tu re  o f  A (a )- f -b u to x y ca rb o n y l- l-b en zo x y m eth y l-L -h is t id in e
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to substantiate the rule on cross ring coupling constants developed 
by Matthews and Rapoport.4**
C olom bo et a l ,46 sy n th es ised  a range o f  L-histid ine 
com pounds derivatised on the imidazole ring. They used two 
methods to determine which nitrogen of the imidazole ring was 
derivatised . The first m ethod involved conversion of these 
d e r iv a t iv e s  in to  N -m e th y l-L -h is t id in e s .  T h e se  A^-methyl 
derivatives were then assigned by comparison with commercially 
available 1- and 3-methyl-L-histidine. This is a fairly reliable 
method so long as the derivatives are easily converted into N- 
methyl-L-histidines and if  the L-histidine is only derivatised on 
the imidazole ring. It is, therefore, not generally applicable. The 
second method involved the measurement of Nuclear Overhauser 
Enhancements (NOEs). This was applied to the derivatives which 
had an RC H 2- type substituent. The two aromatic imidazole 
protons were separately irradiated. I f  the substituent was in the 
1-position (7), then the signal due to the protons of the CH2 group 
would be enhanced only when the proton in the 2-position was 
i r r a d ia te d .
If  the substituent was in the 3-position (8), the signal due to 
the protons of the CH2 group would be enhanced no matter what 
proton was irradiated. This is a good method for determining the
RCLL-,
(7) (8)
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substitution pattern on the imidazole ring. It is widely applicable 
and does not depend on the substitution on the primary amino
function .
3.3 Peptide Synthesis
The principal reaction in the synthesis of a peptide is the
acylation of the amino group of an amino acid by the carboxyl 
group of a second amino acid resulting in the formation of an 
amide bond.
The presence of several functional groups in amino acid
molecules and the necessity to maintain the integrity of the a-
carbon chirality centres during coupling makes peptide synthesis 
more complicated than simple amide formation. Condensation of 
two amino acids formally provides peptides with elimination of 
water. To obtain a defined product, A-B, the amine function of A 
and the carboxyl function of B must be temporarily blocked. This 
is the first step of four consecutive operations generally employed 
in peptide synthesis (Scheme l ) .^ 7 In the second stage the 
carboxyl group o f  the A (a)-pro tected  carboxyl component is 
activated. Peptide bond formation results in condensation of this 
activated carboxyl component with the carboxyl-protected amino 
component. The final stage involves removal of the protecting 
groups. Each of these stages will be discussed in detail in the 
following text, with particular application to L-histidine chemistry.
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Scheme l 47
1. Protection
R O R' O
H3N+-CH-C-0‘ H3N+-CH-C-CT* I
R O R' O
Z-NH-CH-^-OH H2N -tH -t-Y
carboxyl component amine component
2. Carboxyl activation
R O 
Z-NH-tH-t-X
I3. Peptide bond formation I amine component
R O R' O
Z-NH-iH-tNH-tH-li-Y
protected peptide
4. Deprotection
R O R' O
3.3.1 Reversible Blocking of Amino and Carboxyl Groups
In order that the blocking substituent may be satisfactorily 
employed for the masking of an amino acid function in peptide 
synthesis, it should conform to a number of criteria:48
(a) the p ro tected  derivative should be conveniently  available 
through the use of simple organic chemical techniques;
(b) the protection step should proceed in high yield;
(c) the conditions employed for the derivatisation step should not 
lead to racemisation of optically active amino acids;
(d) the protected compound should be easily purified;
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(e) the blocking group should be stable under conditions utilised 
in the coupling step; and
(f) the blocking group should be easily and selectively removable 
without leading to side reactions.
(a) Masking of the Amino Function
Several protecting groups for the masking of the amino 
functions of L-histidine have been reported in the literature. The
majority of  these reports have been concerned with selectively 
masking one of the nitrogens of the imidazole ring. There are two
reasons why this is desired:
(a) masking of the nitrogen in the 1-position has been shown to
suppress racemisation of L-histidine during peptide synthesis;47 
a n d
(b) protecting one of the nitrogen positions allows selective 
alkylation at the other position.
Several protecting groups are no longer considered  to 
provide suitable protection of L-histidine since they do not fulfil 
the criteria previously mentioned. The W(im)-benzyl50 protecting 
group, although stable to nucleophiles, requires drastic conditions 
in the deprotection  stage for its removal. The N (im )-p -  
to luenesu lphony l and N (im )-d in itrophenol derivatives are too 
susceptible to nucleophilic displacement to be o f  any synthetic 
use .51 Those protecting groups which have found practical 
application will now be discussed in greater detail.
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The Trityl Group
Trityl derivatives of L-histidine have been known for a long 
time.52 When reacted with the imidazole function o f  L-histidine, 
the trityl group locates in the less sterically hindered 3-position. 
Barlos et al.53 reported an efficient one pot synthesis of iV-trityl 
amino acids including L-histidine. Sieber and Riniker54 published 
a reassessment of the trityl group as a protecting group for L- 
histidine in peptide synthesis. The trityl group lowers the basicity 
o f  the imidazole ring and its bulk helps to prevent the base 
catalysed rearrangem ent which leads to racem isation. Trity l 
groups in the N(a)~ and Ar(im )-positions are both completely 
stable in neutral and alkaline conditions and towards nucleophiles. 
The iV(im)-trityl group can be cleaved by trifluoroacetic acid while 
the iV(a)-trityl group is much more susceptible to acidolysis and 
can be removed selectively. Due to the steric hindrance caused by 
the bulk of the trityl group, selective alkylation in the 1-position 
can prove to be difficult.
The Phenacyl Group
Fletcher et a / .51 introduced the phenacyl group as suitable 
protection of the imidazole side chain of L-histidine. When the 
phenacyl group was located in the 1-position no detectable  
racem isation  was observed under conditions w hich norm ally 
promote racemisation. The phenacyl group was introduced by 
reacting the silver salt of the N(a)-protected L-histidine derivative 
with phenacyl bromide. The major product was that with the 3- 
position protected. They went on to improve the method by 
protecting the 1-position selectively with the phenacyl group by 
first introducing a trityl group into the 3-position. The phenacyl
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group is stable in strongly acidic and basic conditions. It is 
cleaved by treating the protected compound with zinc in acetic 
acid, although the last traces o f  zinc are difficult to remove. 
Cleavage can also be achieved by photolysis or electrolysis but 
these methods are more complex. Side reactions of the phenacyl 
group in the presence of reactive  acylating agents have been 
o b se rv e d .
The t-Butoxym ethyl Group
Colombo and co-workers55 introduced the /-butoxym ethyl 
g roup  for the p ro tec tion  o f  ca rbobenzoxy  (CBZ), or 9- 
fiuoromethoxycarbonyl (Fmoc), derivatives of L-histidine. The t- 
butoxymethyl group is stable to hydrogenolysis and base but is 
cleaved under mildly acidic conditions. The reagent used to 
syn thesise  r-butoxym ethyl deriva tives  is J-butyl ch lorom ethyl 
ether, which is unstable. This is a fairly new protecting group and 
it has not yet been established whether it will achieve popularity.
The Carbobenzoxy (CBZ) Group
Bergmann and Zervas56 studied the carbobenzoxy group as a 
selectively removable blocking substituent. It has proved more 
versatile and more popular than any other in the preparation of 
synthetic peptides. The carbobenzoxy derivatives of amino acids 
are readily obtainable. They are usually obtained under Schotten- 
Baumann conditions, the general procedure for which has been 
described in Organic Syntheses,5  ^ In contrast to the racemisation 
sometimes observed with other acylating agents such as acetic 
anhydride or benzoic anhydride, the use of benzyl chloroformate 
induces no detectable racemisation when optically active amino
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acids such as L-histidine are em ployed .58 The pro tec ted  
derivatives are stable compounds usually obtained in excellent 
yield. The protecting group can be removed by a variety o f  
m ethods, includ ing  the fo llow ing: ca ta ly tic  hyd rogena tion ,56
aq u eo u s  h y d ro ch lo r ic  ac id ,59 boron  tr ib ro m id e ,60’61 l iqu id  
hydrogen  b rom ide ,67 and tr ie th y ls i lan e .65 The carbobenzoxy 
group protects the amino acid against unwanted acylation and 
against racemisation. The importance of its effect on suppressing 
racemisation will be discussed in Section 3.4.
The t-Butoxycarbonyl Group
Carpino64 introduced the r-butoxycarbonyl (r-BOC) group as 
a general amino protecting group. McKay and Albertson65 and 
Anderson and M cGregor66 applied it to peptide synthesis. The 
introduction of the f-BOC group is not as straightforward as that of 
the carbobenzoxy group, since f-butyl chloroformate is unstable. 
A num ber of reagents have been introduced over the years to 
fa c i l i ta te  the syn thesis  o f  th ese  der iva tives .  D i-r-buty l 
dicarbonate is the reagent most commonly used in the synthesis 
o f  L -h is t id ine  d e r iv a t iv e s .49’67 The c leavage  o f  the t- 
butoxycarbonyl group by acids proceeds through the formation of 
r-butyl ca tions, which are converted  into isobutene by the 
elimination of a proton.68 The other products are carbon dioxide 
and a salt o f  the free amino acid or peptide. Acidic conditions 
which have been used for the cleavage include trifluoroacetic 
acid,69 boron tribromide61 and hydrochloric acid.70 Since the t- 
butoxycarbonyl group is a urethane type of blocking substituent, 
it also possesses the ability to suppress racemisation.
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(b) Masking of the Carboxyl Function 
Salt Formation
The simplest form of protection for the carboxyl function of 
an amino acid is by salt formation.68 The salt can be formed with 
a strong base such as potassium or lithium hydroxide, or with 
carbonate or bicarbonate. Organic bases such as triethylamine or 
other tertiary amines can also be used. The choice o f  base 
depends of course on the reaction solvent which in turn depends 
on the solubility properties of the amino acid.
M ethyl Ester
It is fairly easy to prepare methyl esters of amino acids. In 
addition to the classical method of esterification whereby HC1 gas 
is introduced into a suspension of the amino acid in methanol,7* 
many variations on this have appeared in the literature. For 
example, the addition of the amino acid to a cold mixture of 
thionyl chloride and methanol72 or the treatment o f  amino acids 
with acetone dimethyl ketal and aqueous hydrochloric acid have 
been em ployed.73 Removal of methyl esters is not straight 
forward. The simplest and most common method is saponification 
with aqueous alkali in organic solvents such as methanol. Even at 
low temperatures and in the absence of excess alkali, racemisation 
is common. Several syntheses involving the methyl ester of L- 
histidine have been reported in the literature. The methods used 
for the deprotection  o f  L-histidine methyl es te r  derivatives 
include cleavage of the ester using 6m hydrochloric acid,74 as well 
as saponification of the ester with sodium hydroxide.49 In all 
instances the products are reported to have optical activity.
3 7
There has also been a report in the literature of the use of boron 
tribrom ide to cleave methyl esters with the preservation  o f  
optical activity.61
Benzyl Ester
The use of the benzyl ester as a carboxyl protecting group is 
attractive since it can be removed by reduction thus avoiding the 
problem s associated  with hydrolysis. The procedure for the
esterification of L-histidine with benzyl alchohol in the presence 
of /7-toluenesulphonic acid was first reported by Akaboro et a lJ$  
in 1958. They reacted L-histidine hydrochloride monohydrate 
with benzyl alcohol in the presence of p-toluenesulphonic acid
monohydrate. They obtained both the product and a hydrated 
form in a crystalline state in good yield. They reported that the
hydrated  form was easier  to handle since it was not so
hygroscopic .
In 1970 Felix and W inter76 reported an improved synthesis 
of  L-histidine benzyl ester. These workers found the method of 
Akaboro et al. consistently unsuccessful. Felix and Winter reacted 
A - f - b u t o x y c a r b o n y l - L - h i s t i d i n e  w i th  e t h e r e a l  p h e n y l -  
d iazom ethane  to y ie ld  A -r-bu toxycarbony l-L -h is tid ine  benzy l 
ester in excellent yield. L-Histidine benzyl ester dihydrochloride 
was isolated after treatment of the f-butoxycarbonyl derivative 
with acid. The dihydrochloride salt was also hygroscopic.
More recently, Jones and W ood77 disputed the findings of 
Felix and Winter with regard to their claims that the method of 
Akaboro et al. was consistently unsuccessful. Jones and Wood 
varied the procedure reported by Akaboro et al. only slightly by 
changing the solvent from benzene to chloroform. They used a
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Dean and Stark separator designed for use with solvents denser 
than water in place of the W ieland apparatus em ployed by 
Akaboro et al. They found that this procedure was simpler 
compared to the indirect method of synthesising the benzyl ester 
proposed by Felix and Winter. They managed to obtain the 
product satisfactorily and in good yield (93%). Removal of the 
benzyl ester can be achieved through reduction with hydrogen in 
the presence of a palladium catalyst.48
3.3.2 C o u p lin g  Between A m ino Acids: an O verview
Practically all of the techniques which have ever been used 
for constructing peptide bonds are of the type outlined in Scheme 
2. Many leaving groups, and the reactions for attaching them to 
the electrophilic carbon atom of the carboxyl component, have 
been investigated. Only a small number of these are regularly 
practised  since good yields o f  optically and chemically pure 
products are required as well as convenience and economy. The 
principal coupling methods will be discussed.
RCOOH RCONHR' + HX
R'-NH2
Scheme 2
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(a) The Use of Acyl Halides and Pseudohalides 
Acyl Chlorides
Perhaps the simplest approach to peptide synthesis is the 
activation o f  acylamino acids by conversion into the corresponding 
acyl chlorides followed by reaction with amino acids or amino acid 
esters under Schotten-Baumann conditions.47 Methods based on 
this principle did indeed play an important role in the early days 
of peptide synthesis. This type of method is however unsuitable 
for a number of reasons. Reagents which are used for the acyl 
ch loride  form ation  such as thionyl chloride and phosphorus 
p en tach lo r id e  are too vigorous to be used with sensitive  
substra tes. A lso, simple acylam ino acid chlorides cyclise  
spontaneously to give oxazolones and hence racemisation occurs 
as discussed in Section 3.4. Several amino blocking groups have 
been em ployed in conjunction with this method o f  peptide 
coupling. CBZ-protected amino acid chlorides are unstable,78 
although the chlorides of trifluoroacetyl-, phthaloyl- and tosyl
amino acids are reasonably stable.7^ Since more convenient and
efficient methods are available, the acid chloride method can be 
regarded as no longer useful for conventional peptide synthesis.
A cyl Azides
The use of acyl azides for peptide bond formation was first 
introduced by Curtius in 1902.80 With the introduction of more 
efficient methods o f  peptide bond formation in the 1950s, the use 
o f  A (a ) -p ro te c te d  am ino ac id  az ides  d e c l in e d  sharp ly .  
Nevertheless, it remains an important procedure. The hydrazides
from which the azides are generally made may be obtained by
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hydrazinolysis o f  a protected amino acid ester. In the early days, 
conversion into the azide was usually achieved by adding sodium 
nitrite to a solution of the hydrazide in a mixture o f  acetic and 
aqueous hydroch lo ric  acids at around 0 °C .81 Honzl and 
R u d in g e r8^ studied the influence of temperature, solvents, acidity, 
type of acid and the nitrosating agent on azide formation. On the 
basis of the ir  results, they defined a more refined  method 
involving dry acid and an organic nitrite ester in a dry organic 
solvent at a lower temperature. This method is now generally 
preferred. The azides are subsequently reacted with the amine 
com ponent w ithout delay. This approach is summarised in 
Scheme 3.
RC02R’
I*
RCONHNH2 - S -* .  RCON3 JX -*- RCONHR"
t*
RCONHNH-Prot
conditions: i, NH2NH2; ii, deprotection; iii, NaN02in aqueous
AcOH-HCl or an alkyl nitrite with dry H+; iv, R"NH2
Schem e 3
Num erous side reactions have been recogn ised  in the 
formation and the use of amino acid azides.83 As a result of this, 
the azide method has largely been replaced by cleaner procedures 
since 1950. The azide method remained popular for a number of 
reasons: it is reliable in assembling chains of up to sixty amino 
acids, only minimal side chain protection is required, and it is easy
41
to convert ester protected carboxyl functions into activated azides. 
The most important reason for its continuing popularity was that 
for years it appeared that racemisation during the coupling of acyl 
am ino acid azides never took place. It is now known that 
racemisation does take place with excess base in polar solvents. 
This tendency is greater when L-histidine with an unprotected 
imidazole function is the carboxyl component; with triethylamine 
in dimethyl formamide even r-butoxycarbonyl-L-histidine azide 
was racem ised.84
The azide method is more time consuming since the reaction 
is in three stages.47 Product yields are inferior to those obtained 
by other methods of peptide coupling.83 The rate of  acylation is 
also considerably slower than either the mixed anhydride method 
or dicylohexylcarbodiimide (DCC) mediated coupling.
(b) The Use of Anhydrides
S ym m etrica l A nhydrides
A cylam ino acid anhydrides can be p repared  from the 
corresponding acylamino acids by use of a number o f  reagents 
such as ethoxyacetylene and DCC.47 Aminolysis of a symmetrical 
anhydride proceeds without the formation of side products. This 
is an advantage over some mixed anhydride procedures but only 
half of the acylamino acid taken is incorporated into the product. 
The symmetrical anhydrides o f  f-butoxycarbonyl-, carbobenzoxy- 
and phthaloyl amino acids are generally reasonably stable, clean 
acylating agents.
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M ixed Anhydrides with Carboxylic Acids
There are two main problems with the use o f  a mixed 
anhydride o f  an N-acylamino acid with a carboxylic acid in 
peptide synthesis.47 First, the anhydride has two electrophilic 
sites and therefore two possible sites for reaction with the amine 
component; and second, mixed anhydrides with carboxylic acids 
tend to disproportionate (Schem e 4). The selectivity can be 
im p ro v ed  by in troduc ing  s te r ic  h ind rance  and in d u c t iv e  
depression o f  electrophilicity so as to direct the attack to the 
carboxyl component carbonyl. Mixed pivalic anhydrides are the 
only intermediates in this class to have attained any significant 
p o p u la r i ty .85
(RC0)20  + R mNH2 —^  R C 02H + RCONHR"
f
o  o
R-tt-O -t-R ' + R"N H 2 —^  RCONHR” + R'C02H + R’CONHR" + R C 02H
(R'C0)20  + R"NH2 —^  R 'C02H + R'CONHR"
S chem e 4
M ixed Anhydrides with Carbonic Acids
The most generally successful mixed anhydride m ethod
involves the reaction o f  the carboxyl component with an alkyl 
chloroform ate to produce the mixed anhydride.47 The mixed
anhydride is reacted with the amine component immediately as
outlined in Scheme 5.
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One o f  the carbonyl groups in the activated intermediate is 
flanked by two oxygens, hence its reactiv ity  is diminished. 
Nucleophilic attack is therefore directed toward the carbonyl of 
the original carboxyl component. Side reactions can be minimised 
by the carefu l control o f  the reaction tem perature  and the 
activation time. The value of this technique lies in its speed and 
econom y.
O 0 0
RCOOH + R’O^-Cl Rt-O-t-OR'
RCONHR" + R'OH + C02
conditions: i, 1 equiv tertiary base/unreactive dry solvent/-10 °C/
2 min; ii, R"NH2
Schem e 5
(c) The Activation of Carboxyl Groups by Addition Reactions
The nucleophilic addition of carboxylic acids to cumulated
double bond or triple bond systems gives adducts which are, in 
general, reactive  acylating agents because acyl-oxygen fission 
leads to a carbonyl compound.47 The main method which falls
into this class is the use of carbodiimides.
Dicyclohexylcarbodiimide (DCC) has been used in peptide 
synthesis since 195586 and is still the most important single 
reagent. This is especially true since the advent of solid phase 
synthesis, where it is used to the near exclusion of other coupling 
methods. The procedure involves the mixing o f  the amine and
carboxyl components with DCC in equimolar amounts. When O-
acylisourea formation takes place, the peptide is obtained either
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by direct am ino lysis  or via a symm etrical anhydride  with 
dicyclohexylurea as the by-product as shown in Scheme 6 47
The intermediates are highly reactive and side reactions are 
very common. Extensive racem isation is the outcom e with 
susceptible carboxyl components. Collapse of the O-acylisourea by 
in tram olecular acyl transfer (Scheme 7) is known to compete 
significantly with the desired reaction. This results in a much less 
reactive N-acylurea which reduces the yield and is difficult to 
re m o v e .47
Both of these problems have been reduced significantly with 
the introduction o f  additives such as N -hydroxysuccinim ide.87 
This nucleophile -suppresses N-acylurea formation and gives a 
procedure which is sufficiently free from racemisation.
HNR
HNR
RCONHR”
S ch em e 6
HNR HNRI
HNR
R -C -O -C o=c
R
Scheme 7
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Certain side chains can react with DCC in an undesirable 
m anner. U nprotected im idazo le  groups give A (im )-am idino  
d e r iv a t iv e s ,88 and so u n p ro te c te d  L -h is tid ine  is th e re fo re  
susceptible. This side reaction can be avoided either by protection 
of the imidazole function or negated by subsequent nucleophilic 
displacement of the amidino group.
In some cases the pep tides  form ed have so lub ilit ies
comparable to that of dicyclohexylurea. This will o f  course lead to 
problems with purification. The water soluble diimide reagent N- 
e thyl-A ^-dim ethylam inopropylcarbodiim ide can be used in the 
same way as DCC but has different solubility properties.89 It has 
not as yet been widely used; this may be due to the comparatively 
high cost o f  the reagent.
(d) The Use of Active Esters
Ester aminolysis has been used in peptide synthesis since 
the turn of the last century.90 Gordon et a l.91 revealed that 
aminolysis rates of esters are related to the electron withdrawing
properties of the acid or the alcoHo\ component of the ester. The
withdrawal of electrons enhances the electrophilic character of the 
carbonyl carbon. This facilitates the formation of the tetrahedral 
intermediate with the amine. More recently, Menger and Smith92 
revealed that in contrast to ester saponification, aminolysis of 
phenyl esters in organic solvents proceeds with rate limitation by 
the collapse of the tetrahedral adduct, not its formation (Scheme 
8). The leaving ability of the ester is therefore probably the most 
important consideration. A large number of active esters have 
been investigated.
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R
)OR”
I OK
ft RCONHR' + HOR"
R'NH2
R'NH2
Schem e 8
A num ber o f  methods have been developed to form the 
activated esters. The most common method for their preparation 
involves the use of condensing agents. An example of this is DCC 
m ediated coupling  between a p ro tec ted  acid and the active 
ester.93 The popular active esters are generally crystalline, stable 
compounds. This is advantageous since the reactive intermediates 
can be isolated and are stable on storage, ready for use. They are 
at a low level of activation and therefore the active esters react 
selectively with the amine component in coupling. Side reactions 
including racem isation are generally not a problem. There is 
however a serious danger of racemisation when most active esters 
‘are prepared if  the carboxyl component is susceptible, especially 
in the presence of base. Bodanszky and co-workers94 reported 
that the presence of L-histidine in the amine component can 
greatly enhance O-acylation. This side reaction is catalysed by the 
imidazole function in the side chain of L-histidine.
T he  in d iv id u a l i ty  o f  am in o  ac ids  m eans that no 
generalisation can be made as to the best active ester in peptide 
coupling. The esters are all reactive systems simply by being O- 
a c y l  d e r iv a t iv e s  o f  m o d e ra te ly  s tro n g  a c id s .  N - 
h y d ro x y su c c in im id e  esters are h ighly  reac tiv e ,  c rysta ll ine  
compounds.47 They can be prepared easily and the water soluble
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by-product makes purification easier. They react cleanly and 
rapidly to give an easily isolable product. /?-Nitrophenyl esters 
are popular since /7-nitrophenol is very cheap and the esters can 
generally be synthesised in high yield.47 The products are stable, 
crystalline compounds. /?-Nitrophenyl esters were the first to 
become commercially available. Pentachlorophenyl esters47 were 
developed since the chlorine groups are resistant to catalytic 
hydrogenation while nitro groups are not. These esters are 
c rysta lline  and easy to prepare but there are some steric 
problems due to the two substituents in the ortho positions. 
These difficulties can be overcome by using pentafluorophenyl 
esters or trichlorophenyl esters.
The major drawback of the active ester method is the 
comparatively slow rates of acylation. This becomes increasingly 
significant when steric factors impede acylation. The reaction rate 
can be significantly increased with the addition of catalysts into 
the system. Several workers studied the effect of the addition of 
weak acids and bases as catalysts .47 Konig and G e i g e r 9 5  
introduced 1-hydroxybenzotriazole to catalyse the reactions of p- 
nitrophenol esters and 2,4,5-trichlorophenyl esters.
(e) Reagents for Solid Phase Peptide Synthesis
Merrifield96 introduced the attachment of protected peptide 
intermediates to an insoluble polymeric support. The purpose of 
the Merrifield solid phase approach is to enable quantitative 
separation of the peptide under construction from all excess 
reagents and coproducts after each step by filtration. The peptide 
is totally insolubilised by attachment to a polym er but the
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reagents and coproducts are in solution. Some workers97’98 have
also investigated the possibility of binding the reagents to the 
polymer and hence on filtration at the end of the reaction the 
peptide is left alone in solution.
In most instances o f  solid phase peptide synthesis, the solid
supports are copolymers prepared from a mixture of styrene and
divinylbenzene.68 These cross-linked polymers are insoluble but 
swell to gels in solvents such as dichloromethane. The swelling is 
important since it allows the diffusion of the soluble reactants into 
the inside of the gel particles. The reactions, such as acylation and 
deprotection, can hence be carried out on amino acids and 
peptides attached to the polymer.
The linking of the first residue to the resin requires a 
reactive group on the polymer. Chloromethylation of the aromatic 
nuclei was the first, and still most used, solution to this problem 
(Scheme 9).
An A-protected amino acid is allowed to react with the 
chloromethylated resin in the presence of a base to form an ester 
bond thus attaching the carboxyl group to the polymer. The 
amino protecting group is removed and the amino function is 
available for coupling. Dicyclohexylcarbodiimide (DCC) is the 
reagent most commonly used in solid phase peptide coupling. The 
is represented in Scheme 10. After each operation the 
excess reagen ts  and by-products  are rem oved by repeated
Scheme 9
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washings, simply and efficiently. The final step to remove the 
com pleted chain from the polym er requires exposure to strong 
acids such as hydrobromic acid in trifluoroacetic acid.
The elimination of isolation, purification and characterisation 
o f  intermediates is probably necessary if  large peptides are to be 
constructed within a smaller time frame. There is however the 
risk  that complex mixtures will be produced when there is no 
purification between steps. Careful study of the purity of the final 
products is essential.
Conclusions
All o f  the coupling methods of enduring popularity give 
adequate results most of the time and they are chemically simple. 
Although the active ester in term ediates  can be isolated and 
stored, the slow rates of acylation make this method unattractive
for general use. This method is particularly unsuitable due to the
O-acylation induced by the imidazole function of L-histidine. The 
azide method of peptide coupling is not recommended due to the
many side reactions which can occur. The rate of acylation of the
azides is slower than that in mixed anhydride or DCC mediated
PG-NH-CHR-COOH +
| ^ase
Schem e 10
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couplings. The yields obtained by this method are also inferior to 
those obtained by other methods. The solid state method for 
peptide synthesis is really only advantageous for the construction 
of large peptide chains. Upon examination of these methods, it 
would appear that the DCC and mixed anhydride methods are the 
most effective and convenient for the synthesis of L-histidine- 
containing dipeptides. On application to this work however, the 
DCC method was not useful, since it was difficult to remove the 
dicyclohexylurea from the products at the end of the reactions. 
The water soluble carbodiimide mentioned in Section 3.3.2 (c) was 
applied successfully in some cases, as discussed in Section 4.3. 
However, due to its expense, it was impossible to use this reagent 
in all cases. The mixed anhydride method has proved to be a very 
effective peptide coupling method in the synthesis of the L- 
histidine dipeptides required in this work. This method will be 
discussed in more detail in the following section.
3.3.3 The Mixed Carbonic Anhydride Method of Peptide 
C ou pling
The formation of peptide bonds by the mixed carbonic 
anhydride m ethod was developed sim ultaneously in 1951 by
W ieland and B e rn h a rd ,"  B oissonnas100 and Vaughan.*01 The 
h is to rica l aspects of this m ethod have been discussed by
Greenstein and Winitz47 and by Bodanszky et al.6% Reviews on the 
chemistry of the mixed carbonic anhydrides method and their 
application to peptide synthesis have been compiled. 102,103
There  are several reasons  why the m ixed carbonic
anhydride m ethod is attractive in peptide syn thes is .104 In
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particular it is possible to achieve high reaction rates at low 
temperatures with this method. The reaction is simple to perform
and the purity of the products is high compared to other methods.
The mixed anhydride method is also by far the most economical 
process of peptide synthesis.
The major drawback of this method is the high tendency of 
mixed anhydrides to undergo racemisation, due to the strong 
activation of the carboxyl carbonyl. This has not been a great 
problem in this work since the carboxyl component has very 
rarely been an a-amino acid. In the few cases where the carboxyl 
component has been an optically active amino acid precautions 
were taken to preserve the optical purity. For example A^ot)- 
urethane protective groups are known to suppress racemisation.
Since the mixed anhydrides belong to the group o f  most 
highly activated acyl derivatives in peptide synthesis, they are 
prone to undergo a variety of rearrangements and decomposition 
reactions. Carefully controlled and defined conditions have been 
described in the literature to prevent or minimise these side 
re a c t io n s .105
The mixed anhydride method of peptide bond formation 
involves two separate stages. The first stage is the activation
stage and the second is the coupling stage. These stages will be
discussed in turn.
(a) Activation
The alkyl chloroformate is added to a cold solution of the 
carboxyl component anion in anhydrous organic solvent in the 
presence of a tertiary base (Scheme l l ) . 47 This process is
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sensitive to the nature of the solvent, the reagent, and is prone to 
base catalysed racemisation.105 The activation time is the period 
between the addition of the alkyl chloroformate and the addition 
of the amine component once the mixed anhydride formation is 
co m p le te .
Anhydride formation must be carried out in a manner such 
that the alkyl chloroformate is completely reacted since any 
excess would attack the amine component. This reaction would 
lead to irreversible urethane formation and hence lower yields. 
Fast reaction ensures side reac tions  such as decom position, 
racem isation and disproportionation are minimised.
Activation is influenced by the nature of the reagent, the
tertiary amine, the side chain o f  the carboxyl component, the 
temperature and the reaction time.
Isobutyl chloroformate is the best reagent for the formation 
of mixed anhydrides.104’105 The branched alkyl group increases 
the electron density at the ad jacent carbonyl in the mixed 
anhydride. This therefore reduces attack by the nucleophile and 
the carbonyl o f  the carboxyl function becomes the predominant
point of attack. Better yields are hence obtained compared to the
use of ethyl chloroformate as the reagent.
ZNH-CHR [HN(alkyl)3f
+ [HN(alkyl)3]+Cf+
alkyl-
O
Scheme 11
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Evaluation o f  the effects of many bases led Anderson and 
his co-workers105 to the conclusion that the tertiary amine is not 
only a hydrogen chloride acceptor, but that it reacts with the 
chloroformate, for exam ple isobutyl chloroformate, to form an 
a lky loxycarbonylam m onium  ion complex (9). This com plex 
subsequently reacts with the carboxylate. Evidence supporting 
this mechanism was the low yields obtained when a sterically 
hindered base such as ethyl diisopropylamine was used. This was 
in contrast to the high yields obtained when triethylamine was 
the base.
alkyl
0  L
R O C —  N — a l k y l  C l '
I
alkyl
(9)
A n d e r s o n  a n d  c o - w o r k e r s 105 r e c o m m e n d e d  N -  
methylmorpholine as the tertiary base. It is a weak base and 
hence has little effect on promoting racem isation; it is not 
sterically hindered; and it is sufficiently strong for rapid reaction. 
In situations where racemisation is not an issue, triethylamine is 
as good a choice.
Strictly anhydrous solvents of high purity are essential for 
successful m ixed anhydride formation. Solvents have been 
reported to affect reac tions  of some sim ple unsym m etrical 
anhydrides. Their influence in peptide synthesis has not been 
thoroughly studied. Ethyl acetate, tetrahydrofuran,105 toluene, 10<5 
r-butanol107 and a c e t o n i t r i l e 10  ^ are recommended as the solvents 
which will optimise overall yields. The use of chloroform and
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d ic h lo ro m e th a n e  re su l ts  in im p u re  p ro d u c ts  and  lo w e r
y ie ld s .105’106 When more polar solvents are required for the 
solvation of the carboxyl com ponent, d im ethylacetam ide gives 
better  yields than A,A-dim ethylform am ide.105
An activation time of 1-2 min at -15 °C is recommended for 
mixed anhydride formation. At lower temperatures yields are 
considerab ly  lower and at tem peratures  h igher than 0 °C
disproportionation of the mixed anhydride can o c c u r . ° 9  The 
synthesis  o f  the m ixed anhydride  is very exotherm ic  and
adequate heat dissipation is essential. Temperature control within
the reaction vessel must be strictly controlled by stirring and by 
controlling the rate of addition o f  the alkyl chloroformate.
(b) Coupling
The mixed carbonic anhydrides are not usually isolated but 
are reacted immediately in situ  with the amine component. The 
reaction proceeds quickly to form the peptide bond with carbon 
dioxide and a volatile alchohol as the by-products (Scheme 12).47
As the second stage is not very sensitive to the nature of the 
solvent, the coupling reaction may be carried out in either 
aqueous media or in organic solvents. In an aqueous environment
R'NH-CHR-
R'NHCHR-C
Scheme 12
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the yields of the coupled product are lower than those obtained in 
organic solvent, probably due to competing hydrolysis of the 
a n h y d r id e .104
If base is required to neutralise hydrogen halides of amine 
components, it should be mixed with the amine component shortly 
before coupling is to take p lace.105 Care must be taken to ensure 
there  is no excess of base present as this will p rom ote  
racemisation of the product.
The temperature of the reaction is generally maintained at 
-10 °C for up to an hour. The mixture is then allowed to warm to 
room temperature until the reaction is complete.
(c) Side Reactions
U nder the  com m only  used lo w - te m p e ra tu re  reac t io n  
conditions in the mixed anhydride method, only two side reactions 
have given concern in peptide synthesis. Attack of the amine 
component at the carbonyl of the alkyl formate part of the mixed 
anhydride (Scheme 13) leads to the formation of a urethane side 
product.47 This urethane can also arise from reaction of any 
excess chloroformate from incomplete anhydride formation with 
the amine component.
R'NH-CHR-
alkyl-O-fc-NHR" + R'NHCHRC02H
O
HoNR”
Scheme 13
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It was not proven until 1969*09 that the side product was 
derived from the mixed anhydride. More recently, Bodanszky and 
T o l le 110 studied the urethane side product formation in detail. 
The branched alkyl group of isobutyl chloroformate increases the 
electron density at the adjacent carbonyl of the mixed anhydride. 
Since this diminishes attack by the nucleophile at this centre it
will also diminish the tendency toward urethane formation more 
effectively than ethyl chloroformate. It was found that the only
other real influence on the formation of the urethane side product 
was the steric bulk in the carboxyl component. The mixed
anhydride method is therefore not a suitable peptide coupling
m ethod  for the coup ling  of s te rica lly  h indered  carboxyl 
c o m p o n e n ts .110
The other principal side reaction is the formation of 5(4H)- 
oxazolones.47 The mixed carbonic anhydrides belong to the most 
highly activated acylating species in peptide synthesis. Strong 
electron withdrawal from the carbonyl carbon creates a high risk 
of racemisation at the chiral centre of  the carboxyl component. 
One of the m echanisms of racem isation in peptide  synthesis 
proceeds via the 5(4H)-oxazolone formation (10) (cf. Section 3.4).
R
fio)
This side reaction  is therefore  o f  g reat im portance . 
Vaughan's s tud ies106 showed that the extent of racemisation in
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mixed anhydride coupling can be influenced by the nature of the 
solvent, the reagent, the activation time and the temperature. The 
extent of this side reaction can therefore be controlled by taking 
these factors into control.
(d) Conclusions
The mixed carbonic anhydride method is attractive for 
several reasons; it combines rapid reaction at low tem perature 
with frequently very high coupling yields. The by-products are 
volatile which greatly improves purification of the product. Side 
reactions are few and their extent is often negligible. It is 
undoubtedly the most economic method of peptide synthesis.
3.4 Racemisation in Peptide Synthesis
The single most important side reaction in peptide synthesis 
and a-am ino acid derivatisation is racemisation. It has been 
shown to occur during all methods of peptide coupling when the 
necessary precautions are not taken. The subject has therefore 
been extensively reviewed by several a u t h o r s . 47 ,68 ,111
L-Histidine is a vulnerable amino acid since it bears an 
aromatic ring in the (3-position. This serves to stabilise enolate 
formation to some extent. It is important therefore to understand 
the racemisation processes which can take place before embarking 
on any syntheses involving L-histidine.
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(a) Racemisation of Free Amino Acids
Racemisation o f  a-am ino acids is dependent upon enolate 
formation. Enolate formation results from the attack of base or 
acid on the a-amino acid species.
In aqueous solution racemisation has been known to occur 
over the full pH range. There are four processes by which 
racemisation can take place in an aqueous environment: At very
low pH racemisation will proceed via protonation of the conjugate 
acid (11).
H H
+NH3-C-C0oH + H+ +NH3-C-C02H + HO'i i
R R
( 11) (12)
H
NHo-C-COo + HO'J | -
R
(13)
H
NHo-C-C02"
R
+ HO'
(14)
Near neutrality, hydroxide ions from the water can react with the 
amino acid conjugate acid (12). At higher pH the hydroxide ions 
will react with the zwitterion of the amino acid, leading to 
racemisation (13). Finally at a very high pH the mechanism 
probably involves hydroxide-catalysed enolisation of the amino 
acid conjugate base (14). These processes are not equally viable. 
For example at very high pH, it will be difficult to extract the a- 
proton from the amino acid species since it already possesses a 
negative charge.
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Several s tudies have been  made on the  ex ten t o f  
racemisation of a number of amino acids at various pH values and 
conclusions have been drawn from the results. Under aqueous 
conditions, inductive and resonance stabilisation of the developing 
enolate anion at the a-carbon of an a-amino acid has a major 
effect on racemisation. Thus at neutral pH, acceleration o f  
racem isa tion  was observed  w ith a-am ino acids bearing  an 
electron withdrawing substituent in the side chain. A large 
increase in the rate of racemisation was observed in all the cases 
studied when the temperature of the solution was increased.112
M anning113 studied both the tritium a-exchange and the 
racemisation of amino acids in 6m  hydrochloric acid at 110 °C. He 
established that for normal am ino acids the rates are equal. 
B ada112 observed that 6m  hydrochloric acid caused relatively little 
change in rate as compared to that observed at pH 7.
Racemisation has long been noted as being a rapid process in 
aqueous alkaline so lu tion .114 This is particu larly  true for 
v u ln e ra b le  am ino acids b ea r in g  an e lec tron  w ith d raw in g  
substituent in the (3-position.
A special case has been observed when vulnerable amino 
acids are dissolved in glacial acetic acid. Matsuo et al. 113 studied 
the effects on some amino acids heated in acetic acid. They 
observed that the rate of racemisation was significantly slowed by 
dilution of the acetic acid with water. Addition of sodium acetate 
to acetic  acid was found to increase greatly  the rate  o f  
racemisation of A-acetylphenylglycine. These workers therefore 
proposed that the racem isation o f  amino acids in acetic acid 
solution results when an acetate ion encounters a carboxylic acid
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bearing an a-ammonium ion. The acetate ion behaves as a basic 
ca ta ly s t.
In organic  solutions, a -am ino  acids are vulnerable  to 
racem isa tion  in the presence of bases; in particular tertiary 
amines. This creates a problem when the amino acids are present 
as hydrohalide salts which must be neutralised before a reaction 
involving the amino function can take place. The amount of base 
added must be strictly controlled; in the presence of excess base 
the a-am ino acid is prone to racemisation. Several s t u d i e s 1 *6,117  
have been made on the effects of a number of tertiary amines on 
the racem isation of amino acids. T riethylam ine is the worst 
offender in causing racemisation. N-Methylmorpholine is the base 
which most workers have recommended in peptide synthesis.
(b) Racemisation of Amino Acid Derivatives
Two different mechanisms have been proposed to explain 
the loss of optical purity in reactions involving N-acylamino acids 
and peptides:
(a) the formation of oxazolinone intermediates. These are known 
to racemise easily, and
(b) the direct proton abstraction from the asymmetric a-carbon 
a tom .
The formation of oxazolinones was suggested by Bergmann 
and Zervas as early as 1928118 to explain the racemisation 
observed during the acetylation o f  amino acids. The 5(4H)- 
oxazo lone  m ediated racem isation  m echanism  (Scheme 14)^8 
involves a rate determining cyclisation that is base catalysed. The
61
5(4H)-oxazolone is then proposed to racemise via a resonance 
stabilised tautomer.
W hen X is an e lec tro n eg a tiv e  group or atom , the 
enhancement in the electrophilic character of the carbonyl carbon 
of the carboxyl function will facilitate the attack by the carbonyl 
oxygen of the acyl substituent. This is a problem in peptide 
synthesis  since the ac tiva ted  in term ediates  in the coupling 
reactions have this situation. The resulting cyclic intermediate is 
stabilised by the elimination of HX.
Scheme 14
R  „ R-HX /  \  base
HNv  O —*■ N„. OY
R R
-H+
v r  v r  y °
R R R
The oxazolinones thus formed have a strong tendency, in the 
presence of base, to lose a proton and acquire the resonance 
structures as shown. If R is an electronegative group, such as a 
phenyl group, the probability of ring closure is enhanced, since 
this group will increase the delocalisation of the anion (Scheme
14).
Since the report by Bergmann and Zervas,H8 much evidence 
has been reported  to support the existence of oxazolinone
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intermediates. In fact, some w o r k e r s 1 *9 have managed to isolate 
them and they can be detected in reaction mixtures by their 
characteristic IR absorption at 1832 cm-1.
Factors which have been found to influence the racemisation 
of oxazolinones include the nucleophilicity to basicity ratio of  the 
amino-component in a peptide coupling reaction mixture. A large 
ratio favours the opening of the oxazolinone ring as opposed to 
abstraction of the a-proton. Solvents, such as dioxan, which 
enhance the separation of charges favour racemisation. It has 
been found that A-acylamino acid oxazolinones racemise faster 
than peptide oxazolinones. This suggests that steric hindrance of 
the amino-component has an effect.68
Until recently, it was generally assumed that urethane- 
protected amino acids and peptides do not produce azlactones. 
I so la tio n 120 of optically pure 5(4H)-oxazolones contradicts this 
assumption. It is now believed that the beneficial effects o f  
urethane type protecting groups rests on the electron re lease  
provided by them. Due to this electron release, the anion which 
would be formed by proton abstraction is destabilised (Scheme
15).
101 101
I I
R' R'
Scheme 15
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Considerable experimental evidence indicates an alternative 
mechanism of racemisation. Even though urethane-type protected 
amino acids show no tendency to racemise through oxazolinone 
intermediates, some CBZ-amino acid esters undergo base catalysed 
racem isa tio n . r -B u toxycarbony l-A (im )-benzy l-L -h is tid ine  was 
found to racem ise appreciably when activated by the DCC 
m ethod.121 A mechanism of proton abstraction from the a-carbon 
atom was advanced by Neuberger,122 who suggested that in mixed 
anhydrides, hydrogen bonding with one of the acyl oxygens would 
weaken the C-H bond. This favours ionisation.
fc) Racemisation of L-Histidine
It has been recognised that acyl imidazoles formed from 
peptide acids undergo unusually easy racem isation .1^ 4 It has 
since been clear that the presence of a free imidazole function in a 
peptide coupling reaction increases the risk of racemisation.11  ^ In 
acylation with activated derivatives of L-histidine significant 
racemisation can take place.121 This has been explained by base 
catalysed enolisation (15), or by cyclisation and enolisation
( 1 6 ) .111
N H -
(15) (16)
Support for these mechanisms is seen in substituents such 
as the /7-toluenesulfonyl group, which lower the basicity of the
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im id a z o le  n u c le u s  an d  a lso  re d u c e  the  e x te n t  o f
racemisation. 123>124 Complete protection against loss o f  optical 
purity  in L-histidine derivatives is only expected when the 1- 
nitrogen is protected.
(dl Conclusions
It has become evident that the extent of racem isation is
determ ined by a series of  factors. Until the discovery o f  a
com pletely  racem isation-free coupling method, conservation o f
chiral integrity requires optimisation in the choice of protecting
groups, reagents and solvents to name only a few of the factors to
be considered.
3.5 Determination of Optical Purity
(a) Assays for Optical Purity
There are five principal assays for measuring the extent of 
racemisation of amino acids and their derivatives. The Anderson 
tes t125 is based on the measurement of the specific rotation of the 
crude racemic product when glycine ethyl ester is coupled to N- 
p ro tected  glycylphenylalanine. The racemate is iso lated  on 
fractional crystallisation and its weight is determined to measure 
the extent of racemisation. This test has a sensitivity limit of 1- 
2%. The Young tests 126,127,128 involve the coupling of glycine 
ethyl ester to an A-protected a-amino acid. They depend on the
measurement of the specific rotation of the amide product and
have the same sensitivity limits as the Anderson test. K em pl2^
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described how, in both cases, the sensitivity limit can be bettered 
on the application of a multiple isotope dilution procedure. He 
used 14C-labelled carboxy components.
Weygand and his associates117 developed a number of tests 
b a s e d  on gas c h ro m a to g ra p h ic  (G LC ) s e p a ra t io n s  o f  
diastereoisomers. The carboxyl component was converted into its 
A -trif luoroacety l derivative and the carboxyl function o f  the 
am ino com ponent was converted  into an ester. The two 
c o m p o n e n ts  w ere  co u p led  to g e th e r  and  the  r e su l t in g  
diastereoisomeric mixture was assayed by GLC. There also exists 
a p rocedure whereby A -trifluoroacetyl amino acid esters are 
separated as enantiomers on a chiral c o l u m n . 1^
The Izumiya test131 employs the ion exchange resin of an 
am ino acid analyser to effec t separation o f  d iastereom eric  
peptides after coupling and deprotection. The sensitivity limit o f  
this test is 0.1-1%.
These are the well known general tests. There also exists a 
large num ber o f  assays which have been used in particular 
instances. A list of these can be found in the book of Gross and 
Meienhoffer.47 One important recent development is the use of 
high perform ance liquid chromatography (HPLC) techniques to 
determine the optical purity of amino acid derivatives.47
(b) The Use of Chiral Lanthanide Shift Reagents
N uclear m agnetic resonance (NMR) spectroscopy is a 
valuable technique for the study of molecular structures. The use 
of NMR spectroscopy is sometimes restricted due to insufficient 
sensit iv ity  o f  proton chem ical sh ifts  to changes in the
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stereochem ica l environm ent. Lanthan ide  sh ift  reagents are 
effective in reducing this equivalence of nuclei.13^ There are two
mechanisms that can lead to enantiomeric resolution in the NMR
spectra o f  racem ic substrates in the presence o f  chiral shift
reagents. The first is a difference in the equilibrium constant for 
associa tion  betw een  the enantiom ers and the shift reagent. 
Second ly , the  geom etry  of the com plexes  be tw een  each
enantiomer and the shift reagent may be different.
Chiral lanthanide shift reagents were separately introduced 
by W hitesides133 an(j Goering134 and have been widely used to 
distinguish enantiomers in proton NMR spectra. The majority of 
work involving chiral shift reagents has been perform ed in 
organic solvents and very few chiral shift reagents are known that 
can be used in water.
P e t e r s 135 u se d  la n th a n id e  d e r iv a t iv e s  o f  ( S )- 
[(carboxymethyl)oxy] succinic acid (CMOS) to separate the *H NMR 
spectroscopic signals of the enantiomeric nuclei of amino acids and 
hydroxycarboxylic acids. This ligand has however been shown not 
to be a good choice due to the self association tendency observed 
with lanthanide-CM O S complexes. Kabuto and S asak i136’137 
observed a highly consistent correlation between the absolute 
configuration o f  a-amino acids and the shift o f  their a-proton 
s ignals  in d u ced  by the ch ira l la n th an id e  sh if t reagen t,  
europium(III) propane-1,2-diam inetetra-acetate. They examined 
twenty two substrates of wide variety, including histidine. In all
cases the a -p ro ton  signals due to the L-enantiomers always
showed larger upfield shifts than those due to the D-isomers in 
the presence of the (/?)-form of the chiral shift reagent. In the
case of histidine, however, the signal broadened and it was
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difficult to assign the configuration accurately. M ore recently, 
K ido  and O k a m o to 132 rep o rted  (S ,S)-ethylenediam ine-A f,iV - 
disuccinic acid (EDDS) as a water soluble chiral shift reagent. They 
showed it to be a useful chiral shift reagent for aqueous work, as 
long as the solution pH was maintained between 9 and 11. Their 
study was however limited to four amino acids and it has not 
therefore been established if  it is widely applicable.
(c) The Use of Cvclodextrins
A cyclodextrin  has a central cavity into which organic 
molecules can enter to form inclusion complexes. 138 The nature of 
this association has been studied by various techniques, including 
solution state NMR spectroscopy. Cyclodextrins  are chiral 
molecules. If a molecule containing a chiral centre is placed into a 
cyclodextrin cavity then diastereomeric pairs may be produced.
These would probably have different NMR spectra.
There  are three cyc lodex tr in s  used in ch ira l NMR
spectroscopic w o r k . * 38 The most common cyclodextrin reported is
(3-cyclodextrin ((3CD) probably due to economic considerations. 
(3CD has a torus shape formed by seven amylose units. It has a 
central width of about seven angstroms. a-Cyclodextrin is one 
sugar moiety smaller than |3-cyclodextrin while y-cyclodextrin is 
one sugar moiety larger than (3-cyclodextrin. Different effects will 
be found with the different cyclodextrins due to the variation in 
the cavity size and hence different in teractions with added 
compounds. For optical purity measurements the most effective
reagent should be found by experimentation.
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Casy and M ercer139 reported the application of cyclodextrins 
to analysis of optical purity by proton NMR spectroscopy. They 
drew the conclusions that the use of cyclodextrins has several 
advantages over methods involving derivatisation with optically 
active reagents or the application of chiral shift reagents, namely:
(a) the material is water (and D2O) soluble and so can be used 
with water soluble chiral molecules;
(b) cyclodextrins have no broadening effects on proton resonances 
while the effects of lanthanide chiral shift reagents are sometimes 
obscured due to the param agnetic relaxation effects associated  
with them; and
(c) the proton NMR chemical shift range of cyclodextrins is 
n a r ro w .
(d) Enzymatic Methods
Enzymic procedures of resolution, when successful, y ield 
isom ers w hose absolute configurations are known from the 
procedure itself. This is one advantage over chemical procedures. 
A nother advantage is that once the specificity of an enzyme 
toward amino acids of known absolute configuration has been 
established, its action towards amino acids of unknown absolute 
configuration can, with some accuracy, be predicted.
Many enzymes have been used to resolve racemic amino 
acids.48 Few of  these are suitable for amino acid or peptide 
derivatives. For example amino acid decarboxylase requires both 
the amino- and the carboxyl- function to be unsubstitu ted . 
Another drawback with this method is that with L-amino acid 
decarboxylase, the chirality of the L-isomer is lost in the
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formation of the corresponding amine compound. D av is14^  has 
reported on the action of proteolytic enzymes on some peptides 
and derivatives containing histidine.
Renal acylases have been used to resolve 7V-acylated a-  
amino acids. It is therefore conceivable that if the reaction could 
be followed and the products quantified then this could be a 
method for determining the optical purity of iV-acyl derivatives of 
am ino acids. Chenault et a l. 141 reported the enantioselective
hydrolysis of A-acyl amino acids catalysed by Acylase I. These 
workers found that Acylase I was specific for the position and 
chemical nature of the amide bond in substrates. They found that 
Acylase I was specific to a-amino acids although it did accept a 
range of substituted acetyl and propionyl derivatives. Chenault et 
a l  found that one disadvantage was the incomplete hydrolysis of 
the L-enantiomer.
(e) Conclusions
Many methods are available for the determination of the 
optical purities of amino acid and peptide derivatives. O f the
methods discussed, no particular method appears to be completely 
general for the range of compounds to be synthesised in the
course of this project.
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CHAPTER 4
Synthesis of A-Acylated L-Histidine Derivatives
It has been discovered (Chapter 1) that derivatives of L- 
histidine (1) appear to have an important role in the healthy 
functioning of heart muscle. Many of the L-histidine derivatives 
requ ired  for testing  by the physio log ists  a re  com m ercially  
unavailable. It was necessary to synthesise those L-histidine 
derivatives thought to be present in heart muscle, in order to 
confirm  the ir  p resence  and to enable the physio logists  to 
determine the effects of individual compounds on cardiac muscle.
4.1 Direct A-Acylation Reactions
The first target compounds were optically active A-acetyl 
derivatives of L-histidine and dipeptides containing L-histidine 
shown in F igure 14. Although A-propionyl derivatives of L- 
histidine and the dipeptides are not thought to be present in 
cardiac muscle in nature, it was decided to synthesise these 
derivatives as simple analogues (Figure 14). L-Histidine (1) and 
L-carnosine (2) are both commercially available . The first 
acylation reactions carried out were then the direct acylations of 
these compounds using either acetic or propionic anhydride.
n R
(17) 1 Me
(18) 2 Me
(19) 3 Me
(20) 1 Et
(21) 2 Et
(22) 3 Et
N +
HN- NHCCKCHoJnNHCOR
Figure 14
71
In 1928 Bergmann and Zervas published a method for the
direct acylation of L-histidine (1) which led to an optically active 
product.118 They used one equivalent of acetic anhydride as the 
acylating agent and glacial acetic acid as the solvent (Scheme 16). 
All attempts to copy the procedure of these workers failed to give 
A-acetyl-L-histidine (23) with as high an optical activity as they
had obtained. Bergm ann and Zervas118 heated their reaction 
mixture over a boiling water bath. In an effort to obtain material 
with a higher optical purity, the reaction was carried out at
various temperatures ranging from 0 °C to heating at the same 
temperature that these workers had reported. Each time, the 
optical activity was less than that reported, ranging from zero to
half that of the reported value.
Ac^O/AcOH
co;
Y"o
+NH,HN-
""H
or AcoO/HoO HN j  NHCOCH;
Scheme 16 (23)
Several groups have reported that vulnerable amino acids 
racemise unusually easily when heated in glacial acetic acid. 
Matsuo et al. 115 made a study of the racemisation of amino acids 
in glacial acetic acid (Section 3.4). They concluded that the acetate 
ion acts as a basic catalyst when it encounters a carboxylic acid 
bearing an a-ammonium ion.
On the basis of the observations of Matsuo et a / . ,115 it was 
decided to attempt the acylation of L-histidine (1) and L-carnosine 
(2) using water as the solvent at room temperature. This method 
was successful and the ALacetyl- and A-propionyl- derivatives of
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L-histidine (23,24) and L-carnosine (18,21) were obtained in 
yields typically in excess of  80%. More importantly, the optical 
purities  o f  the compounds were greatly increased. The only 
optical rotation available for comparison was that for A-acetyl-L- 
histidine (23). The value for the synthesised compound was 
+39.5° (c, 0.9 in H2O) compared to the reported value of +44.7° (c, 
1.0 in H2O) . 118
4.2 Peptide Coupling Reactions
The next stage in the work was to obtain the A-acylated 
dipeptide derivatives. The general idea was to couple iV-acyl 
form s o f  g lyc ine , (3-alanine, L-alanine, D-alanine and 4- 
aminobutyric acid to L-histidine to form the acylated dipeptides. 
Coupling of the A-acyl-(3-alanine compounds to L-histidine (1) 
would of course yield the L-carnosine derivatives (18) and (21) 
synthesised by the direct acylation reactions discussed in Section 
4.1. Generating the same compounds in optically active form by 
two routes should test the integrity of each route.
(3-Alanine and 4-am inobutyric  acid were acylated with 
acetic anhydride or propionic anhydride in either glacial acetic or 
propionic acid. The yields of products obtained were always in
excess of 70%. Only A-propionyl-(3-alanine could not be obtained 
in crystalline form. Glycine was acy la ted  according to the method 
described by Herbst and Shemin.142 It was obtained in 88% yield 
and had an identical melting point (207-208 °C) to the reported 
value .142 N-Propionylglycine was obtained in 83% yield by the
reaction of propionic anhydride and glycine in water. L- And D- 
alanine were both acylated with acetic anhydride in water to yield
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5 8 % ,  iV-acetyl-L-alanine and 53% N-acetyl-D-alanine respectively. 
Af-acetyl-L-alanine was isolated with m.p. 123-125 °C and [oc]d20 - 
58° (c, 1.3 in water), compared to the literature values143 of m.p. 
125 °C and [oc]d20 -66.2° (c, 1.0 in water). N-acetyl-D-alanine was 
obtained with m.p. 124-126 °C and [a ]o 2^ +56.6° (c, 1.4 in water), 
compared to the reported values143 of m.p. 125 °C and [a ]o 20 
+66.2° (c, 1.0 in water).
In order to obtain the N-acylated dipeptide derivatives in 
pure form, the first aim was to protect the carboxyl group of L- 
histidine to prevent it from interfering in the peptide coupling 
stage. When considering the options available, the alkyl esters 
and p a r t icu la r ly  the readily  av a ilab le  m ethyl ester, w ere 
considered to be unsuitable. There were three reasons why this 
was so.
(a) The methyl ester is available as the dihydrochloride salt. This 
salt is insoluble in suitable organic solvents commonly employed 
in peptide coupling reactions.
(b) Strong bases are required to liberate the free base form. This 
could cause problems of racemisation of the L-histidine residue if  
the amounts of base added were not strictly controlled.
(c) The methods commonly employed for the removal of methyl 
esters, such as base hydrolysis, promote racemisation.
The choice of ester was then for one which could be
synthesised easily. It should be stable to the conditions employed
in peptide synthesis and it should be removed cleanly without 
promoting racemisation. The synthesis of the benzyl ester of L-
h is t id in e  has been  repo rted  by severa l groups in the
literature,75’76’77 and was discussed in more detail in Section 3.3.1
(b).
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In theory, the benzyl ester o f  L-histidine fulfilled all the 
criteria required of an effective protecting group for the carboxyl 
function o f  L-histidine. In practice however, a num ber o f  
complications occurred. On following the procedure set out by 
Jones and W ood,77 the yields and the chemical as well as the 
optical purities of L-histidine benzyl ester di-/?-toluenesulphonate
(25) obtained differed greatly on each application. Even when the 
conditions were strictly controlled for a number of preparations, 
the yield of the product (25) varied from 45% to 70%. Yields could 
be improved to a maximum of around 80% by filling the Dean and 
Stark apparatus with silica gel and anhydrous sodium carbonate. 
The water was thus removed from the reaction vessel more 
efficiently. The yields were still variable but at least they were 
higher. Since the optical rotation value for L-histidine benzyl 
ester di-p-toluenesulphonate (25) is low, [a]D20 -4.13° (c, 0.94 in 
H 20), it was difficult to determine the optical purities of the 
products obtained in the course of this work.
Satisfied that the reaction could not be im proved further, 
the next stage was to couple the N-acylated second amino acid to 
the benzyl ester of L-histidine (Scheme 17). Two peptide coupling 
methods were investigated, namely the dicyclohexylcarbodiimide 
(DCC) method and the mixed anhydride method. The DCC method 
was soon abandoned since the product could not be isolated from 
the dicyclohexylurea by-product. The mixed anhydride method 
was then explored.
The mixed anhydride was formed on reaction of the N- 
acylated amino acid with ethyl chloroformate. Triethylamine was 
the base and dry dichloromethane was the solvent.
BzOH/pTSA
------------------ p .
RCONHCCH^COjH ^
iBuOCOCl
O O
RCONHCCHj^COCOiBu
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2 equiv. NEt3
C02CH2Ph
.2p-TSA
<yV
------U N H i
COXH^Ph
H
CO(CH2)nNHCOR
(26)
n R
(17) 1 Me
(18) 2 Me
(19) 3 Me
(20) 1 Et
(21) 2 Et
(22) 3 Et
FL/Pd
NHCO(CH2)nNHCOR
Scheme 17
The free base was obtained from L-histidine benzyl ester di- 
/7 -to luenesulphonate  (25) on addition o f  two equ ivalen ts  o f  
triethylamine to a solution of the salt in dichloromethane. In the 
first instance, both the solutions were filtered before mixing. The 
yields of the coupled products were frequently low, but better 
y ields were obtained when the solutions were mixed w ithout 
previously  filtering them. Yields were also im proved when 
isobutyl chloroformate was used in place of ethyl chloroformate to 
form the mixed anhydride. This is due to the better capability of
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the isobutyl chloroformate to promote nucleophilic attack at the 
carbonyl group of the A-acylated amino acid.
The yields of the protected dipeptide products (26) were 
frequently in the range of 60 to 70%. All of the products (26) 
were highly coloured oils and accurate rotation values could not 
therefore be measured. A mixed anhydride was also form ed 
between propionic anhydride and ethyl chloroformate. This was 
reacted with the benzyl ester of L-histidine to yield A-propionyl- 
L-histidine benzyl ester which could be isolated as a solid and was 
optically active with [oc]d20 -17° (c, 0.32 in ethanol).
The final stage involved the removal of the benzyl esters to 
yield the A-acyldipeptides (17)-(22) and A-propionyl-L-histidine 
(24). This was the chief reason that the benzyl ester was chosen 
to protect the carboxyl group of L-histidine: it should be easily 
removed on reduction with hydrogen in the presence of a catalyst, 
thus avoiding harsh conditions which could promote racemisation. 
Hydrogen was maintained over a solution containing each benzyl 
ester in ethanol in the presence of 10% Pd/C and the reaction was 
left overnight. Frequently very little product was obtained and 
the residual material had the benzyl ester intact. It appeared that 
the hydrogenolysis  was inefficient. It was possible that the 
catalyst was being poisoned by the presence of basic nitrogen 
atoms in the compounds. To alleviate this, a couple of drops of 
dilute hydrochloric acid were added to each reaction. Again the 
reactions were allowed to run overnight. On examination of the 
proton NMR spectra of the mixtures at the end of this time, the 
imidazole protons in the aromatic region of each spectrum were 
absent and on integration, more aliphatic protons were present 
than there should have been. This indicated that the imidazole
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ring in each L-histidine derivative was being reduced, which was 
quite surprising. The next step was to monitor the uptake o f  
hydrogen, and the results were plotted graphically as a function o f  
the change in volume vs time. A typical graph for the reduction 
o f  A-acetyl-L-homocarnosine benzyl ester (26; n=3, R=Me) is 
shown in Figure 15.
F igure  15 Typical graph for the removal of the benzyl ester of L- 
histidine derivative (26; n=3, R=Me) by catalytic reduction.
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At the beginning when hydrogen is first passed into the 
reaction vessel, the active sites on the catalyst are saturated. The 
curve then rises steeply indicating the uptake of hydrogen as the 
cleavage of the benzyl ester takes place. The curve then levels 
out when the reaction at the benzyl ester is complete. If the 
compound (26; n=3, R=Me) is left in the presence of hydrogen for 
longer then the curve rises steeply once more, this is when the 
imidazole ring becomes reduced. In general the reduction of the 
benzyl ester in (26; n=3, R=Me) was complete within two hours.
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These conditions were then used to prepare compounds (17)-(22) 
and (24).
In all cases the N -acyl dipeptide derivatives (17)-(22) and
iV-propionylhistidine (24) could  only be iso la ted  as h ighly  
coloured oils and again it could not be determined w hether they 
possessed any optical activity. Attempts were made to remove
the yellow colour by treating these compounds in ethanol with
activated charcoal. These attempts were unsuccessful and the 
intense yellow colour prevailed in each case.
When taking into account the difficulties encountered in the 
first and the final steps of this route in particular, it was decided 
that it was not suitable as a general route to chemically and 
optically active products.
In 1964 Rinderknecht et al. published a synthesis of L- 
carnosine (2) and its methylated derivatives as optically active
compounds.144 The interesting feature in this paper was that they 
protected the acid function of L-histidine as a metal salt. It was 
decided to follow an adaptation of their procedure to set up a new 
general route to the A-acylated dipeptides (17)-(22) (Scheme 18).
Aqueous lithium hydroxide was the first alkali solution to be 
used. The same mixed anhydride method of peptide coupling was 
used since it had been successful in the previous route and 
Rinderknecht et al. 144 had used a similar procedure in their work 
with no apparent problems. There was little concern  about 
racemisation occurring when the carboxyl group was protected as 
the alkali metal salt since it should be difficult to abstract a 
further proton from the a-position.
o o
RCONHCCHj^COCOiBu
\r
N C 02l i +{ j f Y 'h
HN 'J NHCO( CH2) nNHCOR
HC1
'■r
H
z  N+ y \  C 02 
HN NHCO(CH2)nNHCOR
Scheme 18
Various concentrations of the alkali solution were tried and 
the best turned out to be 0.33 M lithium hydroxide in terms of 
yield. The initial pH of the L-histidine solution was varied 
between 9 and 10. The optimum pH was found to be around 9.6. 
At lower pH not all of the acid was protected as the metal salt and 
this led to lower yields of desired product. At higher pH the extra 
base could interfere with the mixed anhydride before it reacted 
with the protected L-histidine and again the result was a lower 
y ie ld .
At the end of the reaction the solution was acidified and the 
product was isolated. In general it was a much simpler reaction to
RC0NH(CH2\1C02H ^
+  -
iBuOCOCl
n R
(17) 1 Me
(18) 2 Me
(19) 3 Me
(20) 1 Et
(21) 2 Et
(22) 3 Et
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carry out than the route involving the benzyl ester (Scheme 17). 
It was difficult however to isolate the product at the end of the 
reaction. The by-product, lithium chloride, is hygroscopic which 
caused some handling difficulties. The lithium chloride also has 
similar solubility properties to some of the A-acyldipeptides. For 
these reasons the base used was changed to potassium hydroxide 
with some success. No general method could be found to isolate 
the A-acyldipeptides as crystalline solids. A different method was 
required for each product. Samples of each product were burned 
to check that no metal salts remained. In addition to this crude 
method, the compounds were each applied to a column and 
analysed by reverse phase HPLC. In all cases only one peak was 
p resen t ind icating  the compounds (17)-(22) were free from 
co n tam in a tio n .
The yields of the isolated products (17)-(22) were higher
than 50% in all cases. These yields were good considering the 
mixed anhydride coupling stage was carried out in an aqueous
environment. The yields were also tolerable since the method
was essentially a one step procedure.
All of the L-histidine derivatives (17)-(22) synthesised had 
certain similarities in the different types of spectra recorded. In 
the proton NMR spectra, all of the compounds exhibited two 
singlets in the aromatic region, each integrating as one proton.
These signals were due to the two imidazole protons. The signal 
in the lower field position (H-2) was sometimes seen to be a 
doublet. The coupling constant was very small, and the splitting 
was due to cross-ring coupling between the two aromatic protons. 
The other imidazole proton (H-4) was never seen as a doublet but 
broadening was observed.40 The other common feature in the
81
proton NMR spectra of these compounds was the appearance o f  an 
ABX system. This system was due to coupling between the 
protons shown in Figure 16.
It was not possible to obtain accurate analytical data for 
these compounds (17)-(22). This was due to the different number 
of moles o f  water present in the crystalline solids. Even after 
e x ten s iv e  dry ing  o f  the com pounds, analy tical data  w ere 
u n re l ia b le .
In the mass spectra of  these A/-acylated derivatives (17)-
(22), the parent ion peak was present in every case. The peak 
which all the derivatives showed in their spectra had m /z  81. 
This peak corresponded to the ion (27).
The derivatives (17)-(22) showed many similarities in the 
infra red spectra. All of the IR spectra showed a sharp peak in 
the region 3300-3500 c m '1 which corresponded to an N-H stretch. 
A group of signals typical of a carboxylic acid could be seen in the 
region 2900-3200 cm-1. Amide stretches were present in the 
reg ion  1600-1640 c m 1, w hile  signals co rrespond ing  to a 
carboxylate anion were observed in the region 1540-1600 cm*1.
Figure 16
H
(27)
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A synthesis o f  W-acetylglycyl-L-histidine (17) has been 
reported in the literature. Bryce et al. *45 coupled Af-acetylglycine 
to Af(im)-benzyl-L-histidine benzyl ester using the active ester 
method of peptide coupling. They isolated the product after 
removal of the benzyl group and the benzyl ester upon treatment 
with hydrogen in the presence of a catalyst. The product Bryce et 
al. isolated was a hygroscopic solid. Although they claim to have 
synthesised iV-acetylglycyl-L-histidine (17), Bryce et <z/. 145 did not 
report an optical rotation value for their product. Indeed the only 
evidence they offered was an R f value. The product obtained in 
the course of this work was a crystalline solid and it was in no 
way hygroscopic. It was obtained in 72% yield and had [ o i ] d 2 0  
+31.1° (c, 1.1 in H2O). The proton NMR spectrum of (17) showed a 
singlet at 5 2.10 which on integration corresponded to the 3 
protons of the acetyl group. The singlet at 5 3.93 integrated as 2 
protons. This signal was due to the two protons of the CH2 group 
o f  the glycyl residue. An accurate mass measurement of this 
compound (17) was made. A value of 254.1021 was obtained 
while (17) required a mass of 254.1015.
N-Propionylglycyl-L-histid ine (20) was obtained in 64% 
yield with [o c ]d 2 0  +22.8° (c, 0.94 in H2O). The propionyl group was 
shown on the proton NMR spectrum of (20) as a triplet at 5 1.17 
and a quartet at 5 2.37. A singlet for the two protons of the glycyl 
residue showed at 5 3.93. The mass spectrum showed peaks 
corresponding to the parent ion as well as the loss o f  the amino 
side chain. Accurate mass m easurem ents gave a mass of 
268.1172 which is the exact mass W-propionylglycyl-L-histidine 
(20) required.
8 3
W-Acetyl-L-carnosine (18) was synthesised both by direct 
acylation of L-camosine (2) and by coupling A-acetyl-(3-alanine to 
L-histidine (1). By the direct acylation procedure the product was 
obtained in 80% yield with [< x ]d 2 0  +14.4° (c, 1.0 in H 2O). This 
compares to a yield of 59% and [ c x ]d 2 0  +20.1° (c, 1.14 in H2O) for 
the product obtained by the mixed anhydride method. Although 
the mixed anhydride route gave a lower yield of product, it was 
considered to be superior since the optical activity of the product 
was higher than that obtained by the direct acylation route. In all 
other respects the products obtained from the two routes were 
identical. A study of the proton and 13C NMR spectra o f  
underivatised carnosine (2) has been reported in the l i t e r a t u r e .  146 
This study allowed the unambiguous assignment of proton and 13C 
resonance signals using a variety of NMR spectroscopic techniques. 
These involved a 13C NMR titration. Measurements of three bond 
iH-iH and 13C-*H spin-spin coupling constants, and of the 13C NMR 
chemical shifts for carnosine in the solid state were made. The 
information obtained can be used to aid the assignment of the 
resonances observed for derivatives of carnosine such as those 
obtained in this work. Figure 17 shows A-acetyl-L-carnosine (18) 
and Table 1 assigns the proton and I3C NMR chemical shifts 
recorded for this compound. A synthesis of A-acetyl-L-carnosine 
has been reported  but an optical rotation value has not been 
q u o te d .147
Figure 17
Table 1 NMR spectral data for A-acetyl-L-camosine (18),
Position l^C shifts (ppm) lH shifts (ppm)
2 133.2 8.58
4 116.7 7.24
5 129.8 -
6 27.3 2.99-3.28
7 54.0 4.46-4.52
8 176.4 -
2’ 174.1 -
3' 35.1 2.44
4’ 35.9 3.35
6’ 173.4 -
7 21.6 1.91
A-Propionyl-L-camosine (21) was also synthesised in two 
ways. The direct acylation of L-carnosine (2) with propionic 
anhydride afforded a 71% yield of product (21) with [a]j)20 +14.6° 
(c, 1.2 in H2O). The method involving the mixed anhydride 
coupling of N-propionyl-p-alanine to L-histidine (1) gave a 53% 
yield of product (21) with [oc]d20 +15.5° (c, 1.2 in H2O). Again the 
m ixed anhydride route produced the superior p roduct with
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respect to optical purity, although the difference was not great. 
No reference to this compound could be found in the literature. 
The proton NMR spectrum of (21) showed the propionyl group to 
be present with a triplet at 5 1.12 and a quartet at 5 2.25. Again 
the methylene groups of the p-alanine residue could be assigned. 
The mass spectrum showed the parent ion as well as the loss of 
the amino side chain. Accurate mass measurement gave a mass of 
282 .1326  w hile N -propionyl-L-carnosine required a value o f  
2 8 2 .1 3 2 8 .
N-Acetyl-4-aminobutyric acid was coupled to L-histidine (1) 
using the mixed anhydride procedure to produce A-acetyl-L- 
hom ocarnosine (19) in 61% yield. The product was optically 
active with [oc]d20 +14.7° (c, 0.8 in H2O). The proton NMR spectrum 
of (19) was similar to that for A-acetyl-L-carnosine (18) with an 
extra multiplet at the lowfield position of 5 1.77. This is due to the 
protons which are coupled to two other methylene groups i.e. 
CFDCFDCH?. This residue was seen in the 13C NMR spectrum at 5 
29.4, 5 34.9 and 5 40.6. An accurate mass measurement gave a 
mass of 282.1332 while N-acetyl-L-homocamosine (19) requires a 
mass measurement of 282.1328. A-Acetyl-L-homocarnosine (19) 
was crystallised from ethanol. One of the crystals was subjected 
to X-ray diffraction by Dr. A. A. Freer.148 The structure obtained
is shown in Figure 18. From the structure it is possible to see that
the compound (19) is present as the zwitterion with the ring 
pro tonated . Figure 19 shows the crystal packing of this
compound. It is interesting to see the bending present in the side
chain and how well this bent structure packs in the crystal. No 
reference to the synthesis or the crystal structure of A-acetyl-L- 
homocamosine (19) has been found in the literature.
Figure 18
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X-ray structure of N-acetyl-L-homocamosine (19)
co;
' / H
NHCO(CH2)3NHCOCH3
(19)
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Figure 19 Crystal packing of N-acetyl-L-homocamosine (19)
jV-Propionyl-L-homocarnosine (22) was obtained in 61% 
yield when iV-propionyl-4-aminobutyric acid was coupled to L- 
histidine. The product had [a]D20 +10.3° (c, 1.3 in H2O). There 
were some problems associated with the isolation of this product
8 8
as it is hygroscopic. Attempts were made to isolate it as a hydrate 
by trying to crystallise it from a mixture containing water since it 
was thought that a hydrated form of the product would not be so 
hygroscopic. Many solvent mixtures were tried but the product 
could only be isolated as an oil when any water was present. A 
hygroscopic solid was obtained from an isopropanol solution on 
addition of acetone. Once more no reference to this compound 
could be found in the literature. The proton and NMR spectra 
o f  (22) were similar to those obtained for the A-acetyl derivative 
(19). The propionyl function was shown as a triplet at 5 0.89 and 
a quartet at 5 2.02 in the proton NMR spectrum. An accurate mass 
measurement was made. The value obtained was 296.1479; N- 
propionyl-L-homocarnosine (22) required a value of 296.1484.
So far the dipeptide derivatives (17)-(22) have been of a 
series in which only the length of the alkyl chain of the second 
amino acid has been varied. None of the second amino acids have 
possessed any chirality. If an optically pure amino acid derivative 
is coupled to L-histidine then any racemisation which occurs in 
the peptide coupling process should be detectable by examination 
o f  the l3C NMR spectrum of  the dipeptide derivative since 
diastereoisomers would be formed.
Both N -acety l-L -a lan ine  and N -acety l-D -a lan in e  w ere  
coupled to L-histidine (1). There was a fear that the N-acylalanyl 
residue would be racemised in the activation stage o f  the mixed  
anhydride coupling procedure. This could provide misleading  
information regarding the optical integrity o f the coupling step. 
Ar-Acetyl-L-alanyl-L-histidine (28) was obtained in 59% yield with 
[o c ] d 2 0  -32.8° (c, 0.9 in 6 m HC1). A-Acetyl-D-alanyl-L-histidine (29) 
was obtained in 58% yield with [o c ] d 2 ^ -42.1° (c, 0.8 in 6m HC1).
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Both the proton and NMR spectra of (28) and (29) showed only 
one diastereoisomer was present in each case (Figure 20). These 
results were encouraging and suggested that the coupling method 
was not inducing racemisation at the chiral centre of L-histidine.
Conclusions
The route involving the carboxyl group protected as a metal 
salt shown in Scheme 18 had a number of advantages over the 
route involving the benzyl ester of L-histidine (Scheme 17):
(a) simplicity of the reaction scheme;
(b) consistent yields; and
(c) formation of crystalline, optically active products.
H
NHCOCH
O
(28) R!=H, R2=Me
(29) Rl=Me, R2=H
9 0
Figure 20 Proton and 13C NMR spectra of (A) N-acetyl-L-alanyl- 
L-histidine (28) and (B) N-acetyl-D-alanyl-L-histidine (29).
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4.3 Determ ination of the Optical Purity of the Compounds 
S y n t h e s i s e d
All o f  the target compounds (17)-(22), (24), (28) and (29) 
were synthesised as discussed in Section 4.2. They all possessed 
optical activity, but it was impossible in most cases to determine 
the optical purity o f  the products. The most s traightforw ard 
method would be to compare the optical rotation values o f  the 
synthesised  com pounds to reported values; how ever, since N- 
acetyl-L-histidine (23) was the only product to have any optical 
rotation data reported in the literature,11** it was necessary to try 
o ther means.
A m ethod was required which would use only small 
amounts o f  the compound under investigation. It would need to 
be generally applicable and sensitive to small amounts o f  any D- 
isomer present. A number of methods for determining the optical 
purity o f  the L-histidine derivatives were investigated. Partially 
ra ce m ic  m ix tu res  m ade from A -a c e ty l-D L -h is t id in e  and  
commercially available A-acetyl-L-histidine (23) were used as the 
control compounds to test the effectiveness o f  each method.
The first method tried was the use o f  cyclodextrins as 
resolving agents. Dr. D. S. Rycroft tried both a- and p-cyclodextrin 
with a racemic mixture of TV-acetylhistidine. On looking at the 
proton NMR spectra of the mixtures in D2O, some broadening of 
the signals was observed, but no useful effect on the signals due 
to the histidine derivative was seen. These results indicated that 
this method would not be useful in determining the optical purity 
of  the compounds synthesised in this project.
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N-acetyl-DL-histidine was converted into the isopropyl ester 
by Dr. D. J. Cole and the resulting racemate was applied to a 
colum n and analysed by gas chrom atography. On a normal 
column one peak showed as was expected. When the racem ate 
was applied to a chiral valine column, it was found that it was not 
v o la t i le  enough . This m eant tha t  the racem ate  re q u ire d  
temperatures far in excess of those which could be used with the 
chiral column. This technique was not therefore useful.
A num ber of chiral lanthanide shift reagents have been 
reported  to be useful in resolving some of the signals in the
proton NMR spectra of racemic amino acids. The chiral lanthanide 
sh if t  reag en t ,  eu rop ium (III)  p r o p a n e - 1,2 -d ia m in e te tra -a c e ta te ,  
was synthesised.136’137 It has been reported that for DL-histidine 
itse lf ,  b road en in g  o f  the signals  occurred , as opposed  to 
separation. This was indeed found to be the case. W hen the 
chiral lanthanide shift reagent was tried in the presence o f  N- 
acetyl-DL-histidine, no effect on the NMR spectrum  was
observed. It appears therefore that the shift reagent requires a 
free a-am ino function as well as the free carboxyl function for
coordination. It was hoped that it would coordinate to the
imidazole ring but this did not appear to happen.
Acylases are known to cleave the amide bonds of A-acyl-L- 
amino acids while leaving A-acyl-D-amino acids intact [Section 
3.5(d)]. Racemic A-acetylhistidine was incubated in D2O at 28° at 
pD 8 for 24 hours with Hog Kidney Acylase I (EC 3.5.1.14). The 
reaction was monitored by proton NM R spectroscopy. As the
reaction progressed the signal corresponding to the acetyl group 
o f  A-acetyl-L-histidine disappeared w hile  at the same time a 
signal with a different chemical shift appeared corresponding to
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the formation o f  acetate as a by-product o f  the enzym atic  
cleavage. The signal corresponding to the acetyl group o f  acetyl- 
D-histidine remained unchanged. The amounts o f  L- and D- 
isomers present could be quantified by integration o f  the two  
different acyl signals at the end o f  the reaction.
A control experim ent was run at pD 8 with A-acetyl-L- 
histidine (23) with no enzyme present. This experiment was to 
check that the amide bond was not being hydrolysed at this pD. 
No change in the proton NMR spectrum of the N-acetyl-L-histidine 
was observed after 24 hours, indicating that any c leavage  
occurring in the reactions with enzyme present was purely due to 
the action of the enzyme. Acylase I was added into this reaction 
mixture to determ ine w hether the basic conditions had caused 
racem isa tion . The p ro ton  NM R spectra show ed tha t the 
experimental conditions did not induce racemisation since the acyl 
peak had completely disappeared. This meant that only A-acetyl- 
L-histidine (23) had been present.
A num ber of experim ents were run using a variety  o f
mixtures of D- and L- A -acetylhistid ine with vary ing  optical 
purities. A selection of the results obtained is shown in Figure 21 
to illustrate how useful this method is for determining the optical 
purities of these acetylhistidine mixtures.
This method should also be applicable for the A-propionyl- 
L-histidine (24), TV-acetyl-L-alanyl-L-histidine (28) and A-acetyl-
D-alanyl-L-histidine (29) synthesised in this project since all three 
compounds have a terminal a-acylamino acid. These compounds
should then be substrates for Acylase I. The experiments with 
the A-acylalanyl residues present should then g ive  an indication
o f  the extent o f  racemisation taking place in the mixed anhydride
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Figure 21 lH NMR spectra of N-acetylhistidine mixtures o f  
different optical purity after treatment with Acylase I. A. Initial 
[oc]d20 0°. B. Initial [a]D20 +39.5°.
i i  /
A
V V
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activation stage. They will not, however, provide any information 
on racemisation at the L-histidine residue on coupling.
The reactions were carried out under identical conditions to 
those used with the A-acetylhistidine mixtures. For A^-propionyl-
L-histidine (24) it was expected that the peaks due to the N- 
p rop iony l group of the L-isom er w ould d isappear w ith  the 
simultaneous appearance of peaks due to propionate. Any peaks 
due to the D-isomer would remain unchanged. No difference in
the proton NMR spectra before and after treatment with Acylase I 
was observed. In the case of A-acetyl-L-alanyl-L-histidine (28), it 
was expected that the signal due to the A-acetyl group w ould  
d isap p ear  com pletely  in the p ro ton  NMR spectrum  i f  the 
compound was optically pure. Any of the peak due to the N- 
acetyl group remaining would then be due to some N-acetyl-D- 
alanyl residue present. Again no change in the proton NMR 
spectra  was observed. It w ould  be  reasonable  to assum e 
there fo re  that neither A -prop iony l-L -h is tid ine  nor N -acetyl-L- 
alanyl-L-histidine were substrates for the enzyme.
For TV-acetyl-D-alanyl-L-histidine (29), it was initially hoped 
that any N-acetyl-L-alanyl residue present would be hydrolysed 
by the enzym e leaving the peak due to the iV-acetyl-D-alanyl 
residue unchanged. If  the derivative was optically pure at the 
alanyl residue, then no change in the proton NMR spectra would 
be expected after treatment with Acylase I. No difference in the 
proton NMR spectra was observed. This is not surprising since N- 
acetyl-L-alanyl-L-histidine (28) did not appear to be a substrate 
for the enzyme.
The length of time, the am ount of enzyme used, the 
temperature of the reaction and the pH were varied in an attempt
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to find cond itions  under w hich these com pounds w ould  be 
substrates for the enzyme. The results were always negative. A 
fresh batch of enzyme was also used but again no changes in the 
NMR spectra were observed.
This method was not universally applicable since it only 
works with A-acylated a-am ino acid derivatives and even some of 
those have been shown not to be substrates for Acylase I. When 
the enzyme was applied to solutions containing N-acyl derivatives 
o f  glycyl-L-histidine, L-carnosine or L-homocarnosine (17)-(22), 
no reaction was observed. The enzymes lipase and peptidase 
were also challenged with these L-histidine dipeptide derivatives 
but neither enzyme cleaved the peptide or the amide bond.
Racemic A-acetylhistidine was mixed with brucine to form a 
mixture of the two diastereoisomers. This mixture was examined 
using proton NMR spectroscopy but no differences in the signals 
due to N-acetylhistidine were observed. The mixture was also 
applied to a reverse phase HPLC column in an attempt to separate 
the d iastereoisom ers. A lthough broadening o f  the peak  was 
observed upon varying the conditions of elution, a separation into 
two peaks was not achieved.
( /? )-a -M ethy lbenzy lam ine  was coupled to the carboxy l 
function o f  the L-histidine derivative using the w ater soluble 
carbodiim ide, ALethyl-Ap-dim ethylam inopropylcarbodiim ide. The 
diastereoisomers obtained were analysed on reverse phase HPLC. 
The results obtained for A-acetylhistidine are shown in Figure 22. 
It can be clearly seen when any of the D-isomer is present. 
Although the signals are not completely resolved, it is still 
possible to estimate the ratio of isomers using the area under each 
peak. When applied to other L-histidine derivatives, the same
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type of separation was observed. The results obtained are listed 
in Table 2. There appears to be a direct correlation between the 
optical purities of the compounds and the ease with which they 
were obtained as crystalline solids. For example, A-acetylglycyl- 
L-histidine (17) appears to have full optical purity compared to N- 
p ropionyl-L-carnosine (21) which was much m ore difficult to 
crystallise. The values quoted are approximate but at least give 
an indication of the optical purities of  the compounds synthesised.
Table  2 Results from optical purity measurements by HPLC.
Derivative [a]D20 % L-isomer
A-Acetyl-DL-histid ine (23) 0° 50
A -A cetyl-L -histid ine (23) +24.3° 80
A -A cetyl-L -histid ine  (23) +46.0° 100
A-Propionyl-L-histid ine (24) +29.9« 75
A -A cety lg lycy l-L -h istid ine  (17) +31.1° 100
A -P ro p io n y lg ly cy l-L -h is t id in e  
(20) +2 2 . 8 0 82
A -A cetyl-L-carnosine (18) +20.10 71
A-Propionyl-L-carnosine (21) + 15.50 58
A -A cetyl-L -hom ocarnosine (19) + 14.70 77
A -P ro p io n y l-L -h o m o ca rn o sin e  
(22)  .......... „  _ + 10.3° 69
N-Acetyl-L-alanyl-L-histid ine (28) and A-acetyl-D-alanyl-L-  
histid ine  (29) w ere run on the same H PLC system . A 
chromatograph was obtained for each compound as well as a
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mixture of the two compounds. Only one peak was present for 
each diastereoisomer. The peak due to (28) had retention time 
2.18 while the peak due to (29) had retention time 2.05. These 
results suggest that (28) and (29) have good optical purity.
F ig u re  22 HPLC traces of the products of the coupling of (R )-a - 
m ethy lbenzy lam ine  with //-ace ty lh is t id in e  m ixtures o f  vary ing  
optical purity
Initial [o c ]d 2 0  +46.0° Initial [ c c ] d 2 0  +24.3° Initial [< x ]d 2 0  0° 
Conclusions
Many methods have been used to try to determ ine the 
optical purity of the derivatives synthesised during the course of 
this work. The most useful method has been to convert the //-acyl
tno
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derivatives (17)-(24) into diastereoisomers and to separate these 
using HPLC. It should have been possible to develop this method 
to find conditions which would allow the complete separation of 
the diastereoisomers had time allowed. It is clearly the most
promising method for determining the optical purities of  the types 
of compounds synthesised during the course of this work.
4.4 Test R esu lts  F o r  T he  C o m p o u n d s  S y n th es ised
The L -h is t id ine  d e r iv a tiv es  (17)-(24) , (28) and (29),
synthesised during this work were tested by Dr. D.J. Miller and his 
co-workers in the Physiology Department at Glasgow University. 
The methods employed were discussed in Section 2.5. The L- 
histidine derivatives were required for three purposes:
1. to determine whether each individual compound was present in 
cardiac muscle and if  so in what concentrations,
2. to test the derivatives as calcium sensitisers o f  the contractile 
apparatus of the heart, and
3. To determ ine the effect of these L-histidine com pounds on 
maximum calcium activated force.
4.4.1 D e te rm in a t io n  of the  P resen ce  of E a c h  D er iv a t iv e  in 
C a rd ia c  M uscle  by H PL C  Analysis
Two d is t in c t  HPLC m ethods were dev e lo p ed  by the 
physio log is ts  at G lasgow  U n iv e rs i ty 18’149 to ana lyse  cardiac 
muscle-derived L-histidine derivatives, some o f  which were N- 
acylated and novel. The first method (reverse-phase HPLC) relies 
on the elution from a non polar stationary phase (octadecyl-silica)
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with a polar mobile phase (aqueous phosphate buffer at low pH) 
o f  a num ber of closely related L-histidine derivatives. These 
compounds differ slightly in a number of respects, for example; 
aliphatic chain length, methylation or not of the imidazole ring, 
and Af-acylation or not of the terminal amino function. This 
method relies upon the separation of the compounds due to their 
ind iv idual hydrophobicities.
The second method (reverse -phase /ion-pair  HPLC) re lies  
upon the interaction of a hydrophobic surfactant anion (1-heptane 
sulphonic acid) with a solute cation (the pH dependent protonated 
terminal am ino group) to form an ion-pair which then absorbs 
onto the non-polar stationary phase. This ion-pair may be eluted 
from the column in a temperature dependent manner. JV-Acetyl 
derivatives are incapable of ion pair formation with a terminal 
amino group and it has been found that their retention times are 
independent o f  the concentration of the hydrophobic surfactant 
an ion .
These two independent HPLC methods were used to examine 
extracts from cardiac muscle. The A-acyldipeptides (17)-(24), 
(28) and (29), synthesised during the course of this work were 
used as reference compounds to identify the peaks present in 
each trace. Identification was based on elution time relative to 
s tandards, co-e lu tion  with reference com pounds, and fraction 
collection and re-analysis with the alternative method.
The biological extracts showed identical properties to a 
number o f  reference compounds on each chromatographic system. 
Figure 23 shows the results of this work using method 1, while 
F igure  24 shows the results obtained when method 2 was 
employed. From the two figures it is possible to see that N-
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a ce ty lca rn o s in e  (18) and N -ace ty lhom ocarnosine  (19) can be 
identified  as constituents o f  cardiac muscle. N -A cetylhistid ine
(23) can be seen as a constituent using method 1 but it cannot be 
separated from the peak due to N -acety l-l-m ethylh istid ine using 
method 2. Method 2 allowed the separation of cam osine (2), 3- 
m ethylcarnosine (4) and homocarnosine. This separation was not 
possible with method 1. The two methods, therefore, complement 
each other. Further work will reveal whether any of the other 
derivatives synthesised in this w ork are present in the heart. 
W ork is continuing to isolate enough of each histidine derivative 
present in cardiac muscle in order to confirm its identity by NMR 
sp ec tro sco p y .
HPLC chrom atographs o f  hum an serum ex trac ts  from 
d ifferen t regions of the body were run. This a llow ed  the 
identification of histidine derivatives (a) in the serum from the 
aorta, the start of the arterial blood supply, which carries blood 
from the left ventricle of the heart ultimately to all o f  the body 
tissues; (b) in the serum from the veins which carry blood from 
the heart muscle; and (c) in the serum in the large vein which 
carries blood from the upper half o f  the body and the head to the 
r ig h t  a trium  o f  the heart. F igure  25 shows the th ree  
chrom atographs obtained and indicates the different distribution 
o f  these histidine derivatives in these regions. It also indicates 
the different concentrations at which these compounds occur in 
these regions. As yet a large number of the peaks in these traces 
remain unidentified. Work is continuing to identify these peaks, 
particularly those present in large concentrations.
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Figure 23 HPLC chromatographs obtained by Method 1. (A).
Extracted perfusate from Langendorff rabbit heart. (B). Authentic
reference compounds. Abbreviations are listed on page V„
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Figure 24 HPLC chromatographs obtained with Method 2. (A).
Extracted perfusate as in Figure 23. (B). Authentic reference
compounds. Abbreviations are listed on page V.
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Figure 25 HPLC chromatographs of human serum extracts. (A.)
Aortic serum. (B). Coronary sinus serum. (C). Superior vena cava
serum. Abbreviations are listed on page V.
lOmins
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4.4.2 Results  From C alc ium -Sensit is ing  and Peak  
Force Experiments
The L -h is tid ine  d e r iv a tiv es  (17 )-(24 ) ,  (28) and (29),
synthesised during the course of this work were tested for their 
effects on the calcium sensitivity of cardiac muscle. They were 
also tested for their effects on maximum calcium-activated force. 
The procedures used were discussed in Section 2.5.
The A -p ro p io n y l  d e r iv a t iv e s  (2 0 )- (2 2 )  and (24) a ll
d e p re s se d  the  fo rce  im m e d ia te ly  (w ith in  seconds)  upon
application to the Ca-activated preparation. Thereafter, no further 
tension responses could be obtained. No reason has been found to 
explain these observations.
iV -acetyl-L -histidine (23), A -acety l-L -alanyl-L -h istid ine (28) 
and N -acetyl-D -alanyl-L -h istid ine (29) had very little  e ffect on 
either the calcium  sensitivity or the peak force measurements. At 
low  levels o f  activation (<30% o f maximum Ca-activated force), 
these com pounds promoted force consistently, but only by a small 
amount. At higher levels o f  activation no effect was observed. 
T hese com pounds did not increase the m axim um C a-activated  
force.
The results for the remaining three compounds are listed in 
Table 3. The results obtained for carnosine and homocarnosine 
are included for comparison. The results collected at pCa 5.52 are
those which indicate the effectiveness of the derivative as a Ca-
sensitiser. The results obtained at pCa 4.0 indicate whether or not 
the derivatives increase the maximum Ca-activated force (these 
are the peak force measurements). From the table it can be seen 
that both N-acetylglycyl-L-histidine (17) and N-acetyl-L-carnosine
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(18) have a fairly potent C a-sensitis ing  effect. A -A cetyl-L- 
hom ocam osine (19) does have an effect on Ca-sensitivity but to a 
m uch lesse r  degree. jV-Acetylglycyl-L-histidine (17) and  N- 
acetyl-L-hom ocarnosine have a com parable effect on increasing  
the m axim um  Ca-activated force while Af-acetyl-L-camosine (18) 
causes only a small increase in the maximum Ca-activated force.
T a b le  3 Enhancem ent o f  tension  production  by L -h is tid ine  
d e r iv a t iv e s .
mean ±s.e.m. (n preparations)
pCa 5.52 pCa 5.22 pCa 4.0
Steady-state tension 24.8 64.7 100.0
(normalised, % of Cmax) ±7.8 (8) ±6.4 (8) (def)
Mean tension increase
(% of control force)
Control
com pound(lO m M )
79.6 
±8.6 (6)
28.0 
±4.2 (6)
14.6 
±0.8 (6)
Homocamosine
14.0
±2.6(4)
2.9
±0.4(4)
1.4
±1.6 (5)
Camosine
36.5
±11.7(4)
12.8
±2.5(5)
1.4
±0.68(5)
N-acetylcamosine
8.0
±3.5(3)
0.5
±3.0(3)
5.3
±1.5(3)
N-acetylhomocamosine
27.2
±4.5(4)
6.6
±0.6(4)
5.7
±1.7(5)
N-acetylglycylhistidine
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Conclusions
The results obtained from the testing o f  these compounds 
have confirmed the presence o f  L-histidine derivatives in cardiac 
muscle as well as in blood being carried to all parts of the body.
The actions of the L-histidine derivatives (17)-(24), (28) and (29),
synthesised during this work on cardiac muscle were investigated. 
Preliminary results indicate two possible modes of action for these 
derivatives: they can behave as Ca-sensitisers to cardiac muscle or 
they can increase the maximum Ca-activated force. Some of the 
compounds such as N-acetylglycyl-L-histidine (17) are capable of 
both actions. Further work testing different m ixtures o f  these
com pounds  is p lan n ed  in o rder to ob ta in  m ore  d e ta i led
in fo rm a tio n .
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CHAPTER 5
yV-Methylated D erivat ives
A number o f  constituents of  cardiac muscle are thought to 
be N -m ethylated L-histidine derivatives. It has already been
established that anserine (1-m ethyl-p-alanyl-L-histid ine) (3) and 
balenine (3-methyl-p-alanyl-L-histidine) (4) occur in muscle. O f 
the derivatives required  for testing purposes, only 1- and 3- 
methyl-L-histidine are commercially available. These compounds 
are, however, expensive to buy. It was necessary, then, to devise 
general synthetic  routes to the range o f  W -methyl-L-histidine 
derivatives requ ired .
The im id azole  ring o f  L-histidine p ossesses  two nitrogens
w hich  can be alkylated . The first m ethods o f  synth esising  
h istid in e  d er iv a tiv es  a lkylated  on the im id a zo le  ring w ere  
designed  to produce a mixture o f  isom ers w hich  w ere then 
separated, for exam ple, by ion exchange chromatography. This 
was not a desirable situation since even i f  the separation was 
effective, the yields obtained o f each isomer were frequently very 
low  (14% ).j50
To obtain compounds in any quantity and to avoid the need
for difficult purification steps, a synthetic sequence leading to one
isom er was required. Since there are two possib le  sites o f  
alkylation on the imidazole ring, in order to methylate one of the 
nitrogens selectively, the other one needs to be protected. Several 
p ro tec ting  groups o ffer  them selves as cand ida tes  and some 
literature is available on the subject (Section 3.3.1).
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5.1 1-Methyl-L-Histidine (33) D ihydrochloride
Beyerman and his associates published a synthesis o f  1- 
m ethyl-L -histid ine (33) d ihydroch loride  in 1972.74 L-Histidine 
(1) was reacted with benzoyl chloride to yield iV(a)-benzoyl-L- 
histidine (30) (Scheme 20). This was subsequently converted into 
the methyl ester (31) in order to im prove the solubility o f  the 
series of  compounds in organic solvents. A second benzoyl group 
was introduced selectively on the 3-position to give (32). The 
benzoyl group was chosen since it is sufficiently acid resistant and 
can be easily introduced and rem oved. Beyermann et a l J 4 
m e t h y l a t e d  th e  1 - p o s i t i o n  w i th  t r i m e t h y  lo x o n i u m  
tetrafluoroborate. In the final step they removed the protecting 
groups by hydrolysing the ester and the amide bonds with 6 m 
h y d r o c h lo r i c  ac id  to  a f fo rd  1-m e th y l - L - h is t id in e  (3 3 )  
dihydrochloride. The yields for all o f  the steps were high and the 
product, on converting into the free base, at the end o f  the
re a c t io n  had  op tica l ac t iv ity  w h ich  was co m p arab le  to
com m ercially  available 1-methyl-L-histidine (33).
Due to the high yields and the high optical purity o f  the 
product obtained from this reaction sequence, there seemed to be 
good  reason to use this method to obtain 1-methyl-L-histidine
(3 3 ) d ih y d ro c h lo r id e  and su b se q u e n tly  o th e r  1 -m e th y la ted  
h is t id ine  derivatives. The first step proceeded without any 
difficulties to yield the crystalline N(a)-benzoyl-L-histidine (30). 
T he  p roduc t was identified  on exam ination  o f  the spectra  
obtained. The proton NMR spectrum of (30) showed the signals 
typical of histidine derivatives, that is, the two singlets in the
aromatic region corresponding to the imidazole protons, and the
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ABX system for -CHCH2-. In addition to these signals a multiplet, 
w hich integrated as five protons, was present in the arom atic  
reg ion  o f  the spectrum. This multiplet was identified  as the 
signals corresponding to the benzoyl group.
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The 13C NMR spectrum of (30) showed a signal associated 
with the quaternary carbon of the amide carbonyl as well as the 
signals due to the quaternary and tertiary carbons o f  the phenyl 
ring. The IR spectrum of (30) showed a resonance for the amide 
at 1630 cm -1 in addition to a carboxylate anion stretch at 1580 
cm-1. An accurate mass measurement was made. A(a)-Benzoyl- 
L-histidine (30) required a mass of 259.0957, w hile the value 
obtained was 259.0956.
The next stage involved the synthesis of the methyl ester 
(31) o f  A (a)-b en zo y l-L -h is t id in e . The p ro ced u re  used was 
published in 1919 by Gerngross . 151 HC1 gas was introduced into a 
suspension o f  A(a)-benzoyl-L-histidine (30) in methanol. At the 
end of the reaction, the product (31) was isolated as a crystalline 
solid with m.p. 158-160 °C and [ cx] d 2^ -27.5° (c, 0.8 in 6 M  HC1), this 
co m p ared  to  the l i te ra tu re  v a lu e , 151 m .p. 159 -160  °C .
Gerngross151 did not quote an optical rotation for (31). The proton 
NMR spectrum was referenced on the peak due to the water 
present at 5 4.67. It was necessary to add DC1 to the D2O solvent 
in order to dissolve the product. The chemical shifts o f  the signals 
are, therefore, at a higher field than they would normally be. The 
signal due to the -CH3 of the ester (31) was seen as a singlet at 5 
1.87, and this singlet integrated as three protons. The 13C NMR 
spectrum of (31) showed a signal at 5 52.2 corresponding to the - 
CH3 of the ester. In the IR spectrum of (31), the ester carbonyl 
was seen at 1750 cm -1. An accurate mass measurement gave a 
mass of 273.1106, while A (a)-benzoyl-L-histid ine methyl ester 
(31) required 273.1113.
The p rocedure  o f  Beyerm an et a l J 4 was fo llow ed to 
introduce a second benzoyl group onto the 3-position o f  the
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im idazole ring (Scheme 20). This was attempted several times. 
W hen the residue obtained at the end o f  the reaction was 
examined by proton NMR spectroscopy and TLC, it was found that 
there  was a little  product but mainly starting  material and 
d icyc lohexy lam ine  hydrochloride present. Separation of this 
mixture could not be achieved by chromatography. The reason 
for the failure of this reaction to give good yields of the dibenzoyl 
product (32) could be due to the imidazole ring being a good 
acylating agent. Any A-acyl imidazole compound is likely then to 
be unstable. Due to the problems encountered in this step, the 
remaining steps of this route (Scheme 20) could not be attempted.
On looking for an alternative route, the first consideration 
was the choice of protecting groups and their ease of preparation. 
Tw o reports  o f  a synthesis o f  A (a),3-b is(r-butoxycarbonyl)-L - 
h istid ine methyl ester (34) have appeared in the literature .4^ 67 
T he  procedure  (Scheme 21) involves one step starting from 
com m ercially  available L-histidine methyl ester dihydrochloride. 
This com pound was reacted with di-r-butyl dicarbonate in the 
presence o f  two equivalents o f  triethylamine. The two reported 
procedures differ in the duration of the reaction and in the work 
up. Both of these were followed in the course of this work. It was 
found that they were comparable for conserving optical purity of 
the product but the procedure reported by Brown et al.49 was 
found to be the superior method in terms of yield and chemical 
purity. At the end of the reaction Brown et al. washed the residue 
in chloroform with a solution o f  citric acid to remove the b y ­
products. It was discovered in the course of this work that not all 
o f  the triethylammonium chloride was removed in this washing 
procedure . The residual m ateria l was then hampering the
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p u r i f i c a t i o n  and  c r y s t a l l i s a t i o n  o f  th e  N ( a ) , 3 - b i s ( r -  
b u to x y c a rb o n y l) -L -h is t id in e  m ethy l e s te r  (34). A b e t te r  
purification was obtained when the residue was first dissolved in 
acetone, filtered and concentrated. The oil obtained was then 
dissolved in chloroform and the procedure of Brown et a lA 9 was 
fo llow ed.
A (a)-3 -b is (r-B u toxycarbony l)-L -h is tid ine  m ethyl es te r  (34) 
was isolated in 87% yield with m.p. 88-90 °C and [oc]d20 +25.9° (c ,
0.9 in CCI4). This compared with the literature values67 for the 
m.p. 85-88 °C and [ocJd2-5 +19.9° (c , 1.16 in CHCI3 ) and the 
literature values49 for the m.p. 96 °C and [a ]o 20 +25.6° (c , 1.0 in 
CCI4). The two f-BOC-groups were recognised on examination o f  
the proton NMR spectrum by the presence of two singlets, each 
integrating as 9 protons, at 5 1.21 and 6 1.40. The other signals 
expected o f  a histidine methyl ester derivative were also present. 
The signals due to the C H 3 carbons of the r-butyl groups were 
seen at 5 28.0 and 5 28.5 in the 13C NMR spectrum of (34), while 
the signals due to the qL'fcfiary carbons of the r-butyl group were 
present at 5 79.7 and 5 85.7. The urethane carbonyls were present 
at 5 147.0 and 5 155.7. In both the proton and NMR spectra of
(34), the peaks in the lower field positions should be due to the t- 
butoxycarbonyl group on the imidazole ring. The IR spectrum 
showed a signal at 1750 cm4  due to the ester and a signal due to 
the urethanes at 1710 cm-1. An accurate mass measurement was 
made. A value o f  369.1903 was obtained while N (a)-3-bis(r-  
butoxycarbonyl)-L-histidine methyl ester (34) required a mass of 
369.1900. Brown et a l .49 found the product (34) was unstable 
while Hodges67 reported the product to be stable for up to nine 
months. The product (34) synthesised in the course of this work
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was also found to be stable on storage as evidenced by repeating 
the melting point, NMR and optical rotation measurements.
H y A. A
1 1
l  y + n h 3
N
H .2cr
l.NEt,
2 .di-t-butyl-
dicarbonate
0=C (34)
OC(CH3)3
Mel/DMF
1r
Me
(35)
Deprotection
u
Me
+NH
(33)
Scheme 21
The next stage was then to find a methylating agent for the 
methylation o f  the 1-position of (34). Two reagents were used, 
the first was trimethyloxonium hexachloroantimonate. When this 
reagent was used a black tar like substance was obtained which
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was insoluble in a number of organic solvents as well as water. 
No product could be isolated from this reaction mixture.
The second reagent tried was methyl iodide. The procedure 
initially involved using methyl iodide as the solvent as well as the 
m ethylating agent, but even after 24 hours very little reaction 
had taken place. Acetonitrile was then used as the solvent with 
m ethyl iod ide  in excess, but again  very little  p roduct was 
obtained . W hen ethyl acetate was the solvent, the reaction  
betw een methyl iodide and the pro tected  L-histidine derivative 
took place but a mixture of com pounds was obtained. N,N-  
Dimethyl formamide (DMF) was found to be the best solvent for a 
cleaner and faster reaction, although there was still a mixture o f  
compounds present at the end of the reaction.
On looking at the mixture o f  reaction products, the most 
obvious explanation  was that the f-butoxycarbonyl group was 
removed from the 3-position of (34) before the methylation took 
place. This would result in a mixture of the 1- (35) and 3-methyl 
isomers. Proton NMR spectroscopy proved that this was not the 
case. The region where the N -Me signals occurred contained too 
many singlets to be only a mixture of the two isomers (Figure 26). 
W hen some base was added to the mixture in D2O, one set of 
im idazole protons shifted while the other set did not. If the 
mixture contained the two isomers then both sets of  the imidazole 
protons would be expected to shift. This led to the conclusion that 
the m ix ture  con ta ined  the 1-methyl derivative  and the 1,3- 
dimethyl derivative. This mixture was separated by extracting a 
so lution o f  the mixture in chloroform  or ethyl acetate with 
aqueous ammonia.
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F i g u r e  26 A. N M R sp e c tru m  o f  the m ix tu re  o f
m onom ethylated (3 5 ) and dim ethylated salt products obtained on 
m e th y la t io n  of N (a ) ,3 -b is (r -b u to x y ca rb o n y l) -L -h is t id in e  m ethy l 
ester  (34). B. Proton NMR spectrum obtained upon addition o f  
base to the mixture.(35) and the 1,3-dimethylated salt.
A
i
B
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The desired , c ry sta l l ine  iV (a)-r-bu toxycarbonyl-l-m ethy l-L - 
h istidine methyl ester (35) was obtained on addition o f  ethyl 
acetate to the oil after evaporation of the dried organic portion. 
The yields of the product (35) obtained were low, around 40%. It 
w ould  appear  that the  r -bu toxycarbony l g roup  lo w ers  the 
n u c leo p h il ic i ty  o f  the  r ing  to such an ex ten t  th a t  the
m onom ethyla ted  com pound  is more nucleophilic  tow ards  the
methyl iodide than is the protected compound. This was probably 
also the mixture obtained when ethyl acetate was the solvent. 
The result is that more o f  the dimethylated salt product was 
obtained since the reaction was left for longer in ethyl acetate.
7 V (a )- /-B u to x y c a rb o n y l- l-m e th y l-L -h is t id in e  m eth y l e s te r
(35) was obtained as a crystalline solid with m.p. 108-110 °C and 
[oc]d20 +27.9° (c, 0.47 in CHCI3). The NMR spectrum showed one 
peak at 5 1.42 which integrated as nine protons and two singlets 
at 5 3.61 and 5 3.75 which each integrated as three protons. 
Nuclear Overhauser Enhancement (NOE) experiments were carried 
out to determine two things; to distinguish between the O-Me and 
the iV-Me signals of (35) and to determine which ring nitrogen had
been m ethylated. Irrad ia tion  o f  the p ro ton  at C-2 on the
imidazole ring of (35) gave a NOE of 4.9% on the singlet at 5 3.61 
while irradiation of the singlet at 5 3.61 produced a NOE of 7.5% on 
the signal due to the proton at C-2. Irradiations of the proton at 
C-4 and the s inglet at 5 3.75 gave no N uclear O verhauser 
Enhancements. It can be concluded from these experiments that 
the 1-position o f  the ring is methylated and the N-M e  signal 
resonates at a higher field than the O-Me signal. The 13C NMR 
spectrum of (35) showed a signal due to the N-CH 3 carbon at 
534.0. In the IR spectrum of (35), the ester was seen at 1750
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c m 1, the urethane showed as a signal at 1715 cm -1 and a signal 
due to the N -Me could be seen at 2960 cm-1. The mass spectrum 
o f  (35) contained peaks due to the parent ion as well as a peak 
with m/z 95 common to L-histidine derivatives methylated on the 
imidazole ring. An accurate mass measurement of 283.1530 was 
o b ta in e d  w h i le  A ( a ) - r - b u t o x y c a r b o n y l - 1 - m e th y l - L - h i s t id in e  
methyl ester (35) required a mass of 283.1532.
Beyerman and his associates74 had heated their protected 
derivative (Schem e 20) in 6 m hydrochloric acid for nine hours 
with no repercussions on the optical activity of the compound. It 
was therefore assumed that this method could also be safely used 
to hydrolyse the carbamate and the ester of (35). The reaction 
was monitored by TLC and the removal of the protecting groups 
was found to be complete in three hours. The 1-methylhistidine 
(33) d ih y d ro c h lo r id e  ob ta ined , how ever, was found to be 
com pletely  racem ic  by optical ro ta tion  m easurem ents . The 
conditions for acid hydrolysis were varied. The mildest conditions 
used were to stir the compound in 6 m hydrochloric acid at room 
temperature for twenty four hours. Each time the product had an 
optical rotation value of zero.
Felix reported the use of boron tribrom ide to effect the 
cleavage o f  methyl esters as well as carbam ates within two 
hours .61 This method had been successful for a num ber o f  
protected amino acids including A(cx)-carbobenzoxy-L-histidine. It 
was reported  that this method had no detectable , detrim ental 
effects on the optical purity of the products. The procedure 
reported  by Felix  was tried for the deprotection  of N (a)-t-  
b u to xycarbony l- l-m ethy l-L -h is tid ine  methyl es te r  (35). A fter 
two hours the product o f  the reaction  after  w ork-up was
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exam ined  by proton NMR spectroscopy. The carbam ate was 
indeed cleaved, but the methyl ester was intact. This procedure 
was tried again and the course of the reaction was monitored by 
TLC. The methyl ester was entirely removed only after four days. 
The product at the end of this time did not exhibit any optical 
activity. This implied that, since the methyl ester was so resilient 
to cleavage, it was easier for the bromide ion to abstract the a -  
proton than to attack the methyl group (Scheme 22).
The important feature for the conservation of optical purity 
in the final deprotection stage (Scheme 21) seems to be the order 
in which the protecting groups are removed. Beyerman and his 
a sso c ia te s 74 used an am ide to p ro tec t  the a -am ino  function  
(Schem e 20). In their case the methyl ester is likely to be  
hydrolysed first and then the amide. In both the procedures used 
in this work (Scheme 21) to deprotect the N(a)-r-butoxycarbonyl- 
1-methyl-L-histidine methyl ester (35), the carbamate is removed
first. The next choice would then be to remove the methyl ester
selectively in the presence of the carbamate. It was thought 
feasible to try base hydrolysis of the ester since carbamates are
supposed to be stable under basic conditions. In practice the 
carbam ate  was also rem oved on treatm ent with l M  sodium  
hydroxide for ten minutes and the product was once again
racemic. The carbamate was probably hydrolysed upon addition 
of acid in the work up.
No o ther methods o f  deprotecting  com pound (35) w ere  
a ttem p ted  hence 1 -m e th y lh is t id in e  (33) d ihydroch lo r ide  was 
isolated as a racemic product on hydrolysis o f  (35) with 6 m  
hydrochloric acid.
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The racemic product obtained was a hygroscopic solid. The 
A-Me signal could be seen in the proton NMR spectrum for (33) as 
a singlet at 5 3.86 which integrated as three protons. It resonated
at 5 34.7 in the NMR spectrum. In the IR spectrum of (33), the
NH stretch could be seen at 3420 cm *1 and a group of signals 
typical of  a carboxylic acid were seen in the region 2700-3040 
cm -1. The A-Me was seen at 2680 cm ' 1 and a signal due to the 
carboxylate anion could be seen at 1595 cm-1. The mass spectrum 
showed the parent ion as well as a peak due to the ion with m/z  
95, typical o f  an A-methylated histidine derivative. An accurate 
m ass  m e a su re m e n t  o f  169.0845 w as o b ta in e d  w h ile  1-
methylhistidine (33) required a mass o f  169.0851.
It should be possible for the racemic 1-methylhistidine to be
acylated with acetic anhydride and the acylated product to be 
resolved by the action of Acylase I. This should lead to 1-methyl- 
L -h is tid ine  and A -ace ty l- l-m e th y l-D -h is t id in e .  U nfortunate ly , 
time did not allow for this resolution to be carried out.
5.2 3-Methyl-L-Histidine (39) Dihydrochloride
T here  have been  two syn thetic  routes  to 3-methyl-L-
histidine (39) reported in the literature. Barlos et al. reported a 
two stage synthesis  starting from A (a)- tr i ty l-L -h is t id ine  (36)
(Schem e 2 3 ) .152 These workers reacted  this com pound with
methyl iodide in the presence of sodium to yield a mixture of 1- 
(37) and 3-m ethyl-A (a)-trity l-L -histid ine  (38). 3 -M ethyl-A (a)- 
trityl-L-histidine (38) crystallised preferentially from the reaction 
mixture. The trityl group was removed upon treatment with acid.
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There were various problems with this route. Barlos et a l . 152 used 
com m ercially  available N (a)-trity l-L-h istid ine (36), but this was 
not available in the course o f  this work.
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A search of the literature revealed that this compound is not 
very accessible. Barlos et al. have published a route to tritylated 
L-histidine derivatives.^3 They managed to synthesise a mixture 
o f  Af(oc),3-ditrityl-L-histidine and 3-trityl-L-histidine but not N(a)-  
trityl-L-histidine (36). The reason for this is probably because the 
Ar(a)-trity l derivative is less stable than the 3-trityl derivative .54 
Since the starting material was not available either commercially 
or by synthesis, this was not a viable route. It would not have 
been attractive even if  the starting material was available since
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the presence o f  sodium in the reaction mixture was likely to 
induce racemisation. Also a mixture was obtained which would 
have meant low er yields o f  the desired product and po ten tia l 
difficulties with purification.
The synthesis of 3-methyl-L-histidine (39) d ihydrochloride  
was reported by Noordam et a / . 153 They synthesised the methyl 
es te r  of L -h istid ine  and w ent on to react it w ith  N,N'~
carbonyld iim idazole  to form the cyclic derivative (7S)-5,6,7 ,8-
te tra h y  d ro -7 - (m e th o x y c a rb o n y l) -5 -o x  o im id a z o [ l  ,5 -c] p y r im id in e  
(40) (Scheme 24). This reaction formed a ring between the N(a)~ 
atom and the 1-position; thus the 3-position was rendered the 
only site available for alkylation. Noordam et al. used methyl
iodide to methylate the 3-position and hydrolysed the methylated 
sa lt  (41) w ith  ac id  to a f fo rd  3 -m e th y l-L -h is t id in e  (39) 
dihydrochloride. On converting the salt they obtained into its free 
base , the 3 -m ethy l-L -h is tid ine  (39) obtained had com parab le  
optical activity  to com m ercia lly  available 3 -m ethyl-L -h is tid ine
(39). This reaction sequence appeared to be s traightforw ard , 
hence it was em ployed as the chosen route to 3-m ethyl-L-
histidine (39) dihydrochloride in the course of this work.
Commercially available L-histidine methyl ester was used as 
the starting material in this work. This was reacted with N,N'~ 
carbonyld iim idazole  as described  by Noordam et al. 153 The 
product (40) had m.p. 155-157 °C and [oc]d2^ +58.4° (c, 0.9 in 
methanol) compared to the literature values153 o f  m.p. 156-157 °C 
and [a ]o 25 +59° (c, 1.2 in methanol). In the proton NMR spectrum 
the ABX system could be clearly seen as well as a singlet at 5 3.80, 
integrating as three protons, due to the 0-M e. Noordam et a l . 153 
assigned the carbon of the O C H 3 as the higher field signal as
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compared to the signal due to CHCH2 . The 13C NMR spectrum of
(40) obtained in the course o f  this work showed the CHCH2 at 5 
53.4 while the OCH3 resonated at 5 54.1. The ester was seen in the 
IR spectrum at 1755 cm -1 and the carbonyl o f  the urea was seen 
at 1715 cm -1. An accurate mass measurement o f  195.0620 was 
obtained while the product (40) required a value o f  195.0643.
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Me (39)
6M HC1
MeOOC
NH
(40)
Mel/DMF
MeOOC.
NH
r
N =
Me (41)
Scheme 24
The next step was to methylate (+)-(7S)-5,6,7,8-tetrahydro- 
7 -(m e th o x y ca rb o n y l)-5 -o x o im id azo [ l ,5 -c ]p y r im id in e  (40). This 
was achieved on following the reported procedure. The product
(41) was obtained in crystalline form with m.p. 160-162 °C and 
[cc]d20 +43.4° (c, 1.0 in water), compared to the literature values153
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of m.p. 162 °C (dec) and [oc] d 25 +46.0° (c, 0.7 in water). The N-CH3 
was seen in the proton NMR spectrum as a singlet at 6 3.87, 
in tegra ting  as three protons. It resonated  in the 13C N M R 
spectrum at 6 40.0. The IR spectrum showed a stretch due to the 
ester at 1760 cm *1 and the carbonyl of the urea was seen at 1700 
cm -1. The mass spectrum contained peaks due to the parent ion 
and the ion with m/z  95, typical of  A -m ethyla ted  h is tid ine  
derivatives. A value of 210.0881 was obtained from an accurate 
mass measurement, while (41) required a mass of 210.0879.
N oordam  et a l . 153 w ent on to treat the N -m ethyla ted  
derivative (41) with 6m  hydrochloric acid to obtain 3-methyl-L- 
histidine (39) dihydrochloride. The compound was isolated as a 
hygroscopic solid in 84% yield. Contrary to the results obtained 
by Noordam et a / . , 153 the product (39) was racemic. The N -Me 
signal was seen in the proton NMR spectrum at 5 3.59 and in the 
13C NMR spectrum at 5 36.2. NOE experiments were carried out to 
confirm  that the 3-methyl isomer had been synthesised. W hen 
the proton at C-2 of (39) was irradiated, an NOE of 1.7% was 
observed in the signal due to the protons of the N-M e  group. 
When the proton at C-4 was irradiated, an NOE of 2.3% was seen in 
this signal. Irradiation of the N-Me protons of (39) produced an 
NOE o f 1.5% in the signal due to the proton at C-2, and an NOE of 
1.8% in the signal due to the proton at C-4. These results 
confirm ed that 3-methylhistidine had been synthesised. The IR 
spectrum of (39) showed peaks due to N-CH3 stretch at 2940 cm -1, 
the carboxylic acid stretches in the region 2500-2800 cm-1, and 
the carboxylate anion at around 1630 c m '1. The mass spectrum of  
(39) showed the parent ion peak and the peak with m/z  95, 
typical o f  N-methylated histidine derivatives. An accurate mass
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measurement of (39) gave a value of 169.0848, while C7H 11N3O2 
required a mass of 169.0851.
The rou te  to 3 -m e th y lh is t id in e  (39) d ih y d ro c h lo r id e  
described is not generally applicable in this work since the a- 
n i t ro g e n  atom o f  the L -h is t id in e  residue  re q u ire s  to be 
underivatised for the reaction with A W ’-carbonyldiimidazole. The 
route also failed to produce an optically active product. For these 
reasons, a second route to 3-methyl-L-histidine was investigated
with a view to extending it to the synthesis o f  the dipeptide 
d e r iv a t iv e s .
Brown et a l . 49 reac ted  Ar(a ) ,3 -b is (r -b u to x y c a rb o n y l) -L -  
h is t id ine  methyl ester (34) w ith benzy lch lorom ethy l e ther to 
protect the 1-position of the imidazole ring of L-histidine. This
reaction was used in the course of this work to allow methylation
to take place at the 3-position on the ring (Scheme 25).
yV(a),3-bis(r-Butoxycarbonyl)-L-histidine m ethyl este r (34) 
was obtained as described in Section 5.1. This compound was 
reacted with benzylchloromethyl ether as described by Brown et 
a l . 49 l-Benzoxym ethyl-A r(a)-f-bu toxycarbonyl-L -h is tid ine  m ethyl 
este r hydrochloride (42) was obtained in crystalline form with
m.p. 140-142 °C and [a ]o 20 -16.9° (c, 1.0 in methanol) compared 
to the literature values49 of m.p. 152 °C and [a ]o ^5 -19.1° (c, 1.0 in 
methanol). The benzoxymethyl group was seen in the proton NMR 
spectrum as an f t E a t  5 4.69, integrating as two protons, a 
singlet at 5 5.82, integrating as two protons and a singlet at 5 7.29, 
integrating as five protons. The lower field imidazole proton was 
shifted downfield to 5 9.78. The signal due to OCH2N was seen in 
the *3C NMR spectrum at 5 72.8 and that due to PI1CH2O was seen 
at 5 77.1. The signals due to the benzyl group were present in the
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aromatic region o f  the spectrum. In the IR spectrum o f  (42),
stretching due to the C -0  of the ether could be seen at 1100 cm -1 
as well as the urethane at 1740 cm -1 and the ester at 1745 cm -1. 
An accurate  mass m easurem ent o f  (42) gave the  mass as 
3 8 9 .1 9 3 4 ,  w h i le  1 -b e n z o x y m e th y l- J V (a ) - / -b u to x y c a rb o n y l-L -  
histidine methyl ester required 389.1950.
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The next stage was to methylate the compound (42). It was 
first trea ted  in DMF with one equivalent o f  trie thylam ine to 
liberate the free base form. Methyl iodide was then used as the 
m ethylating agent. The methyl ester (43) o f  1-benzoxymethyl- 
N ( a ) - f - b u t o x y c a r b o n y l - 3 - m e t h y l - L - h i s t i d in i u m  io d id e  w as 
isolated at the end of the reaction as a crystalline solid with m.p. 
134-136 °C and [ cc] d 2 0  -13.7° (c, 0.93 in ethanol). The N-Me  signal 
was seen in the proton NMR spectrum  at 5 3.96. This was 
d is tingu ished  from the O-Me signal once Nuclear O verhauser 
Enhancem ent (NOE) experiments had been carried out. These 
experiments were also used to confirm the location of the methyl 
group on the 3-position (43). W hen the proton at C-2 of the 
imidazole ring in (43) was irradiated an NOE of 2.5% was observed 
in the signal at 5 3.96. When the proton at C-4 was irradiated an 
N OE of 2.7% was observed in this signal. When that signal at 5 
3.96 was irradiated an NOE of 1.7% was observed in the signal due 
to the proton at C-2 and an enhancement of 6.1% was observed in 
the signal due to the proton at C-4. Since irradiation of both the 
imidazole protons induced an NOE in the signal due to the methyl 
protons then the methyl group must be in the 3-position of (43). 
The N-Mq  signal could be seen in the 13C NMR spectrum at 5 37.5. 
The IR spectrum of (43) showed a stretch due to NH at 3390 cm '1, 
the ester at 1740 cm-1, the urethane at 1710 cm -1 and the ether 
at 1100 cm -1. The mass spectrum of (43) showed peaks due to 
the loss o f  the benzyloxymethyl group and the loss of  the t- 
butyloxycarbonyl group. There was also a peak due to the methyl 
imidazohjl ion (44).
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The final stage was to remove the protecting groups to yield 
3-m ethyl-L-histid ine (39). The first step in the depro tec tion  
sequence was to remove the methyl ester from (43). The fastest 
method of doing this was base hydrolysis. There was a fear that 
this would cause some racem isation of the L-histidine residue but 
there are several cases reported  in the literature where sodium 
hydroxide has been used to hydrolyse methyl ester derivatives o f  
L-histidine. In each case the product was reported to be optically 
a c t iv e .  1 -B enzoxy  m e th y l -A (a ) - r -b u to x y  ca rb o n y l-3  -m e th y l-L -
histidinium iodide was isolated as an oil. When an optical rotation 
measurement was made, the acid was racemic. The ester (43) was 
then treated with 6 m hydrochloric  acid for three hours in an 
a ttem p t to genera te  the  ac id  w ith some optica l ac t iv i ty .  
Unfortunately the product from this reaction was also racemic. It 
was evident, in each case, from the proton and NMR spectra 
that the methyl ester had been completely hydrolysed.
The next stage was then to remove the benzoxym ethyl 
group by reduction with hydrogen in the presence of a catalyst. 
The procedure published by Brown et a l 49 was followed to effect 
the removal of this protecting group. Even after forty eight hours 
at a tm ospheric  p ressure  no reaction  was observed and the 
protected derivative was recovered each time. Catalytic transfer 
hydrogenolysis was also attem pted with ammonium form ate as 
the hydrogen source. Again no reaction was observed. A third
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method of removing the benzoxymethyl group by reduction with 
hydrogen in the presence of a catalyst was attempted, this time 
under pressure . The reaction  was m on ito red  by rem oving  
aliquots and examining them using proton NM R spectroscopy. It 
appeared that the imidazole ring was being reduced as well as the 
benzoxymethyl group. Thus the integration o f  the proton NMR
signals showed the disappearance of both the im idazole protons 
and the benzoxym ethyl protons compared to the other signals. 
The only explanation for the failure of the benzoxymethyl group 
to be removed cleanly is the positive charge on the imidazole ring 
which will probably render the ring more susceptible to reduction.
The only m ethod  rem ain ing  for the rem oval o f  the
benzoxymethyl group was by acidolysis. This method was used
by Colombo et a l but no data are available for the product they 
obtained. Firstly the methyl ester (43) was hydrolysed as before 
by the action of sodium hydroxide. The acid derivative extracted 
from the reac tion  m ixture was subsequently  treated with 6 M
hydrochloric acid. After 24 hours of heating, the mixture was
examined by NMR spectroscopy. The proton NMR spectrum was 
very complex. A singlet could be seen at 5 2.55, two singlets at 5 
3.55 and 5 3.67 and what appeared to be three sets of  imidazole 
protons. The product was extracted w ith tr ie thy lam ine  in
chloroform to convert everything into the free base form and the 
proton NMR spectrum was run again. It was clearer now that the 
mixture was composed essentially of two compounds, most likely 
the 1- and 3-methyl isomers of histidine. The NMR spectrum 
showed two N -Me signals as well as two sets of signals for the 
histidine nucleus. This added weight to the idea that a mixture of
the two isomers had formed. TLC also indicated that the mixture
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contained the two isomers. No explanation for this occurrence has 
been found.
5.3 Dipeptides Containing 1-Methylhistid ine
A genera l route  to the synthesis  o f  1-m ethylglycyl-L- 
h istidine (50), 1-methyl-L-carnosine (anserine) (3), and 1-methyl- 
L -hom ocam osine (51) was required. The general idea was to 
protect the amino function of the second amino acid, couple this to 
L-histidine methyl ester, protect selectively the 3-position o f  the 
imidazole ring, methylate the 1-position and finally deprotect to 
obtain the product as shown in Scheme 26.
The first stage was to find a suitable protecting group for
the amino function of the second amino acid. The carbobenzoxy 
(CBZ)-group was chosen, since it should be stable under the 
conditions employed during the peptide coupling step, and it could 
also be selectively removed in the presence o f  other protecting
gro u p s .
Thus CBZ-glycine, CBZ-f3-alanine and CBZ-4-am inobutyric 
acid were synthesised under Schotten-Baumann conditions .48 The 
yields of the products (45) were always in excess of  70% and the 
th ree  deriva tives  were obtained as c ry s ta ll in e  solids. The 
compounds showed a number of common features in the different 
spectra obtained.
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The proton NMR spectra for each compound (45) showed a 
singlet which integrated as five protons, around 5 7.5 and a 
singlet, integrating as two protons, at around 5 5.2. These signals 
were due to the CBZ-group. The CH2 of the CBZ-group was seen at 
around 5 68.0 in each of the NMR spectra. The signals due to 
the phenyl ring of the CBZ-group resonated in the aromatic region 
as expected. The quaternary carbon of the urethane was seen at 
around 5 159.0 for each of the derivatives. The IR spectra for 
compounds (4Q showed a stretch due to NH at around 3340 cm -1 
in each case, as well as signals due to a carboxylfk ac\4 . in the 
region 2900-3100 cm -1. The urethane was seen at around 1700 
cm -1 and the ca^o p ^ \ev y e  1550 cm -1 in the spectrum of each o f  
the CBZ derivatives (45).
The mass spectra o f  (45) showed a common peak with m/z  
91 which corresponded to the benzyl ion and the parent ion was 
seen in all three cases. An accurate mass measurement was made 
for each compound. A mass of 209.0682 was measured for CBZ- 
glycine (45, n = l) ,  while this com pound required a mass o f  
209.0688. CBZ-p-alanine (45, n=2) required a value o f  223.0845, 
this was also the mass measured. CBZ-4-aminobutyric acid (45, 
n=3) required a mass o f  237.1001, the value ob ta ined  was 
2 3 7 .0 9 9 8 .
The next stage was to couple these CBZ-protected amino 
acids (45) to L-histidine methyl ester. L-Histidine methyl ester 
was liberated from the commercially available dihydrochloride by 
the addition of exactly two equivalents of trie thylam ine to a 
suspension of the salt in methanol. The mixed anhydride method 
o f  peptide coupling was employed since it had been successful in 
the past. Again isobutyl chloroformate was used to generate the
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mixed anhydride with the protected second am ino acid  in the 
activation stage. The coupling reaction was then a llow ed to 
proceed. The product (46) in each case was isolated as a solid in 
yields in excess of 70%. The spectra obtained for each dipeptide 
derivative (46) showed a number of common features.
In the proton NMR spectrum for each CBZ-dipeptide methyl 
este r (46), the signals common to the h is tid ine  residue were 
clearly seen. That is, the two imidazole protons in the aromatic 
region and the ABX system due to -CHCH 2-. These were in 
addition to the signals due to the CBZ-group discussed previously 
and a singlet at around 5 3.87, integrating as three protons, due to 
the methyl ester. The NMR spectra showed signals due to the 
CBZ-group, the histidine residue, a quartet at around 5 53.1 due to 
the methyl ester, and two singlets at around 5 174.0 due to the 
ester and the amide carbonyls.
The IR spectra of compounds (46) had a number of common 
features. A signal due to NH stretching was seen at around 3320 
cm -*, while the ester was observed at around 1750 cm -1. The 
signal due to the carbonyl o f  the urethane occurred at around 
1700 cm "1 and that of the amide could be seen at around 1650 
cm -1. The mass spectra of (46) all contained the relevant parent 
ion peak as well as a peak due to the ion m/z  81, common to 
histidine derivatives and a peak due to the benzyl group.
N -C arbobenzoxyglycyl-L -histid ine  m ethyl es ter  (46, n = l)  
was isolated as a solid in a yield of 67%. The product had m.p. 89- 
91 °C and [a ]o 20 -2.3° (c , 1.0 in 83% aqueous ethanol). The glycyl 
residue was seen as a singlet at 5 3.99, integrating as two protons, 
in the proton NMR spectrum and a signal at 5 45.0 in the 13C NMR 
spectrum. An accurate mass m easurem ent o f  360.1422 was
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obtained while the calculated value for C 17H 20N4O 5 was 360.1434. 
No reference to this derivative could be found in the literature.
N -C arbobenzoxy-L-carnosine  m ethyl es te r  (46, n=2) was 
obtained in 72% yield when CBZ-p-alanine was coupled to L- 
histidine methyl ester. The product had m.p. 92-94 °C and [a ]o 2^ 
-4.4° (c, 1.0 in 83% aqueous ethanol). The (3-alanyl residue was 
identified in the proton NMR spectrum as two triplets at 5 2.60 
and 5 3.54, each integrating as two protons. The two signals due 
to this residue were seen at 5 37.1 and 5 38.6 in the 13C NMR 
spectrum. An accurate mass of 374.1589 was measured while 
C 18H22N4O5 required a value of 374.1590. Again no reference to 
this compound could be found in the literature.
Ar-CBZ-4-am inobutyric acid (45, n=3) was coupled to L- 
histid ine m ethyl ester to give A -carbobenzoxy-L-hom ocarnosine 
methyl ester (46, n=3) in a yield of 78%. The product had m.p. 
103-105 °C and [ cx] d 2 0  -7.0° (c, 1.0 in 83% aqueous ethanol). The 
proton NMR spectrum showed a multiplet at 5 1.92 and triplets at 
5 2.41 and 5 3.32, each integrating as two protons. These signals 
were due to the 4-aminobutyryl residue. The l^C NMR spectrum 
showed three signals due to this residue at 5 30.2, 5 34.2 and 5 
41.4. An accurate mass measurement was obtained. A value of 
388.1745 was measured while C 19H 24N4O5 required M, 388.1747. 
No reference to this compound was found in the literature.
The next stage was to protect the 3-position of the imidazole 
ring in compounds (46) in order to allow methylation of the 1- 
position (Schem e 26). A num ber of pro tecting  groups were 
considered. The trityl group was the first choice for protecting the 
3 -position since it would be stable during the m ethylation 
reaction and could be removed under mild acidic conditions. The
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most important reason, though, was that only the 3-trityl isom er 
would be formed since steric hindrance would prevent the 1-trityl 
isom er from forming. T rity l ch loride  was reacted  with N- 
carbobenzoxy-L-hom ocarnosine methyl ester in the presence o f  
triethylamine. The identity of the isolated product was confirmed 
using  pro ton  NMR spectroscopy. A -C arbobenzoxy-3-tr ity l-L - 
hom ocam osine was then treated with methyl iodide. The reaction 
was allowed to proceed for up to forty eight hours but the 
maximum yield of product obtained was 17%. This was judged by 
integration of the signals in the proton NMR spectra. The reaction 
was probably failing to produce good yields due to the steric 
congestion around the imidazole ring caused by the trityl group. 
This was most likely preventing the approach of the electrophile 
and hence hindering the reaction from taking place.
The acetyl group was the next choice for protecting the 3- 
position of the imidazole ring in (46). It is known that A-acyl 
im idazole  derivatives are unstab le  but the use of the acetyl 
protecting group for the imidazole ring has been reported . ^ 4 This 
group was considered since the derivatives would be easy to 
prepare and again the group was thought to locate specifically at 
the 3 -position  of the ring. A -Carbobenzoxy-L-hom ocarnosine 
methyl ester (46, n=3) was reacted with acetic anhydride using 
the procedure of Jones et a l . l ^4 Attempts to purify the product 
from acetic acid at the end of the reaction resulted in the partial 
decomposition of the 3-acetyl product. It was decided then not to 
isolate the 3-acetyl derivative but to react it immediately with 
methyl iodide. The reaction proceeded well and a good yield of 
methylated product was isolated (67%). Unfortunately the desired 
A -c a rb o b e n z o x y - l- in e th y l-L -h o m o c a rn o s in e  m ethy l e s te r  was
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contaminated with about 10% o f  the 3-isomer as determ ined by 
integration of the imidazole signals in the proton NM R spectrum. 
Several attempts were made to purify the desired product by 
chromatography but these failed. It was then decided to abandon 
this route since the aim had been to synthesise a single isomer 
without the need for difficult purification procedures.
The search for a successful protecting group for the 3- 
position continued. The r-butoxycarbonyl (f-BOC) group was 
chosen as the next candidate. It has been reported  that the 
reaction of di-r-butyl dicarbonate with the imidazole ring of an L- 
h is t id in e  d e r iv a t iv e  p ro d u c e d  bo th  the 1- and  3-r-B O C  
derivatives . 154 Because these isomers had been easily separated 
using chromatography, it was decided to apply these methods to 
this work.
The first procedure used to introduce the r-BOC-group onto 
the imidazole ring was that used by Jones and his co-workers . 154 
It involved mixing di-r-butyl d icarbonate with the L-histidine 
derivatives (46) in d ich lorom ethane  and leaving the solution 
overnight. On examination of the oil obtained on removal of the 
solvent, proton NMR spectroscopy showed that little reaction had 
taken place. The reaction mixture was left for a longer time but 
still very little reaction occurred. The situation did not change 
even when the amount of di-r-buty 1 dicarbonate was increased or 
th e  s o lv e n t  w as  c h a n g e d  to m e th a n o l .  W h e n
diazobicyclo[2 .2 .2]octane (DABCO) was added to the reaction 
mixture, the reaction proceeded and all o f the starting material 
disappeared. DABCO is a non nucleophilic base and probably 
enhances the nucleophilicity of the imidazole ring by abstracting a 
proton. The imidazole ring would then be more reactive towards
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the reagent. The two isomers (47) and (48) w ere formed as 
expected. T he  m ixtures were separated using flash  colum n 
chromatography in the first instance. Better separation was later 
achieved when gravity column chromatography was used. Thus 
bo th  the 1- (47) and 3 - r -b u to x y c a rb o n y l-A -c a rb o b e n z o x y -
dipeptide methyl esters (48) were isolated isocratically with ethyl 
acetate as the eluant. Ethyl acetate was also the solvent used to
develop TLC plates. The compounds (47) were used in the
synthesis of the dipeptides containing 3-m ethylhistid ine and will 
be discussed in Section 5.4.
The derivatives (48) had a number of common features in 
their spectra. The r-butyl group was seen in the proton NMR 
spectra as a singlet at around 5 1.60, integrating as nine protons. 
The r-butyl group appeared as a quartet at 5 28.5 and a singlet at 
around 5 87.0 in the NMR spectrum. The urethane carbonyl 
was seen at around 5 147.0. The IR spectra of (48) showed the 
este r s tretch at around 1755 cm-1, the urethane stretches at 
around 1730 cm -1 and the amide stretch between 1650 and 1700 
cm-1- The mass spectra of (48) showed, in each case, the parent 
ion, a peak due to the loss of the r-BOC-group and the peak with 
m/z  81, typical of histidine derivatives.
3 - / -B u to x y c a rb o n y l-A (a ) -c a rb o b e n z o x y g ly c y l-L -h is t id in e  
methyl ester (48, n= l) ,  isolated as an oil in 44% yield, had Rf 0.2. 
The product was optically active with [cc]d2^ +12° (c, 0.9 in CHCI3). 
An accurate mass measurement gave a value o f  460.1936. The 
value calculated for C22H28N4O7 was 460.1958.
3 - r -B u to x y c a r b o n y l -A - c a r b o b e n z o x y - L - c a rn o s in e  m e th y l  
ester (48, n=2 ) (R f 0.23) was obtained in 53% yield with [ oc] d 2 0  
+ 17.1° (c, 0.96 in CHCI3). A value of 474.2101 was obtained when
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the accura te  mass was m easured. T he  value calcula ted  for 
C 23H 30N4O 7 was 474.21114.
3 -r-B u to x y carb o n y l-A Lc a rb o b e n z o x y -L -h o m o c a rn o s in e  
methyl ester (48, n=3) was isolated in 63% yield. The product had 
R f  0.25 and [a ]o 2^ +14.6° (c , 1.1 in CHCI3). An accurate mass 
m e a su re m e n t  o f  4 88 .2282  was o b ta in e d  w hile  the va lu e  
calculated for C24H32N4O 7 was 488.2271.
The next stage in the sequence was to methylate the 1- 
position o f  compounds (48). Methyl iodide was employed as the 
m ethylating agent since it had been used successfully in other 
applications. The procedure used for the methylation of N (a),3- 
bis(J-BOC)-L-histidine methyl ester (34) discussed in Section 5.1 
was followed. Again mixtures of  the monomethylated and the 
dim ethylated salt products were obtained. The desired A-CBZ-1- 
methyldipeptide methyl esters (49) were isolated by extracting a 
solution o f  the product in chloroform with aqueous ammonia to 
rem ove the dimethylated salt.
The 1-methyl derivatives (49) shared a number of common 
features in their spectra. Each of the proton NMR spectra showed 
a peak  due to the methyl ester in the region 5 3 .40-3.60, 
integrating as three protons. The AB part of the ABX system due 
to -CHCH2- was observed as a broad doublet in each of the proton 
NMR spectra. These spectra also showed a broad singlet due to NH 
in the region of 5 5.0-6.0. The A-CH3 was seen as a quartet in the 
13C NMR spectra at around 5 32.0-33.0. In the IR spectra a stretch 
due to A-CH3 was observed in the region 2950-2985 cm-1. The 
mass spectra contained the parent ions as well as peaks due to the 
loss of the amino side chains. The mass spectra also showed peaks 
due to the benzyl ion and the peak with m/z  95, common to N-
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methylated histidine derivatives. No reference to any of these 
compounds could be found in the literature.
A (a )-C arb o b en zo x y g ly cy l- l-m e th y l-L -h is t id in e  methyl este r  
(49, n = l)  was isolated as an oil in 65% yield. The product had 
[a ] D20 -3 .8 ° (c, 1.1 in ethanol). The proton NMR spectrum showed 
the signal due to the -CH2- of the glycyl residue as an AB system, 
this was probably due to steric interactions. An accurate mass 
measurement was made. A value of 374.1592 was obtained while 
the calculated mass for C 18H 22N4O5 was 374.1590.
A -C arb o b e n z o x y - l-m e th y l-L -c a rn o s in e  m ethy l e s te r  (49, 
n=2) was obtained in 58% yield. The oil was optically active, with 
[ oc] d 2 0  -4.0° ( c ,  0.7 in ethanol). A value o f  388.1752 was obtained 
from an accurate mass measurement. The calculated value for 
C 19H24N4O5 was 388.1747.
A -C a rb o b e n z o x y - l-m e th y l-L -h o m o c a rn o s in e  m ethy l e s te r  
(49, n=3) was obtained in 56% yield as an oil. The product had 
[ oc] d 2 0  -5.8° (c , 0.8 in ethanol). An accurate mass measurement of 
402.1879 was obtained while the calculated value for C20H 26N4O5 
was 402.1903.
The final stage in this reaction sequence was to deprotect 
the terminal amino function and the acid function in compounds 
(49). A num ber of methods were investigated in an effort to 
obtain optically active products. Each of the methods used was 
app lied  to the depro tec tion  o f  A -c a rb o b e n z o x y -l-m e th y l-L -  
carnosine methyl ester (49, n=2) as a model compound in order 
that they could be compared.
The first three methods involved the removal o f  the methyl 
ester and the CBZ-group using a one step procedure. The 
com pound (49, n= 2 ) was treated with 6 m  hydrochloric  acid.
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Hydrolysis of the ester and the CBZ-group was complete in around 
six hours when the solution was heated at 90 °C. On examination 
o f  the 1-methylcarnosine (3) dihydrochloride obtained at the end 
o f  the reaction, the compound was found to be racemic by optical 
ro ta tio n  m easurem ents . The p ro tec ted  com pound was then 
treated with 6M hydrochloric acid at room temperature. The 
complete removal of the ester and the urethane took 24 hours at 
this temperature and the product (3) was still not optically active.
The second method was to treat the protected com pound 
(49, n=2) with boron tribromide .61 The same observations made 
in Section 5.1 were noted, that is, the removal of the CBZ-group 
was com plete within two hours but the methyl ester was only 
completely removed after a num ber o f  days. The product (3) 
obtained from this reaction was also racemic by optical rotation 
measurements (cf. Scheme 22).
The third method was to dissolve the protected com pound 
(49, n=2) in 6 m hydrochloric acid, treat the solution with 10% 
palladium on carbon and subject the mixture to hydrogenolysis. 
The removal of the CBZ-group was effected before the hydrolysis 
o f  the m ethyl ester was com plete. The hydrogenolysis  was 
stopped in order to prevent reduction of the imidazole ring and 
the rem aining methyl ester was removed on heating the acidic 
solution. Once again the 1-methylcarnosine (3) dihydrochloride 
was racemic at the end of the reaction.
The next deprotection sequences attempted, involved the 
selective rem oval of the ester o f  (49, n=2) followed by the 
removal of  the CBZ-group. To remove the ester, a methanolic 
solu tion  of TV-carbobenzoxy-l-m ethyl-L-carnosine methyl es te r  
was treated with lM sodium hydroxide. The reaction was
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complete in ten minutes. When an optical rotation measurement 
o f  the A-carbobenzoxy- 1-methylcarnosine obtained was made, the 
value was 0°. This method was then not suitable for removal of
the methyl este r  since it induced racem isation. The second 
m ethod for the selective removal of the methyl ester was to 
hydrolyse the ester (49, n=2) with 6M hydrochloric acid for two 
hours. The isolated product was shown to have the CBZ-group 
in tact on examination of the NMR spectra. W hen an optical 
rotation was measured, the value was -3.5° (c, 1.7 in methanol). 
The product then possessed some optical activity.
The next stage was to find a suitable method to remove the 
CBZ-group. Both of the methods tried involved the removal of this 
group by hydrogenolysis. Catalytic transfer hydrogenolysis  was 
the first procedure used. Ammonium formate was the hydrogen 
donor and cleavage was achieved in one hour. The product 
iso lated  from the reaction mixture was not, however, optically 
active. A m ethanolic solution of A -carbobenzoxy-l-m ethy l-L - 
carnosine was then treated with 1 0 % palladium  on carbon and
h y d ro g e n a te d  at a tm o sp h e r ic  p ressu re . O nce  again  the
deprotected product (3) obtained at the end o f  the reaction was 
racem ic .
None of the methods employed produced an optically active 
p roduct hence the deprotection  of A (a )-ca rb o b en zo x y g ly cy l- l-  
methyl-L-histidine methyl ester (49, n= l)  and A-carbobenzoxy-L- 
hom ocarnosine methyl ester (49, n=3) was achieved upon the 
treatment of these compounds with 6 m hydrochloric acid at 90 °C. 
This was the most straight forward method and the highest
y ie ld ing  depro tection  reaction . The three  1-m ethylh is tid ine  
d ipeptide derivatives, (3), (50) and (51), showed the signals
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typical of a histidine derivative in the proton NMR spectra. That 
is, the two imidazole protons in the aromatic region and the ABX 
system due to -CH C H 2 -. The signals typical o f  a h istid ine 
derivative were also present in the l^C NMR spectra. The mass 
spectra all contained the parent ion and the ion with m/z  95, 
typical of N-m ethylhistidine derivatives.
1 -M ethylg lycylh istid ine  (50) d ihydrochloride  was iso la ted  
as a hygroscopic solid in 89% yield. The product was not optically 
active. The proton NMR spectrum contained the N -Me signal as a 
singlet integrating as three protons at 5 3.73. The singlet due to 
the -CH2- of  the glycyl residue resonated in the same region. The 
13C NMR spectrum of (50) showed the jV-Me signal at 5 34.7, the 
-CH2- of the glycyl residue at 5 41.2, the carbonyl of the amide at 5  
169.9 and that o f  the acid at 5 171.3. NOE experiments were 
carried out to confirm that the methyl group was located in the 1- 
position. When the proton at C-2 of (50) was irradiated an NOE of 
2.5% was observed in the singlet due to the N -Me protons. No NOE 
was observed when the proton at C-4 was irradiated. When the
singlet due to N-Me protons was irradiated, an NOE of 5% was 
observed in the signal due to the p ro ton  at C-2 but no 
enhancement was observed in the signal due to proton at C-4. 
The results of these experiments led to the conclusion that the
imidazole ring is indeed methylated in the 1-position. The amide 
was seen in the IR spectrum at 1740 cm-1, while the acid was
seen at 1630 cm -1. An accurate mass measurement of (50) was
made. A value of 226.1067 was obtained while C9H 14N4O 3 
required a mass of 226.1066.
1-M ethylcarnosine (3) dihydrochloride was isolated as a 
hygroscopic solid  in 8 6 % yield. W hen an optical ro tation
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m easurem ent was made, the value was 0°. The proton NM R 
spectrum showed the N -Me signal as a singlet, integrating as three 
protons at 5 3.67. The signals due to the p-alanyl residue were 
seen as two triplets, each integrating as two protons, at 6  2.54 and 
6 3.04. The ^ C  NMR spectrum showed signals due to the carbons 
o f  the p-alanyl residue at 5 32.7 and 5 36.4. The carbon of the N- 
Me group resonated at 5 34.0, while the signal due to the carbonyl 
of the amide was seen at 5 172.2 and that due to the acid at 5 
172.5. NOE experiments were run to determine the substitution 
pattern on the imidazole ring of (3). When the proton at C-2 was 
irradiated an NOE of 7.1% was observed in the signal due to the N- 
M e group. When the proton at C-4 of (3) was irradiated no 
significant enhancement was observed in the other signals. W hen 
the protons of the N-Me group were irradiated an NOE of 15.5% 
was observed in the signal due to the proton at C-2, while no
significant enhancement was observed in the signal due to the 
proton at C-4. These results confirmed that the imidazole ring is 
m ethylated in the 1-position. The amide was seen in the IR 
spectrum at lbbO cm_l, while the acid was observed at 1735* cm-1. 
An accurate mass measurement o f  (3) gave a value of 240.1223. 
C 10H 16N4O3 required a measurement of 240.1222.
1-Methylhomocarnosine (51) d ihydrochloride was obtained 
as a hygroscopic solid in 87% yield. The product obtained was 
racem ic by optical activity m easurem ents. The proton NM R 
spectrum showed a signal, integrating as three protons, due to the 
TV-Me group at 6 3.68. A multiplet at 5 1.74 and two triplets at 5
2.31 and 5 2.84, all integrating as two protons, were due to the
-CH2CH2CH2- of  the 4-aminobutyryl residue. The signals due to
this residue were seen in the I3C spectrum at 6 23.1, 5 31.7 and 5
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39.9. The carbon o f  the N -Me group resonated at 5 34.6, while a 
signal due to the amide carbonyl was seen at 5 171.2 and that due 
to the acid was observed at 5 178.0. NOE experiments were used 
to establish which imidazole isomer had been synthesised. When 
the proton at C-2 (51) was irradiated, an NOE o f 4.8% was 
observed in the signal due to the N -Me protons. W hen the proton 
at C-4 was irradiated, no enhancements were observed. When the 
protons of the N -Me group were irradiated, an NOE o f 4.8% was 
observed in the signal due to the proton at C-2, while no 
enhancement was observed in the signal due to the proton at C-4. 
The IR spectrum of (51) contained a signal due to the amide at 
1 '(?(-©■ cm-1 and a signal due to the acid at 1730 c m '1. A value of 
254.1377 was obtained from an accurate mass m easurem ent, 
while C 11H 18N4O3 required a value of 254.1379.
1-M ethylglycylhistidine (50), 1-methylcarnosine (3) and 1- 
m ethy lhom ocarnosine  (51) w ere, therefore, ob ta ined  as their  
dihydrochloride salts as pure isomers. Unfortunately, none of the 
compounds synthesised possessed any optical activity. It remains 
to be proved at which step in the synthesis, racemisation of these 
compounds was occurring. The product of each step in the 
sequence would have to be examined to determ ine the optical 
purity of the intermediate. This would undoubtedly require the 
deprotection of at least one of the carboxyl or amino functions 
which in itself may induce racemisation. It seems highly likely 
that most of the racemisation takes place in the final deprotection 
steps since the conditions required to remove the methyl ester are 
known to be sufficient to cause racemisation o f  susceptible cx- 
amino  acid res idues .47,68 j f  time had allow ed, a different 
protecting group would have been chosen for the carboxyl
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function o f  L-histidine. This protecting group would have been 
stable under the conditions of the reaction scheme but should be 
m ore labile  in the final deprotection step. F o r  exam ple the 
carboxyl function could have been protected as the r-butyl ester 
which is more labile to acid than is the methyl ester.
5.4 Syn thes is  o f  Dipeptides  C o n ta in in g  3-M ethyl-L-  
h i s t i d i n e
It has a lready been es tab lished  that 3 -m ethy lca rnos ine  
(balenine) (4), occurs in muscle tissue. The other two compounds 
o f  i n t e r e s t  a re  3 - m e th y lg ly c y lh i s t id in e  (5 3 )  and  3- 
m ethylhom ocarnosine. These three compounds are not available 
com m ercia lly  and although balenine has been iso la ted  from  
natural sources, no synthetic route to these compounds has been 
found in the literature.
The rou te  to the dipeptides containing 1-m ethylhistid ine 
was discussed in Section 5.3. The route (Scheme 26) involved 
protecting the 3-position of the imidazole ring o f  each of the 
derivatives with the r-butoxycarbonyl (f-BOC) group. The 1-f-BOC 
isom ers (47) were also formed in this reaction and could be 
iso la ted  by chrom atography . Both l-f-butoxycarbonyl-./V(a)- 
carbobenzoxyglycyl-L-histid ine methyl ester (47, n = l)  and 1 -f- 
b u to x y ca rb o n y l-N -ca rb o b en zo x y -L -c a rn o s in e  m ethy l es ter  (47, 
n=2 ) were isolated in sufficient yield to be used in the synthesis of 
the 3-m ethyl derivatives (Scheme 27). 1-f-Butoxycarbonyl-N- 
carbobenzoxy-L-hom ocarnosine methyl ester (47, n=3) was only
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form ed in very small amounts and could not be isolated in pure 
fo rm .
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Scheme 27
l- r -B u to x y c a rb o n y l- iV (a ) -c a rb o b e n z o x y g ly c y l-L -h is t id in e  
methyl ester (47, n= l)  was isolated as an oil in 37% yield. The 
product was optically active with [ a ] o ^  -29.3° (c, 0.98 in CHCI3). 
T he  p roduct was iden tified  on exam ination  o f  the spec tra  
obtained. The f-butyl peak was seen as a singlet, integrating as 
nine protons, at 5 1.58 in the proton NMR spectrum. The -CH2 - of 
the glycyl residue was seen as an AB system, integrating as two 
protons, at 5 4.20. The signals typical of a histidine methyl ester 
derivative and a CBZ derivative were also in evidence. The l^C 
NMR spectrum of (47, n= l) showed peaks due to the r-butyl group 
at 5  28.5 and 5 85.1. The carbon of the -CH2- of the glycyl residue, 
resonated  at 5 49.3. The carbonyl of  the r-BOC-group was 
observed at 5 148.9, while that of the CBZ-group could be seen at 5 
152.0. The IR spectrum showed peaks due to the ester at 1820
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c m 1, the urethanes at 1760 c m 1 and the am ide at 1745 cm-1. 
The mass spectrum of  (47, n = l)  showed peaks due to the loss of 
the /-BOC-group and the ion with m/z 81, common to histidine 
d e r iv a t iv e s .
1 - / - B u to x y  c a rb o n y l -A - c a r b o b e n z o x y -L - c a rn o s in e  m e th y l  
ester (47, n=2) was isolated as an oil in 27% yield. An optical 
rotation measurement gave [a ]o 20 -10.7° (c, 1.0 in CHCI3). The 
proton NMR spectrum of (47, n=2) showed the /-butyl peak as a 
singlet, integrating as nine protons, at 5 1.57. The p-alanyl residue 
was seen as two triplets at 5 2.53 and 5 3.93, each integrating as 
two protons. The l^C NMR spectrum of (47, n=2) contained peaks 
due to the f-butyl group at 5 28.5 and 5 86.4. The carbonyl of the 
f-BOC-group resonated at 5 152.3, while that of the CBZ-group was 
seen at 5 154.2. The ester was observed in the IR spectrum at
1790 cm-1, while the urethanes were seen at 1755 cm -1 and the
amide at 1680 cm -1. The mass spectrum of  (47, n=2) contained 
the parent ion as well as peaks due to the loss of  the urethanes 
and the ion with m/z 81, typical of histidine derivatives. An 
accurate mass m easurem ent gave a value o f  474 .2122, while 
C23H 30N4O 7 required a measurement of 474.2114.
M ethy la tion  of protected com pounds (47) was achieved 
using methyl iodide. The method was the same as that described 
in Sections 5.1 and 5.3 and a mixture of the 3-methyl and the 1,3- 
dim ethyl derivatives was obtained. The 3-m ethyl com pounds
(52) were iso la ted  on treatm ent with aqueous am m onia  as 
previously  described.
A (oc)-Carbobenzoxyglycyl-3-m ethyl-L-histidine methyl ester
(52, n= l)  was obtained in 48% yield. The oil was optically active
with [a]D20 _18 ° (c, 1.3 in CHCI3). The proton NMR spectrum
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showed the signal due to the protons of the A-Me group as a
singlet, integrating as three protons, at 5 4.65. This group was
seen in the 13C NMR spectrum at 6 37.5. The IR spectrum of (52, 
n = l)  contained signals due to A-CH3 at 2990 cm -1, the ester and 
urethane at 1750 c m 1 and the amide at 1730 cm -1. The mass
spectrum showed the parent ion peak as well as a peak due to the 
m ethy la ted  im idazole  ion with m /z  95. An accurate  mass
m easurem ent o f  (52, n = l)  gave a value o f  374.1589, w hile  
C 18H 22N4O5 required a measurement of  374.1590.
A -C arb o b en zo x y -3 -m e th y l-L -ca rn o s in e  m ethy l es te r  (52, 
n=2) was obtained in 54% yield. An optical rotation measurement 
gave [a ]o 2^ -3.2° (c, 0.9 in CHCI3). The proton NMR spectrum
showed the two singlets due to the N -Me and the methyl ester
protons were very close in chemical shift at 5 3.72. In the
NMR spectrum, the peak due to the N -M q was seen at 5 33.5. The
IR spectrum showed stretches due to A-CH3 at 3000 cm-1, the 
ester at 1790 cm -1, the urethane at 1750 cm ' 1 and the amide at 
1690 cm-1. The mass spectrum contained peaks due to the parent 
ion and the ion with m/z  95, typical of A-methylated histidine 
derivatives. A value of 388.1738 was obtained when an accurate 
mass measurement of (52, n=2) was made. C 19H 24N4O5 required a 
value of 388.1747.
The final stage involved the rem oval o f  the protecting 
groups from compounds (52). The same m ethods as those 
discussed in Section 5.3 were used and again the products (4) and
(53) of each method were racemic. It was decided then to use 
acid hydrolysis for the removal of both the methyl ester and the 
CBZ-groups in order to obtain the best yields o f  products.
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3-M ethylg lycylh istid ine (53) d ihydrochloride was ob ta ined
as a hygroscopic solid in 79% yield. The proton NMR spectrum 
show ed  the signal due to the N -M c  protons as a s ing le t,  
integrating as three protons, at 5 3.68. This signal was seen in the 
13C NMR spectrum of (53) at 6 31.9. NOE experiments were used 
to d e te rm in e  w hich  o f  the  A -m ethy l isom ers  had  b e e n
synthesised. When the proton at C-2 of (53) was irradiated an 
NOE of 2% was observed in the signal due to the JV-Me protons. 
W hen the proton at C-4 was irradiated an NOE of 2.4% was 
observed in that signal. When the protons of the N -M q group 
were irradiated an NOE of 1.7% was observed in the signal due to 
the proton at C-2 and an NOE of 1.5% was observed in the signal 
due to the proton at C-4. These results led to the conclusion that
3 - m e th y lg ly c y lh i s t id in e  (53 )  d ih y d r o c h lo r id e  h ad  b e e n  
synthesised. The IR spectrum contained stretches due to A-CH3 at 
3110 cm*1, the amide at IMG cm *1 and the acid at 17>IG> cm*1. 
The mass spectrum of (53) showed peaks due to the parent ion 
and the ion with m/z 95. An accurate mass measurement gave a 
value of 226.1071 while C9H 14N4O3 required a value o f  226.1066.
3-M ethylcarnosine (4) d ihydrochloride was iso lated  as a
hygroscopic solid in 81% yield. The proton NMR spectrum of (4)
showed the peak due to the N-Me group as a singlet integrating as 
three protons, at 6 3.71. The signal due to this group was seen in 
the 13q  NMR spectrum at 6 34.6. NOE experiments were used to 
determ ine the substitution pattern o f  the imidazole ring. When 
the proton at C-2 of (4) was irradiated an NOE o f  15% was 
observed in the signal due to the /V-Me protons. When the proton 
at C-4 was irradiated, an NOE of 4% was observed in this signal. 
Irradiation of the protons of the N -Me group produced a NOE of
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11 % in the signals due to the protons at C-2 and C-4. These 
resu lts  indicated that 3 -m ethy lcam osine (4) d ihydrochloride  had 
been synthesised. The IR spectrum showed a stretch due to the 
am ide at 1725 cm -1 and the acid at 1610 cm -1. The mass 
spectrum of (4) contained peaks due to the parent ion and the ion 
w ith  m/z  95, typical o f  A -m ethy lh is tid ine  deriva tives . An 
accura te  mass m easurem ent gave a value o f  240.1211 w hile 
C 10H 16N4O3 required a value of 240.1129.
Since the 1-f-BOC derivatives used in the synthetic route to 
p ro d u c e  these  d ip ep tid es  co n ta in ing  3 -m e th y lh is t id in e  w ere  
essentially by-products in the route to the dipeptides containing 
1-m ethylhistid ine, the am ount o f  m ateria l ob ta ined  was very 
small. The route was not therefore useful in producing large 
quantities of the dipeptides containing 3-methylhistidine. It was 
also not possible to obtain 3-methylhomocarnosine by this route. 
F o r  these reasons, an a l te rn a tiv e  rou te  (S chem e 28) was 
investigated. A-Carbobenzoxy-L-carnosine methyl ester (46, n=2) 
was the starting material for this route. The synthesis of this 
compound was discussed in Section 5.3.
A -Carbobenzoxy-L-carnosine methyl es te r  (46, n=2) was 
r e a c te d  w ith  ace t ic  a n h y d r id e  to p ro d u c e  3 -a c e ty l -A -  
carbobenzoxy-carnosine methyl ester (54). Most of the acetic acid 
was removed but the compound was not isolated due to it being 
u n s ta b le .  In s tead  it was re a c te d  s tra ig h t  aw ay w ith  
benzy lch lorom ethy l ether. l-B enzoxym ethy l-A -carbobenzoxy-L - 
carnosine methyl ester (55) was isolated as an oil in 86% yield. 
The product was optically active with [cc]d20 -6.0° (c, 1.6 in 
methanol). The proton NMR spectrum o f  (55) showed three 
singlets at 6 4.68, 6 5.01 and 6 5.69, each integrating as two
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protons. These were due to the CH2 protons of the CBZ- and the 
benzyloxym ethyl-groups. The spectrum also showed a complex 
signal in the aromatic region, integrating as eleven protons. The 
IR spectrum o f  (55) showed a stretch due to the ester at 1740
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cm -1, the urethane at 1715 cm -1 and the amide at 1670 cm-1. The 
mass spectrum of (55) showed the peak with m/z  81, typical o f  
h is tid ine  derivatives.
The next stage was to m ethylate  the 3-position o f  (55).
Methyl iodide was once again the reagent of choice. The reaction 
was monitored over 48 hours but little change could be seen by 
TLC. The reaction mixture was exam ined by proton N M R 
spectroscopy at the end of this time. It could be seen that very 
little methylated product had been formed This may have been 
due to steric hindrance around the imidazole nucleus. This was 
therefore not going to be a viable route for the synthesis o f  
dipeptides containing 3-m ethylh istid ine .
5.5 Conclusions
The w ork to produce indiv idual N -m ethylated L-histidine 
derivatives was being run concurrently . This meant that any
p ro b le m s  e n c o u n te re d  w ere  s h a re d  b e tw e e n  g ro u p s  o f
compounds. For example all o f  the compounds were protected by 
the methyl ester and hence problem s with conserving optical
activity were encountered for all o f  the derivatives. If time had 
allowed, other protecting groups for the carboxyl function would 
have been investigated. For example the f-butyl ester or silyl 
esters would be more labile at the end of the reaction sequence.
Clearly a new route is required for the synthesis o f  the
d ipep tides  conta in ing  3 -m ethy lh is t id ine  and in particu la r  3-
methylhomocarnosine. Different protecting groups would need to 
be investigated. A lot of work would be required to find a
suitable combination for the protection o f  the nitrogens in the
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im idazole ring. It is obvious from the results obtained in the 
synthesis o f  3-methylhistidine that the benzoxym ethyl group is
w holly  unsuitab le  for p ro tec ting  the 1-position o f  these  L-
histid ine derivatives prior to m ethylation. It seems that it is 
im possible to remove it cleanly to leave the desired 3 -m ethyl 
d e r iv a t iv e .
1-M e th y lh i s t id in e  (3 3 ) ,  3 - m e th y lh i s t id in e  (3 9 ) ,  1-
m e th y lg ly c y lh is t id in e  (50), 3 -m e th y lg ly c y lh is t id in e  (53 ),  1-
m e th y lc a r n o s in e  (3 ) ,  3 - m e th y  l c a r n o s in e  (4) a n d  1- 
m e th y lh o m o c a rn o s in e  (51)  w e re  s y n th e s is e d  as t h e i r  
d ih y d ro c h lo r id e s  to p ro d u c e  c h e m ic a l ly  p u re  i s o m e r s .  
Unfortunately none of the compounds were optically active. This 
was true even for the 3-methylhistidine (39) obtained using the
procedure  o f  Noordam et a / . 153 These workers c la im ed  to 
synthesise material which was com parable in optical activity to 
that o f  the natural compound. That was not the case with the 
compound produced in the course of this work.
It should be possible for the racemic TV-methyl derivatives 
to be acylated with acetic anhydride and the TV-acylated product 
to be resolved by the action o f  Acylase I. This should lead to 1- 
methyl-L-amino acid or dipeptide and JV-acetyl-l-methyl-D-amino 
acid or dipeptide. Unfortunately, time did not allow for this
resolution to be carried out.
5.6 Testing of TV-Methylated Histidine Derivatives
The testing o f  the TV-methylated h istid ine  d e r iv a t iv e s  
syn thes ised  during the course o f  this work is s till be ing  
undertaken. The results are not available at this time.
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Chapter 6 
E x p e r im e n t a l
6.1 General
Infra red spectra were recorded on a Perkin E lm er 580 
spectrophotom eter. N uclear  magnetic resonance  spec tra  were 
obtained with a Perkin Elm er R32 spectrometer operating at 90 
MHz, or a Bruker WP200-SY or AM200-SY spectrometer operating 
at 200 MHz (5h) and 50 MHz (5c). Spectra were run in D2O with t- 
butanol as the internal standard at 1.30 ppm (5h) and 31.6 ppm 
(5c) unless otherwise specified. The multiplicities o f  the 13C NMR 
spectra were determined using DEPT spectra with pulse angles of 
0=90° and 0=135°. Equilibrium  Nuclear Overhauser Enhancement 
measurements were perform ed by the difference m ethod at 2 0 0  
MHz. The samples were dissolved in either CDCI3 or D2O for these 
measurements. Mass spectra were recorded using an A.E.I. MS 12 
or 902 spectrometer.
All melting points were measured on a K ofler  hot-stage 
apparatus and are uncorrected. Optical rotations w ere measured 
with an Optical Activity Ltd. AA-10 polarimeter in a 1 dm cell.
TLC was carried out on Merck Kieselgel 60 F254 plastic 
sheets of 2mm thickness. Ninhydrin or iodine were used as the 
v i s u a l i s i n g  a g e n t s .  T L C  s o l v e n t  s y s t e m  1:
chloroform /m ethanol/am m onia (80:19:1); solvent system  2: ethyl 
acetate; so lvent system 3: ch lo ro fo rm /m ethano l/w a te r/am m onia
(25:22:5:5). Chromatographic purification was carried out by dry 
column chromatography using Kieselgel 60 (Merck, 70-230 mesh).
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HPLC was carried out using a reverse phase Silica C18 column and 
a solvent system of water and methanol (55:45).
T riethylam ine was purified  by distillation from potassium  
hydroxide and stored over potassium hydroxide pellets. N,N- 
D im ethy lfo rm am ide  (DMF) was purif ied  by d is t i l la t ion  from 
calcium hydride and stored over 4A sieves. Organic solutions 
were dried over anhydrous magnesium sulphate.
6.2 Experimental to Chapter 4
6.2.1 Ar-Acylation of Amino Acids
General procedure 1
The amino acid (10 mmol), was dissolved in water (3 ml). The 
solution was stirred at room temperature while acetic or propionic 
anhydride (20 mmol) was added. Stirring was continued for 15 
min then the mixture was concentrated under reduced pressure at 
temperatures below 40 °C to yield a glassy residue.
General procedure 2
The amino acid (10 mmol) was dissolved in glacial acetic or 
propionic acid (3 ml). Acetic or propionic anhydride (20 mmol) 
was added and the mixture was heated at reflux for 1 h. At the 
end of this time, water (1 ml) was added and the solution was 
concentrated under reduced pressure to yield a glassy residue.
N-Acety l -L-his t id ine  (23)
L-Histidine (1.55 g, 10 mmol) was acylated with acetic anhydride 
as described in general procedure 1. The resultant glassy residue 
so lid if ied  on storing  in a des icca to r  co n ta in in g  po tass ium
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h y d ro x id e  p e l le ts  and p hosphorus  p en to x id e  u n d e r  vacuum . 
Recrystallisation from water on the addition o f  acetone yielded N- 
acetyl-L-histidine (23) (1.69 g, 8 6 %); m.p. 154 °C; [ cx] d 2 0  +39.5° (c,
0.9 in H2O), lit . , 118 m.p. 169 °C (dec.), [ oc] d 2 0  +44.7° (c , 1.0 in H 2O); 
Umax (KBr disc) 3350, 3140, 1660, 1590 and 1550 cm -1; 5h 2.05 
(3H, s), 3.09-3.38 (2H, AB part of an ABX system), 4.52-4.59 (1H, X 
part of an ABX system), 7.33 (1H, s) and 8 .6 6  (1H, s); 5c 23.8 (q, 
CH3CO), 29.3 (t, CH2CH), 56.1 (d, CH2CH), 118.1 (d, C-4), 131.7 (s, C- 
5), 135.1 (d, C-2), 175.4 (s, COCH3) and 178.5 (s, CO2H); m/z 197 
(M +, 16.3%), 138 (25%), 110 (56%) and 81 (100%). Found: M \  
197.0798. C 8H 11N3O3 required M, 197.0800.
N -P ropiony l-L -h is tid ine  (24)
L-Histidine (1.55 g, 10 mmol) was acylated according to general 
procedure  1 using propionic anhydride as the acylating agent. 
The resultant glassy residue was stored in a vacuum desiccator 
containing potassium hydroxide pellets and phosphorus pentoxide. 
The solid obtained was recrystallised from ethanol to yield N- 
propionyl-L-histidine (24) (1.75 g, 83%); m.p. 118-120 °C; [ a ]o 2^ 
+29.9° (c, 1.2 in H 20 ) ;  umax (KBr disc) 3400, 3110, 1640 and 1580 
cm-1; 5H 1.09 (3H, t), 2.30 (2H, q), 3.06-3.38 (2H, AB part o f  an 
ABX system), 4.53-4.60 (1H, X part of an ABX system), 7.32 (1H, s) 
and 8.63 (1H, s); 5C 11.4 (q, CH2CH3), 29.5 (t, CH2CH), 31.0 (t, 
CH2CH3), 55.8 (d, CH2CH), 118.7 (d, C-4), 131.8 (s, C-5), 135.0 (d, C- 
2), 178.5 (s, COCH2) and 179.3 (s, CO2H); m/z 211 (M+, 2.6%), 165 
(14%), 137 (26%), 120 (56%) and 81 (100%). Found: M +, 211.0962. 
Calcd. for C 9 H 13N3 O3 ; M , 211.0957.
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N -A c e ty lg ly c in e
Glycine (7.5 g, 0.1 mol) was dissolved in water (30 ml) according 
to the method described  by H erbst and S h em in . 142 A cetic  
anhydride (20.4 g, 0.2 mol) was added dropwise with stirring. 
After 20 min the solution was left to stand overnight at 0 °C to 
allow crystallisation to take place. The product was collected by 
filtration and recrystallised from water to yield N -acetylglycine 
(10.3 g, 8 8 %); m.p. 207-208 °C, lit . , 142 88-92%, m.p. 207-208 °C; 
Umax (KBr disc) 3350, 1720, 1580 and 1550 cm-1; Sh 2.11 (3H, s) 
and 4.04 (2H, s); 5C 23.6 (q, COCH3), 43.1 (t, CH2NH), 175.5 (s, 
COCH3) and 176.7 (s, C 0 2H); m/z 117 (M +, 10.4%) and 72 (100%). 
Found: M +, 117.0424. C4H 7NO3 required M, 117.0426.
N -P ro p io n y lg lyc in e
Glycine (3.8 g, 0.05 mol) was acylated by the method described in 
general procedure 1 using propionic anhydride as the reagent. 
T h e  solid  p roduced  on concen tra tion  o f  the so lu tion  was 
crystallised from methanol to yield  N-propionylglycine (5.44 g, 
83%); m.p. 124-126 °C; umax (KBr disc) 3350, 1705, 1600 and 
1550 cm-1; 6 H U 8 (3H, t), 2.38 (2H, q) and 4.03 (2H, s); 5C 11.1 (q, 
CH 3CH2), 30.6 (t, CH 3CH2), 43.0 (t, CH2NH), 175.5 (s, COCH2) and 
180.3 (s, CO2H); m/z  131 (M +, 43.4%), 84 (54%) and 57 (100%). 
Found: M \  131.0583. Calcd. for C5H9NO3 , M, 131.0582.
N -A c e ty l -$ -a la n in e
(3-Alanine (8.9 g, 0.1 mol) was acylated with acetic anhydride in 
acetic acid using general procedure 2. A glassy residue was 
obtained on concentration of the solvent. This was dried under 
vacuum in the presence of potassium hydroxide to produce a solid
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w hich was crystallised  from acetone to y ield  N-acetyl-(3-alanine 
(10.3 g, 79%); m.p. 79-81 °C, lit. , 147 80-82 °C; umax (KBr disc) 3350, 
1710, 1620 and 1565 c m 1; 5H 2.03 (3H, s), 2.65 (2H, t) and 3.49 
(2H, s); 5C 23.8 (q, COCH3), 35.4 (t, CH2C 0 2H), 37.1 (t, CH2NH), 176.1 
(s, COCH3) and 178.1 (s, C 0 2H); m/z 131 (M+, 26%) and 8 8  (100%). 
Found: M \  131.0589. C5H9 NO3 required M, 131.0582.
N -P ro p io n y l-§ -a la n in e
p-A lanine (4.45 g, 0.05 mol) was acy la ted  with p rop ion ic  
anhydride in propionic acid as described in general procedure 2 . 
The resultant oil was stored in a vacuum desiccator containing 
potassium hydroxide to remove any residual traces of acid. The 
product, N-propionyl-f3-alanine, was isolated as an oil (7.25 g, 
71%); umax (CHCI3 solution) 3460, 3020, 1740, 1670, 1640 and 
1530 cm-1; 5h (D20 ;  HOD was the internal standard at 4.63 ppm) 
0.88 (3H, t), 2.01 (2H, q), 2.38 (2H, t) and 3.23 (2H, t); 5C (dioxan 
was the external standard at 67.8 ppm) 10.7 (q, CH2CH 3), 30.2 (t, 
CH 2CH3), 34.6 (t, CH2C 0 2), 36.1 (t, CH2NH), 177.2 (s, NHCO) and
179.1 (s, C 0 2H); m/z  145 (M +, 41%), 99 (89%) and 8 8  (89%). 
Found: M +, 145.0738. Calcd. for C6H 11NO3; M, 145.0739.
N -A c e ty l -L -a la n in e
L-Alanine (4.45 g, 0.05 mol) was acylated with acetic anhydride in 
w ater according to general procedure 1. The resultant oil was 
stored in a vacuum desiccator containing potassium hydroxide for 
several h. The oil was subsequently crystallised  from ethyl 
acetate to yield N - a c e t y l - L - a l a n i n e  (3.8 g ,  58%); m.p. 123-125 °C; 
[ a ] D 2 0  -58° ( c ,  1.3 in H20 ) ,  lit. , 143 m.p. 125 °C, [ a ] o  -66.2° (c , 1.0 i n  
H 20 ) ;  umax (KBr d i s c )  3320, 1710, 1620 a n d  1560 cm4 ; 5h  1.47
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(3H, d), 2.08 (3H, s) and 4.39 (1H, q); 6C 18.1 (q, CHCH 3), 23.5(q,
COCH3), 50.6 (d, CHCH3), 175.9 (s, COCH3) and 178.7 (s, CO2H); m/z
131 (M +, 6.7%) and 8 6  (100%). Found: M + 131.0580. C5H9NO 3 
required M , 131.0582.
N -Ac ety I-D- a la n in e
D-Alanine (2.22 g, 25 mmol) was acylated exactly in the manner 
described previously for the acylation of L-alanine. The product 
was crysta llised  also from ethyl acetate to y ie ld  TV-acetyl-D-
alanine (1.75 g, 53%); m.p. 124-126 °C; [a]D20 +56.6° (c, 1.4 in H2O), 
lit . , 143 m.p. 125 °C, [a]D20 +66.2° (c , 1.0 in H 2O); umax (KBr disc) 
3280, 3095, 2980, 1710, 1705, 1610 and 1560 c m '1; 6 H L47 (3H, 
d), 2.08 (3H, s) and 4.38 (1H, q); 5C !8.1 (q, CHCH3), 23.5 (q, 
COCH3), 50.7 (d, CHCH3), 176.1 (s, COCH3) and 178.8 (s, CO2H); m/z 
131 (M+, 5.5%) and 8 6  (100%). Found: M \  131.0583. C5H9NO 3 
required Af, 131.0582.
N -A ce ty l-4 -a m in o b u tyr ic  acid
4-Aminobutyric acid (8.24 g, 0.08 mol) was acylated using acetic 
anhydride in acetic acid according to general procedure 2. The 
solid residue  obtained on concentration  o f  the solvent was
recrystallised from acetone to yield A-acetyl-4-aminobutyric acid 
(9.49 g, 82%); m.p. 123-125 °C; umax (KBr disc) 3360, 1720, 1595
and 1550 cm -1; 5H 1.86 (2H, m), 2.03 (3H, s), 2.47 (2H, t) and 3.27
(2H, t); 5C 23.8 (q, COCH3), 25.8 (t, CH2CH2NH), 33.1 (t, CH2C 0 2H),
40.5 (t, CH2NH), 176.1 (s, COCH3) and 180.0 (s, CO2H); m/z 145 (M+, 
19%), 102 (100%), 8 6  (98%) and 72 (74%). Found: M \  145.0746. 
Calcd. for C6H 11NO3 ; M, 145.0739.
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N -P ro p io n y l-4 -a m in o b u tyr ic  a c id
4-A m inobutyric  acid (8.24 g, 80 mmol) was acylated by using 
propionic  anhydride in propionic acid as described in general 
procedure 2. The resultant oil was crystallised from acetone to 
y ield A-propionyl-4-aminobutyric acid (9.86 g, 78%); m.p. 100- 
102 °C; Umax (KBr disc) 3355, 1700, 1605 and 1550 c n r 1; 5H 1.16 
(3H, t), 1.86 (2H, m), 3.29 (2H, q), 2.46 (2H, t) and 3.28 (2H, t); 5c
12.1 (q, CH2CH3), 26.4 (t, CH2CH2NH), 32.2 (t, CH2CH 3), 33.6 (t, 
CH2CO2H), 40.9 (t, CH2NH), 180.40 (s, COCH2) and 180.43 (s, CO2H); 
m/z  159 (M+, 15.4%), 112 (26.3%), 102 (38.3%), 100 (20%) and 8 6  
(43%). Found: M \  159.0886. Calcd. for C7H 13NO3; Af, 159.0895.
6 .2 .2  A - A c y ld ip e p t id e s
L-Histidine benzyl ester ditosylate (25)
A suspension o f  L-histidine free base (1.55 g, 1 mmol) and p-  
to lu e n e su lp h o n ic  acid m o n o h y d ra te  (4 .42  g, 1 m m ol) in 
chloroform  ( 1 0  ml) was heated at reflux together with benzyl 
a lchohol (10 ml). The water produced in the course o f  the 
reaction was collected in a Dean and Stark separator designed for 
use with solvents denser than water. The removal of  water was 
more efficient when the separator was filled with silica gel and 
anhydrous sodium carbonate. After 24 h, the mixture was cooled, 
filtered, and the solvent was rem oved under reduced pressure. 
The residue obtained was triturated with diethyl ether to yield L- 
histidine benzyl ester ditosylate (25) as a white hygroscopic solid. 
Yield 45-70%; m.p. 140-146 °C; [a ]o 2^ -2.4° (c, 1.0 in H2O), lit. , 77 
93%, m.p. 138-146 °C, [a ] D20 -4.13° (c, 0.94 in H20 ) ,  lit.,7  ^ 85-90%, 
m.p. 146-149 °C, [a ] D30 -2.4° (c, 4.7 in H 20 ) ;  umax (KBr disc) 3120
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and 1730 c m '1; 5h  (CD3OD; CD 2HOD was the internal standard at 
3.50 ppm) 2.54 (6 H, s), 3.51-3.65 (2H, AB part of an ABX system), 
4.53-4.63 (1H, X part o f  an ABX system), 4.78 (2H, s), 7.40-7.94 
(14H, aromatic H) and 8.99 (1H, s); 5c (CD3OD; CD2HOD was the 
internal standard at 49.7 ppm) 21.6 (q, PI1CH3), 26.7 (t, CHCH2),
53.1 (d, CHCH2), 73.4 (t, C H 2Ph), 119.9 (d, C-4), 127.2-130.2 
(aromatic), 136.0 (s, Ph), 142.2 (d, C-2), 143.4 (s, C-5) and 170.4 
(s, CO2CH2); m/z 155 (2.3%), 110 (8 %), 91 (100%) and 81 (45%).
G e n e ra l  p ro c e d u re  3
M ixed Anhydride Coupling o f  N -Acylamino Acids to the Benzyl  
Ester o f  L-Histidine
L-Histidine benzyl ester ditosylate (25) (10 mmol) was dissolved 
in d ic h lo ro m e th a n e  c o n ta in in g  t r ie th y la m in e  ( 2 0  m m o l) .  
Triethylam m onium  tosylate was rem oved on fil tra tion  and the 
solution of the free base was stored at 0 °C until it was required. 
T h e  A -a c y la m in o  ac id  (15 m m ol) was d is s o lv e d  in
dichloromethane (25 ml) containing triethylamine (15 mmol) and 
the solution was cooled to -5 °C with the aid of an ice/methanol 
bath. Ethyl chloroformate or isobutyl chloroformate (15 mmol) 
was added to the cooled solution with stirring. Stirring was 
continued for 5 min. At the end of this time the mixture was
filtered  and the f iltra te  was added to the coo led  solu tion
containing L-histidine benzyl ester. The resulting mixture was 
stored at 0 °C until TLC (solvent system 1) showed the reaction to 
be complete. The organic solution was washed tw ice with an
equivalent volume o f  sodium bicarbonate solution ( l M) .  The 
organic layer was dried, filtered and concentrated under reduced 
pressure at room temperature to yield an oil.
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N -Propionyl-L -histid ine  benzyl ester
L-Histidine benzyl ester ditosylate (25) (1.15 g, 1.9 mmol) was 
reacted with propionic  acid (0.28 g, 3.8 m m ol) according to 
general procedure 3 to yield the product as an oil. This oil was 
c ry s ta ll ised  from chloroform . N -P rop iony l-L -h is tid ine  benzyl 
ester was isolated on filtration (0.35 g, 62%); m.p. 124-125 °C; 
[a]D2^ -17.0° (c, 0.32 in ethanol); umax (KBr disc) 3300, 1740, 1660 
and 1535 c m '1; 5h  (CD3OD; CD2HOD was the internal standard at
3.5 ppm) 1.25 (3H, t), 2.39 (2H, q), 3.12-3.37 (2H, AB part of an 
ABX system), 4.87-4.94 (1H, X part of an ABX system), 5.31 (2H, 
s), 6.99 (1H, s), 7.50 (5H, s) and 7.82 (1H, s); 5C (CD3OD; CD2HOD 
was the internal standard at 49.3 ppm) 1 0 .6  (q, CH 3CH 2), 30.1 (t, 
CH2CH), 30.2 (t, CH 3CH2), 54.4 (d, CH2CH), 68.2 (t, PhCH2), 118.3 (d, 
C-4), 129.5 (d, Ph), 129.6 (d, Ph), 129.8 (d, Ph), 134.6 (s, C-5),
136.6 (d, C-2), 137.4 (s, Ph), 173.1 (s, NHCO) and 177.3 (s, CO2CH2); 
m/z  301 (M +, 20%), 110 (79%), 91 (81%) and 81 (60%). Found: M + 
301.1423. Calcd. for C 16H 19N3O3; M, 301.1426.
A num ber o f  A -acylam ino acids were coupled  to L-histidine 
benzyl ester. All o f  the products showed the benzyl ester present 
in the proton and 13C NMR spectra. These derivatives also showed 
similarities in their IR spectra to the data quoted for ALpropionyl- 
L-histidine benzyl ester. The accurate mass data collected for 
these compounds are listed below:
(A). The value obtained for A-acetylglycyl-L-histidine benzyl ester 
was 344.1479, while the mass calculated for C 17H 20N 4O4 was 
3 4 4 .1 4 8 5 .
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(B). A value o f  358.1628 was obtained for A-propionylglycyl-L- 
histidine benzyl ester. C 18H22N4O4 required a measurement o f  
3 5 8 .1 6 4 1
(C). The mass measured for N-acetyl-L-carnosine benzyl ester was 
358.1618, this compound required a value o f  358.1641.
(D). A measurement o f  372.1807 was obtained for W-propionyl-L- 
cam osine benzyl ester. C 19H24N4O4 required a mass o f 372.1798.
(E). The mass m easured for A -acetyl-L-hom ocarnosine benzyl 
ester was 372.1794, while this com pound required a value o f  
3 7 2 .1 7 9 8 .
(F). A value  o f  386.1948 was ob ta ined  for iV-propionyl-L- 
homocamosine. This compound required a mass of 386.1954.
General procedure 4
M ixed Anhydride Coupling o f  N -Acylamino Acids to L-Histidine  
Protected as a Metal Salt.
L-Histidine (2.4 g, 15 mmol) was dissolved in sufficient lithium or 
potassium hydroxide solution (0.33m) to produce a pH of 9.6. This 
solution was stored at 0 °C until it was required. The second N- 
acylated amino acid (18 mmol) was dissolved in the minimum 
am ount o f  e thyleneglycol d im ethyle ther, DMF or aceton itr ile  
containing triethylamine (1.8 g, 18 mmol). The resultant solution 
was cooled to -5 °C with the aid o f  an ice/methanol bath. 
Isobuty lchloroform ate  (2.45 g, 18 mmol) was added dropw ise 
with stirring and the mixture was stirred for a further 3 min. The 
triethylammonium chloride formed was removed by filtration and 
the filtrate  was added with vigorous stirring to the solution 
containing L-histidine. The stirring was continued for a few min 
to allow the evolution of carbon dioxide to take place. The
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mixture was then stored at 0 °C for 2 h. Once the reaction was 
com plete  the solution was acid ified  to pH 5 on addition  o f  
hyd roch lo ric  acid (lM). It was then concentra ted  at room  
temperature and under reduced pressure to yield the product as a 
glassy residue.
N -A ce ty lg lycy l-L -h is t id in e  (17)
A-Acetylglycine (2.11 g, 18 mmol) was coupled to L-histidine (2.4 
g, 15 mmol) using general procedure 4. Lithium hydroxide was 
the aqueous base and e thyleneglycol dim ethyl e ther was the 
o rgan ic  solvent. The re su ltan t  residue was tr i tu ra ted  w ith  
isopropanol (50 ml) and the mixture was then heated. Enough 
water (approx. 12  ml) was added to the mixture to dissolve the oil 
which was formed on heating the solution at reflux. Unreacted L- 
h istid ine  crystallised  out on cooling. This was rem oved by 
filtration and isopropanol was added dropwise to the filtrate until 
it turned cloudy. C rystallisation of the product subsequently  
occurred. The product was recrystallised  from water on the 
addition o f  isopropanol until the flame test for the presence o f  
l i th ium  was negative. N -A cety lg lycy l-L -h is tid ine  (17) was 
obtained as a white solid (2.74 g, 72%); m.p. 140-142 °C; [gc]d20  
+31.1° (c, 1.1 in H 20);  umax (KBr disc) 3400, 3300, 1640 and 1570 
cm-1; 5h 2.10 (3H, s), 3.13-3.40 (2H, AB part of an ABX system), 
3.92 (2H, s), 4.54-4.61 (1H, X part of an ABX system), 7.30 (1H, s) 
and 8.64 (1H, s); 5C 23.7 (q, COCH3), 29.2 (t, CHCH2), 44.5 (t, 
CH2NH), 55.9 (d, CHCH2) 118.8 (d, C-4), 131.6 (s, C-5), 135.1 (d, C- 
2), 172.9 (s, COCH3), 176.6 (s, COCH2) and 178.1 (s, C 0 2H); m/z 254 
(M +, 1.9%), 81 (100%) and 72 (8 6 %). Found: M \  254.1021. 
C 10H 14N4O4 required M, 254.1015.
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N -Propiony lg lycyl-L -h istid ine  (20)
N-Propionylglycine (2.36 g, 8 mmol) was coupled to L-histidine 
(2.4 g, 15 mmol) using general procedure 4 with acetonitrile  as 
the organic solvent and potassium hydroxide as the aqueous base. 
The product was extracted from the residue at the end o f  the 
reaction into boiling ethanol. The ethanol solution was filtered 
and a llow ed to s tand  until the  p roduc t c ry s ta l l i s e d  out. 
R ecrys ta llisa tion  from an e thano l/w ate r  m ixture  p ro d u ced  N- 
propionylglycyl-L-histidine (20) (2.57 g, 64%); m.p. 200-202 °C, 
[ cx] d 2 0  +22.8° (c, 0.94 in H2 O); i)max (KBr disc) 3300, 1640 and 
1545 cm-1; 6 H 1.17 (3H, t), 2.37 (2H, q), 3.11-3.40 (2H, AB part o f  
an ABX system), 3.93 (2H, s), 4.55-4.62 (1H, X part o f  an ABX 
system), 7.30 (1H, s) and 8.65 (1H, s); 6C 11.3 (q, CH2CH 3), 29.1 (t, 
CH2CH), 30.8 (t, CH2CH3), 44.5 (t, CH2NH), 55.7 (d, CH2CH), 118.8 (d, 
C-4), 131.4 (s, C-5), 135.1 (d, C-2), 173.0 (s, COCH2CH 3), 177.9 (s, 
COCH2NH) and 180.7 (s, C 0 2H); m/z  268 (M+, 2.9%), 137 (31%), 8 6  
(44%) and 81 (100%). Found: M+, 268.1172. Calcd. for C 16H 11N4O4 ; 
M, 268.1172.
N -Acetyl-L-carnosine (18)
Method 1
L-Carnosine (2) (2.26 g, 10 mmol) was acylated  with acetic 
anhydride in water by the method described in general procedure 
1. The glassy residue was stored in a vacuum  desicca tor 
containing potassium hydroxide pellets and phosphorus pentoxide 
until a white solid was obtained. The solid was recrystallised 
from methanol to yield A-acetyl-L-carnosine (18) (2.14 g, 80%); 
m.p. 158-160 °C; [a]D20 +14.4° (c, 1.0 in H20).
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Method 2
N-Acetyl-p-alanine (1.57 g, 12 mmol) was coupled to L-histidine 
(1.59 g, 10 mmol) by the method described in general procedure 4 
with potassium hydroxide as the aqueous base and acetonitrile as 
the organic solvent. The white solid produced on removal of  the 
solvent was heated in methanol. The hot methanol solution was 
filtered and the filtrate allowed to stand until crystallisation of the 
product took place. Recrystallisation from methanol yielded N- 
acetyl-L-carnosine (18) (1.58 g, 59%); m.p. 158-160 °C; [cc] d20 
+20.1° (c, 1.14 in H 20 ) ;  umax (KBr disc) 3450, 3320, 1630, 1590 
and 1520 cm -1; 5h (D2O; acetone was the internal standard at 2.20 
ppm) 1.91 (3H, s), 2.44 (2H, t), 2.99-3.28 (2H, AB part o f an ABX 
system), 3.35 (2H, t), 4.46-4.52 (1H, X part of an ABX system), 
7.24 (1H, s) and 8.58 (1H, s); 5c (D20 ;  dioxan was the external 
standard at 67.8 ppm) 21.6 (q, COCH3), 27.3 (t, CH2CH), 35.1 (t, 
COCH2), 35.9 (t, CH2NH), 54.0 (d, CH2CH), 116.7 (d, C-4), 129.8 (s, C- 
5), 133.2 (d, C-2), 173.4 (s, COCH3), 174.1 (s, COCH2) and 176.4 (s, 
C 0 2H); m/z 268 (M+, 1.0%), 110 (29%), 8 8  (33%), 82 (100%) and 81 
(70%). Found: M +, 296.1479. C 11H 16N4O4 required M, 268.1172.
N -Propionyl-L-carnosine (21)
Method 1
L-Carnosine (2) (2.26 g, 10 mmol) was acylated with propionic 
anhydride as described in general procedure 1 with water as the 
solvent. The resultant oil was triturated with acetone then dried 
in a vacuum desiccator containing potassium hydroxide pellets  
and phosphorus pentoxide until a white solid  formed. The  
product was recrystallised from ethanol to y ield  A-propionyl-L-
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camosine (21) (2.0 g, 71%); m.p. 194-195 °C; [a]D20 +14.6° (c, 1.2 
in H2O).
Method 2
Af-Propionyl-(3-alanine (1.74 g, 12 mmol) was coupled to L- 
histidine (1.59 g, 10 mmol) according to the method desribed in 
general p rocedure  4. Acetonitrile was the organic solvent and 
potassium hydroxide was the aqueous base. At the end o f  the
reaction the oil was heated in ethanol and filtered. The filtrate 
was allowed to stand until the product crystallised. N-Propionyl- 
L-camosine (21) was isolated as a white solid (1.5 g, 53%); m.p. 
194-195 °C; [«]D20 +15.5° (c, 1.2 in H 20 ) ;  umax (KBr disc) 3310, 
3285, 1660, 1630, 1570 and 1545 cm-1; 5H 1.12 (3H, t), 2.25 (2H, 
q), 2.53 (2H, t), 3.07-3.36 (2H, AB part o f  an ABX system), 3.45 
(2H, t), 4.52-4.58 (1H, X part of  an ABX system), 7.32 (1H, s) and 
8.64 (1H, s); 5C 11.5 (q, CH2CH3), 29.3 (t, CHCH2), 31.0 (t, CH2CH3),
37.1 (t, CH2CO), 37.7 (t, NHCH2), 56.0 (d, CHCH2), 118.6 (d, C-4),
131.8 (s, C-5), 135.2 (d, C-2 ), 175.3 (s, CO CH 2C H 3), 178.4 (s, 
COCH2CH2) and 179.8 (s, C0 2H); m/z  282 (M +, 1.5%), 137 (28%), 
109 (63%) and 81 (100%). Found: M \  282.1326. Calcd. for 
C 12H 18N4O4 ; M, 282.1328.
N -Acety l-L -hom ocarnosine  (19)
N-Acetyl-4-aminobutyric acid (1.74 g, 12 mmol) was coupled to L- 
histidine (1.59 g, 10 mmol) according to general procedure 4. DMF 
was the organic solvent and lithium hydroxide was the aqueous 
base. T h e  resu ltan t  g lassy  res id u e  was tr i tu ra ted  with 
isopropanol (50 ml) which was subsequen tly  decanted off. 
Ethanol (15 ml) and water (1 ml) were added and the mixture was
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heated until a clear solution was obtained. Isopropanol was added 
on cooling to produce a turbid solution from which the product 
crystallised. The crystalline solid was washed with 1% water in 
acetone to rem ove residual l i th ium  chloride and was then 
recrys ta llised  from ethanol to y ie ld  A -acety l-L -hom ocarnosine  
(19) (1.95 g, 69%); m.p. 120 °C; [a ] D20 + 14 .70  (c, 0.8 in H20 ) ;  umax 
(KBr disc) 3320, 3280. 3100, 1630 and 1540 c m 1; 6 h  1.77 (2H, t),
2.02 (3H, s), 2.33 (2H, t), 3.06-3.38 (2H, AB part o f  an ABX 
system), 3.16 (2H, t), 4.56-4.60 (1H, X part of an ABX system), 
7.32 (1H, s) and 8.64 (1H, s); 5C 23.8 (q, COCH3), 26.6 (t, CH2CH),
29.4 (t, CH2CH2CH2), 34.9 (t, CO CH 2), 40.6 (t, CH2NH), 55.9 (d, 
CH2CH), 118.7 (d, C-4), 131.8 (s, C-5), 135.1 (d, C-2), 176.1 (s, 
COCH3), 177.4 (s, COCH2), 178.5 (s, C 0 2H); m/z 282 (M +, 0.2%), 8 6  
(89%) and 81 (90%). Found: M \  282.1332. Calcd. for C 12H 18N 4O4 ; 
M, 282.1328.
N-Propiotiyl-L-hom ocarnosine (22)
Af-Propionyl-4-aminobutyric acid (3.18 g, 20 mmol) was coupled 
to L-histidine (2.3 g, 15 mmol) according to the method described 
in general procedure 4. Acetonitrile was the organic solvent and 
potassium hydroxide was the aqueous base. The residual oil was 
dissolved in the minimum am ount o f  hot isopropanol. The
solution was cooled and filtered. Acetone was added to the
filtrate to initiate crystallisation o f  the product. A-Propionyl-L- 
hom ocarnosine  (2 2 ) was o b ta ined  on f iltra tion as a w hite  
hygroscopic solid (2.71 g, 61%); m.p. 114-116 °C; [cx]d2^ +10.3° (c ,
1.3 in H 2O); umax (KBr disc) 3420, 3280, 1640 and 1550 cm"1; 5h
(D2O; dioxan was the external standard at 3.53 ppm) 0.89 (3H, t),
1.51 (2H, in), 2.02 (2H, q), 2.08 (2H, t), 2.80-3.12 (2H, AB part of
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an ABX system), 2.92 (2H, t), 4.28-4.35 (1H, X part o f  an ABX 
system), 7.06 (1H, s) and 8.38 (1H, s); 6 c  ( P 2O; dioxan was the 
external reference at 67.8 ppm) 10.7 (q, CH2CH 3), 25.8 (t, CHCH2),
28.6 (t, CH2CH2CH2), 30.3 (t, CH2CH3), 34.0 (t, COCH2CH2), 39.6 (t, 
CH2NH), 55.0 (d, CHCH2), 117.8 (d, C-4), 130.9 (s, C-5), 134.3 (d, C- 
2), 176.4 (s, COCH2CH3), 177.6 (s, COCH2CH2) and 179.1 (s, CO2H); 
m /z  296 (M +, 1.8%), 120 (93%) and 81 (100%). Found: M \  
296.1479. Calcd. for C 13H20N4O4 ; M, 296.1485.
N -A cety l-L -a lany l-L -h is tid ine  (28)
A-Acetyl-L-alanine (1.31 g, 10 mmol) was coupled to L-histidine 
(1.22 g, 7.9 mmol) using general procedure 4. DM F was the 
organic solvent and lithium hydroxide was the aqueous base. The 
residue obtained at the end of the reaction was triturated with 
isopropanol (20 ml). The mixture was heated and water (3 ml) 
was added, methanol was then added dropwise until a clear 
solution resulted. The cooled solution was filtered, the filtrate was 
concentrated, and the residue was crystallised from ethanol to 
yield  A-acetyl-L-alanyl-L-histidine (28) (1.26 g, 59%); m.p. 150- 
152 °C; [a ] D20 -32.8° (c, 0.9 in 6 m HC1); umax (KBr disc) 3450, 3280, 
1645 and 1540 cm’1; 6 H 1.39 (3H, d), 2.08 (3H, s), 3.11-3.39 (2H, 
AB part of an ABX system), 4.30 (1H, q), 4.51-4.57 (1H, X part of 
an ABX system), 7.32 (1H, s) and 8.64 (1H, s); 6C 18.4 (q, CHCH3),
23.5 (q, COCH3), 29.2 (t, CH2CH), 51.7 (d, CHCH3), 55.9 (d, CH2CH),
118.8 (d, C-4), 131.4 (s, C-5), 135.1 (d, C-2), 175.9 (s, COCH3),
176.5 (s, COCHCH3) and 180.0 (s, C 0 2H); m/z 268 (M+, 1.4%), 164 
(24%), 137 (78%), 120 (100%), 109 (31%) and 81 (91%). Found: 
M+, 268.1168. Calcd. for C 11H 16N4O4 ; M, 268.1172.
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N-acety l-D -a lanyl-L-h is tid ine  (29)
N-Acetyl-D-alanine (1.97 g, 15 mmol) was coupled to L-histidine 
(1.55 g, 10 mmol) using general procedure 4. DM F was the 
organic solvent and potassium hydroxide was the aqueous base. 
The residue obtained was heated in ethanol and the solution was 
cooled and filtered. The ethanol solution was left at room 
temperature until the product crystallised. W-Acetyl-D-alanyl-L- 
histidine (29) was obtained as a white crystalline solid (1.56 g, 
58%); m.p. 133-135 °C; [oc] D20 -42.1° (c, 0.8 in 6 m HC1); umax (KBr 
disc) 3280, 1640, 1565 and 1540 c m 1; 6 H 1.39 (3H, d), 2.06 (3H, 
s), 3.11-3.39 (2H, AB part of an ABX system), 4.31 (1H, q), 4.51- 
4.57 (1H, X part of an ABX system), 7.32 (1H, s) and 8.64 (1H, s); 
6 C 18.4 (q, CHCH3), 23.5 (q, COCH3), 29.2 (t, CHCH2), 51.8 (d, CHCH3),
55.9 (d, CHCH2), 118.8 (d, C-4), 131.4 (s, C-5), 135.1 (d, C-2), 175.9 
(s, COCH3), 176.6 (s, COCH) and 177.9 (s, C 0 2H); m/z 268 (M+, 1.9%), 
164 (22%), 137 (75%), 109 (34%) and 81 (85%). Found: M+, 
268.1170. Calcd. for C 11H 16N4O4 ; M, 268.1172.
6.2.3 Procedures Used For the Determination of Optical 
P u r i t y
Coupling o f  (R)-a-Methylbenzylamine to N-Acyldipeptides  
A -e th y l -A '-d im e th y la m in o p ro p y lc a rb o d i im id e  (39 .5  mg, 0 . 2  
mmol) was added to a suspension of the N-acyldipeptide (0 .2  
mmol) in pyridine (3 ml). (ft>oc-Methylbenzylamine (25.8 jul, 0.2 
mmol) was added and the m ixture was s tir red  at room  
tem perature overnight. The solution was concen tra ted  under 
reduced pressure and the resultant oil was extracted with ethyl 
acetate ( 3 x 3  ml). The combined organic extracts were washed
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with water (2  ml), dried and concentrated under reduced pressure 
to yield  the d iastereo isom eric  p roducts. Each p roduc t was 
dissolved in methanol (2 ml) and applied to the HPLC column. The 
peaks were detected by a UV spectrometer at 254 nm.
E u ro p iu m  (111) - (R ) -p r o p a n e -1,2 -d ia m i ne t e tra -a c e  ta t  e 
Concentrated  hydrochloric  acid (6  mmol) was dropped into a 
suspension of europium(III) oxide (0.35 g, 1 mmol) in water (5 
ml). The mixture was heated at reflux with stirring until a clear 
solution was obtained. More acid was added to effect dissolution 
if  required . Potassium  carbonate solu tion  ( lM ) was added 
dropwise to precip ita te  the europium(III) carbonate. The solid 
was collected on filtration and dried. The dried solid was then 
added  g rad u a lly  to a warm so lu tion  o f  ( /? ) -p ro p a n e - l ,2 - 
diaminetetra-acetate (0.6 g, 2 mmol) in water (8  ml). The solution 
was adjusted to pH 9 upon the addition o f  potassium  carbonate 
solution (lM ). The solution was filtered and the filtrate was 
concen tra ted  under reduced p ressu re  to y ie ld  the  product, 
e u ro p iu m (I I I ) - ( /? ) -p ro p a n e - l ,2 -d ia m in e te tra -a c e ta te .  T his  was 
used accord ing  to the procedure pub lished  by K abuto  and 
S asak i . 136’137
Reaction o f  N -Acetylhistidine with Brucine
Brucine (0.43 g, 1 mmol) was added to a solution o f  acetyl-DL- 
histidine (0.2 g, 1 mmol) in ethanol (6  ml). The solution was 
heated for 1 0  min and then concentrated under reduced pressure 
to yield a syrup. The product crystallised from water.
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Reaction o f  N -Acylamino Acids and Peptides with Acylase I  
The N-acylamino acid or peptide (0.1 mmol) was dissolved in D20  
(1 ml). The solution was adjusted to pD 8 upon addition of sodium 
deuteroxide (lM). Hog Kidney Acylase I (5 mg, 1700 U/mg) was 
added and the solution was incubated at 38 °C for 24 h.
6.3 E x p e r im e n ta l  to C h a p te r  5
6.3.1 S y n th e s is  o f  1 - M e th y lh is t id in e  (33)
M ethod 1^4
N (a )-Benzoyl-L -h istid ine  (30)
L-Histidine monohydrochloride (6.3 g, 33 mmol) was dissolved in 
sodium hydroxide solution (2 m ; 30 ml). The solution was ice 
cooled and stirred while benzoyl chloride (4.64 ml) was added 
simultaneously with sodium hydroxide solution (2M; 65 ml) over a 
period of 1.5 h. At the end of this time the solution was acidified 
with the addition of hydrochloric acid (5M; 21 ml) and finally 
glacial acetic acid (17.6m ; 0.29 ml). The A(a)-benzoyl-L-histidine 
precipitated immediately, solidifying into little rods. The reaction 
mixture was left at 0 °C for 1 h and then it was filtered. The solid 
was collected and washed with ice cold water and diethyl ether. 
The product was dried at 100 °C. Recrystallisation from boiling 
w ater yielded pure A(a)-benzoyl-L-histidine (30) (5.75 g, 87%); 
m.p. 246-247 °C; [a]D20 -44.0° (c, 1.0 in 2m HC1); lit .,74 m.p. 247 °C; 
[a ] D20 -46.6° (c, 6.4 in 2 m HC1); i w  (KBr disc) 3475, 3440, 3280, 
3120, 1630 and 1580 c m 1; 5h (D 20/DC1; r-butanol was the 
internal standard at 1.3 ppm) 3.33-3.57 (2H, AB part of an ABX 
system), 4.96-5.04 (X part of an ABX system), 7.37 (1H, s), 7.42-
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7.75 (5H, s) and 8.67 (1H, s); 6 c  (D2O/DCI; r-butanol was the 
internal standard at 31.6 ppm) 28.0 (t, CHCH2), 54.2 (d, CH CH 2),
119.2 (d, C-4), 129.2 (d, Ph), 130.8 (d, Ph), 134.0 (s, C-5), 134.7 (d, 
C-2), 135.2 (s, Ph), 172.3 (s, NHCO) and 175.1 (s, CO2H); m/z  259 
(M +, 4%), 110 (14%), 105 (100%) and 81 (100%). Found: M + 
259.0956. Calcd. for C 13H 13N3O3; M, 259.0957.
N(a)-Benzoyl-L-histid ine methyl ester (31)
A(a)-Benzoyl-L-histidine (30) (2.7 g, 10.4 mmol) was suspended 
in methanol (27 ml). The mixture was saturated with HC1 gas at 
room temperature. The resulting solution was heated at reflux for 
2  min and the solvent was subsequently removed under reduced 
pressure. The residue was dissolved in absolute ethanol and once 
again the solution was concentrated. The oil was stored in a 
vacuum desiccator containing potassium hydroxide pellets until no 
traces o f  the acid remained. The residue was then dissolved in 
hot water ( 2 0  ml), the solution was cooled and treated with 
ammonia (0 .8 8 ) until there was a permanent odour of the amine. 
N (a )-B en zo y l-L -h is tid in e  m ethyl e s te r  (31) c ry s ta ll ised  in to  
prisms. These were collected on filtration, washed with water and 
dried at 100 °C (1.9 g, 67%); m.p. 158-160 °C; [oc]D20 -27.5°, (c, 0.8 
in 6 m HC1), lit . ,74 m.p. 159-160 °C; umax (KBr disc) 3280, 1750, 
1660 and 1530 cm-1; 5h (D2O/DCI; HOD was the internal standard 
at 4.67 ppm) 1.39-1.65 (2H, AB part of an ABX system), 1.87 (3H, 
s), 3.05-3.15 (1H, X part o f  an ABX system), 5.43-5.80 (6 H, 
aromatic H) and 6.73 (1H, s); 6 c  (D2O/DCI; dioxan was the external 
standard at 67.8 ppm) 26.0 (t, CHCH2 ), 52.2 (q, CO2CH3), 53.5 (d, 
CHCH2), 117.2 (d, C-4), 127.2 (d, Ph), 128.7 (d, Ph), 128.8 (d, Ph),
131.9 (s, Ph), 132.8 (d, C-2), 133.2 (s, C-5), 170.6 (s, NHCO) and
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171.9 (s, CO2CH3); m/z  273 (M +, 11%), 152 (26%), 105 (100%) and 
81 (74%). Found M + 273.1106, C 14H 15N3O3 required; M, 273.1113.
A ttem pted  synthesis o f  N (a ) ,3-dibenzoyl-L-histidine m ethyl ester  
(3 2 )
Benzoyl chloride (0.75 g, 5.4 mmol) in tetrahydrofuran (THF) (3.8 
ml) was added to a stirred mixture of A (a)-benzoyl-L-histid ine 
methyl ester (31) (1.4 g, 5 mmol) and dicyclohexylamine (0.94 g,
5.2 mmol) in THF (38 ml) over a period of 1.5 h. Stirring was 
continued for 30 min and the solution was then filtered. The solid 
was washed with THF (3 ml) and the combined THF solutions were 
concentrated under reduced pressure to give an oily residue.
M ethod 2
N(a),3-b is(t-Butoxycarbonyl)-L-histid ine methyl ester  (34) 
L-Histidine methyl ester dihydrochloride (2.42 g, 0.01 mol) was 
dissolved in methanol (8  ml) containing triethylam ine (2 . 0 2  g, 
0.02 mol). Di-r-butyl dicarbonate (4.8 g, 0.02 mol) was added 
with stirring. Stirring was continued for 20 h. A white precipitate 
form ed during the course o f  the reaction. The solvent was 
concentrated , and the residue was taken up in acetone and 
filtered. The filtrate was evaporated under reduced pressure. 
Chloroform (10 ml) was added and the mixture was extracted 
with 10% citric acid ( 2 x 2  ml). The organic layer was further 
extracted with water (2 ml). After drying, the organic layer was 
concentrated to yield an oil. The oil was crysta llised  from 
p e tro le u m  e ther  (b .p . 40 -60  °C) to y ie ld  A (a ) ,3 -b is ( r -
butoxycarbonyl)-L-histidine methyl ester (34) (3.21 g, 87%); m.p.
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88-90 °C; [a ] D20 +25.9° (c, 0.9 in CC14); lit.,67 m.p. 85-88 °C, M d 20 
+ 19.9° (c, 1.16 in CHCI3); lit . ,49 m.p. 96 °C, [ oc] d 2 0  + 25.6° (c, 1.0 in 
CCI4 ); U m ax (CHCI3 solution) 3440, 2980, 1750, 1710, 1500, 1480 
and 1380 cm-1; 5h (CDCI3 ; CHCI3 was the internal standard at 7.25 
ppm) 1.21 (9H, s), 1.40 (9H, s), 2.83 (2H, AB part o f  an ABX 
system), 3.51 (3H, s), 4.30-4.40 (1H, X part of an ABX system), 
5.74 (1H, d), 6.96 (1H, s) and 7.78 (1H, s); 6 c  (CDCI3; CHCI3 was the 
internal standard at 77.7 ppm) 28.0 (q, C(CH3)3), 28.5 (q, C(CH3)3),
30.4 (t, CHCH2), 52.4 (d, CHCH2), 53.4 (q, CO2CH3), 79.7 (s, C(CH3)3),
85.7 (s, C(CH3)3), 114.7 (d, C-4), 137.1 (d, C-2), 138.9 (s, C-5),
147.0 (s, C02C(CH3)3), 155.7 (s, C0 2C(CH3)3) and 172.5 (s, CO2CH3); 
m/z  369 (M+, 3.8%), 313 (22%), 196 (16%), 152 (77%), 110 (22%) 
and 81 (6 8 %). Found: M + 369.1903, C n H 27N 3 0 6  required; M , 
3 6 9 .1 9 0 0 .
Attem pted  N -M ethyla tion  o f  the Im idazole Ring o f  L-Histidine  
Derivatives Using Trimethyloxonium Hexachloroantim onate  
The protected L-histidine derivative (5 mmol) was dissolved in 
a n h y d ro u s  n i t r o m e th a n e  (10  m l).  T r im e th y lo x o n iu m  
hexachloroantimonate (6  mmol) in anhydrous nitromethane (5 ml) 
was added at room temperature with vigorous stirring. Stirring 
was continued for four h. The solution was then concentrated 
under reduced pressure to yield a black tar like substance which 
was insoluble in water and various organic solvents.
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General procedure 5
N-M ethylation o f  the Imidazole Ring o f  L-Histidine Derivatives 
The L-histidine derivative (5.0 mmol) was dissolved in DMF (3 ml) 
and methyl iodide (1.42 g, 10 mmol) was added. The reaction 
mixture was heated at reflux (45 °C) until TLC (solvent system 1) 
showed the reaction to be complete. Water (2 ml) was added and 
the solution was concentrated under reduced pressure. The DMF 
was removed on azeotroping with further volumes of water. The 
oil was dissolved in ethyl acetate or chloroform (5 ml) and the 
solution was extracted with aqueous ammonia until the organic 
portion was colourless. The organic layer was dried, filtered and 
concentra ted  under reduced pressure.
N (a )- t-B u to xyca rb o n y l- l-m e th y l-L -h is t id in e  m e th y l  es ter  (35) 
Af(a),3-bis(r-Butoxycarbonyl)-L-histidine methyl ester (34) (1.7 g, 
5 mmol) was m ethylated according to genera l procedure 5. 
Diethyl ether was added to the oil obtained on concentration of 
the ethyl acetate  and crystallisation took place to yield N(a)-t-  
bu toxycarbonyl-l-m ethyl-L-histid ine methyl ester (35) as a white 
crystalline solid (0.57 g, 40%); m.p. 108-110 °C; [cx]d2^ +27.9° (c, 
0.47 in CH CI3); Umax (CHCI3 solution) 3450, 3040, 2995, 2980, 
1750, 1710, 1500 and 1440 c m 1; 5h (CDCI3; CHCI3 was the internal 
standard at 7.25 ppm) 1.42 (9H, s), 2.95-3.22 (2H, AB part of an 
ABX system), 3.61 (3H, s), 3.75 (3H, s), 4.48-4.58 (IH , X part of an 
ABX system), 5.25 (1H, NH), 6.71 (1H, s) and 7.62 (1H, s); 6 C (D20 ;  
dioxan was the external standard at 67.8 ppm) 26.2 (t, CHCH2),
28.3 (q, C(CH3)3), 34.0 (q, NCH3), 52.9 (d, CHCH2), 54.0 (q, OCH3),
82.5 (s, C (CH 3)3), 119.0 (d, C-4), 131.4 (s, C-5), 136.0 (d, C-2 ),
157.9 (s, C 0 2C(CH3)3) and 173.4 (s, C0 2CH3); m/z 283 (M+, 2 .1 %),
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227 (17%), 210 (18%) and 95 (100%). Found M + 283.1530. Calcd. 
for C 13H21N 3O4 ; M, 283.1532.
General procedure 6
Deprotection o f  Methyl Ester and Carbamate Derivatives by Acid  
H y d r o ly s is
The protected derivative (1 mmol) was dissolved in a minimum 
amount of  methanol. Hydrochloric acid (6 M; 15 ml) was added 
and the solution was heated at 90 °C until TLC (Solvent system 1) 
showed the deprotection to be complete. The solution was then 
concentrated under reduced pressure to yield the free amino acid 
or peptide as the acid salt.
General procedure 7
C lea va g e  o f  M ethy l E s ters  a n d  C a rb a m a tes  with B oron  
T rib ro m id e^^
The pro tected  histidine derivative (2.0 mmol) was dissolved in 
dry methylene chloride (25 ml) and cooled to -10 °C with the aid 
o f  an ice/m ethanol bath. lM Boron tribrom ide in m ethylene 
chloride (1 mmol per atom which is complexed) was added and 
the mixture was stirred at -10 °C for a further h. Stirring was 
continued at room temperature for several d until TLC (solvent 
system 1) showed complete c leavage o f  the ester had been 
effected. W ater (50 ml) was added with care and the layers were 
separated. The organic portion was washed with water (3 x 25 
ml). The com bined aqueous layers w ere concentrated  under 
reduced pressure. The solid obtained was dissolved in methanol 
and concentrated several times.
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\-M eth y lh is t id in e  (33) d ihydroch lor ide
l -M e th y l-A (a ) - r -b u to x y c a rb o n y l-L -h is t id in e  m ethyl e s te r  (35) 
(0.242 g, 0.86 mmol) was dissolved in a small amount o f  methanol 
and treated with hydrochloric  acid (6 m, 1 2  ml) according  to
general procedure 6 . The reaction was complete in 3 h. 1-
M e th y lh is t id in e  (33) d ih y d ro c h lo r id e  was iso la te d  as a 
hygroscopic foam. The product was crystallised from ethanol on 
the addition of diethyl ether. (0.138 g, 95%); m.p. 214-218 °C, 
lit . ,74 m.p. 216-219 °C (dec), R f  0.61 (TLC solvent system 3); umax 
(KBr disc) 3420, 2940, 2680, 2500 and 1595 cm4 ; 6 H 3.28 (2H, AB 
part o f  an ABX system), 3.86 (3H, s), 4.01-4.08 (1H, X part o f  an 
ABX system), 7.32 (1H, s) and 8.44 (1H, s); 6C 26.6 (t, CHCH2), 34.7 
(q, NCH3), 55.1 (d, CHCH2), 122.9 (d, C-4), 130.3 (s, C-5), 138.9 (d, 
C-2) and 174.8 (s, C 0 2H); m/z 169 (M +, 1%), 124 (4%) and 95 
(100%). Found: M +, 169.0845. C7H n N 3 0 2 required M , 169.0851.
1-M ethylh is tid ine  (33) d ihydrobrom ide
l -M e th y l-A f(a )-L b u to x y c a rb o n y l-L -h is t id in e  m ethyl e s te r  (35) 
(0.24 g, 0.85 mmol) was dissolved in methylene chloride ( 2 2  ml).
The solution was treated with boron tribromide according to the
method described in general procedure 7 . The oil obtained on 
concentration of the methanolic solution was dissolved in a small 
amount of water and boiled with activated charcoal. The charcoal 
was removed upon filtration o f  the mixture through celite. The 
aqueous solution was then concentrated  to yield  an oil. All 
attempts to crystallise the oil failed. The oil had identical proton 
and 13C NMR, IR and mass spectra to the product (33) obtained as 
the dihydrochloride salt.
6.3 .2  3 -M ethy lh ist id in e  (39)
M e t h o d ! 153
1 8 0
( + ) - (7 S ) -5 ,6 ,7 ,8 - T e tr a h y d r o - l - (m e th o x y c a r b o n y l ) -5 -o x o im id a z o -  
[ \,5 -c]pyrim id ine  (40)
A mixture of L-histidine methyl ester dihydrochloride (1.5 g, 6.2 
mmol) and 7/, W-carbonyldiimidazole (1.0 g, 6.2 mmol) in DMF (31 
ml) was stirred at 60 °C for 3 h. At the end o f  this time, the 
solvent was removed under reduced pressure, yielding an oil. The 
oil was dissolved in sodium bicarbonate solution (lM; 62 ml) and 
the aqueous solution was extracted with chloroform (8  x 12  ml). 
T h e  com bined  o rgan ic  ex trac ts  w ere  d ried , f i l te re d  and  
concentrated under reduced pressure to yield a solid. The product 
(40) was crystallised from methanol (1.1 g, 94%); m.p. 155-157 °C; 
[ oc] d 2 ^ +58.4° (c, 0.9 in methanol), lit . , 153 m.p. 156-157 °C, [ cx] d 2 5  
+59.0° ( c ,  1.2 in methanol); u m a x  (KBr disc) 3120, 1755, 1715 and 
1410 cm-1; 5h (CDCI3 ; CHCI3 was the internal standard at 7.25 
ppm) 3.07-3.43 (2H, AB part of an ABX system), 3.80 (3H, s), 4.32- 
4.40 (1H, X part of an ABX system), 6.44 (1H, NH), 6.87 (1H, s) and
8.14 (1H, s); 5c (CDCI3 ; CHCI3 was the internal standard at 77.7 
ppm) 23.8 (t, CHCH2), 53.4 (d, CHCH2), 54.1 (q, OCH3), 124.5 (s, C- 
5), 127.1 (d, C-4), 135.9 (d, C-2), 148.4 (s, NCONH) and 170.2 (s, 
CO2CH3); m/z 195 (M +, 27%), 152 (39%) and 81 (100%). Found: 
M +, 195.0620. C8H9N 3O 3 required M, 195.0643.
(+ ) - (7 S ) -5 ,6 ,7  f i - T e  tra h y d r o -1 - (m e t  hoxy  c a r b o n y l ) - ! - m e th y l - 5 - 
oxoim idazo[\,5-c]pyrim idinium  iodide (41)
Methyl iodide (3.3 g, 23.5 mmol) was added to a solution of (+)- 
(7 S )-5 ,6 ,7 ,8 - te t ra h y d ro -7 - (m e th o x y c a rb o n y l) -5 -o x o im id a z o [ l  ,5-
181
c]pyrimidine (40) (0.29 g, 1.5 mmol) in DMF (3 ml). The mixture 
was heated at reflux for 2.5 h. It was then cooled to room
tem perature  and diethyl ether (15 ml) was added. The oil 
crystallised on standing at 0 °C overnight. The product (41) was 
recrystallised from methanol (0.47 g, 93%); m.p. 160-162 °C; [cc]d2^ 
+43.4°, (c, 1.0 in H2O), lit. , 153 m.p. 162 °C (dec.), [a ]o 25 +46.0° (c, 0.7 
in H2O); umax (KBr disc) 3095, 1760 and 1700 cm-1; 5h (D2O; HOD 
was the internal standard at 4.67 ppm) 3.38-3.41 (2H, AB part of 
an ABX system), 3.67 (3H, s), 3.87 (3H, s), 4.62-4.67 (1H, X part of 
an ABX system), 7.32 (1H, s) and 9.26 (1H, s); 6 c  (D2O; dioxan was 
the external standard at 67.8 ppm) 22.6 (t, CHCH2), 38.0 (q, NCH3), 
53.1 (d, CHCH2), 55.0 (q, OCH3), 121.9 (d, C-4), 129.5 (s, C-5), 136.4 
(d, C-2), 146.8 (s, NCONH) and 172.4 (s, CO2CH3); m/z 210 (M +, 8 %), 
and 95 (32%). Found: M +, 210.0881. C9H 12N 3O 3 required M,
2 1 0 .0 8 7 9 .
3-M ethylh is tid ine  (39) d ihydrochloride
(+ ) - (7 S ) -5 ,6 ,7 ,8 -T e tra h y d ro -7 - (m e th o x y  c a rb o n y l) -2 -m e th y  1-5- 
oxoimidazo[l ,5-c]pyrimidinium iodide (41) (0.4 g, 1.2 mmol) was 
dissolved in hydrochloric acid (6 m; 5 ml). The solution was heated 
at reflux for 8 h. The solution was concentrated under reduced 
pressure  to yield 3-m ethy lh is tid ine  (39) d ihydroch loride  as a 
glassy solid. The product was crystallised from ethanol upon the 
addition of diethyl ether (0.23 g, 79%); m.p. 254-256 °C, l i t . , 153 
m.p. 258-259 °C (dec.), [a ] D25 +8.2° (c, 2.7 in H20 ) ;  RF 0.57 (TLC 
solvent system 3); umax (KBr disc) 2940, 2500-2800 and 1630 cm- 
6 h (D2O; HOD was the internal standard at 4.67 ppm) 2.97-3.13 
(2H, AB part of an ABX system), 3.59 (3H, s), 4.16-4.22 (1H, X part 
of an ABX system), 7.07 (1H, s) and 8.05 (1H, s); 6 c  (D2O; dioxan
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was the external standard at 67.8 ppm) 27.6 (t, CH CH 2), 36.2 (q, 
NCH3), 54.9 (d, CHCH2), 122.4 (d, C-4), 130.4 (s, C-5), 137.3 (d, C-2) 
and 173.9 (s, CO2H); m/z 169 (M +, 1.9%) and 95 (43%). Found: M \  
169.0848. C 7H 11N 3O2 required M, 169.0851.
Method 2
l -B e n zo x y m e th y l- 'N (a )- l-b u to x y c a rb o n y l-L -h is t id in e  m e th y l  es te r  
hydrochloride (42) .49
Benzyl chloromethyl ether (0.33 ml, 2.37 mmol) was added to a 
solution o f  Af(oc),3-bis(/-butoxycarbonyl)-L-histidine methyl ester 
(34) (0.58 g, 1.5 mmol) in dichlorom ethane (3.6 ml) and the 
mixture was set aside overnight. The solution was concentrated 
and the residue was dissolved in methanol (0.6 ml). Diethyl ether 
(7.2 ml) was added to produce a slightly turbid solution from 
w h ic h  1 - b e n z o x y  m e th y l -  N( a)  - r - b u to x y  c a r b o n y l  - L - h i s t i d in e  
methyl ester hydrochloride (42) crystallised (0.52 g, 82%); m.p. 
138-140 °C; [ oc] d 2 0  -16° (c, 1.0 in methanol), l i t . ,49 m.p. 152 °C, 
[ oc] d 2(* -19.1° (c, 1.0 in methanol); umax (KBr disc) 3300, 3100, 
3000, 1745, 1720 and 1370 c m 1; 6 h  (CDCI3 ; CHCI3 was the internal 
standard at 7.25 ppm) 1.38 (9H, s), 3.02-3.40 (2H, AB part of an 
ABX system), 3.72 (3H, s), 4.48-4.62 (1H, X part of  an ABX 
system), 4.68 (2H, d), 5.82 (2H, s), 7.18 (1H, s), 7.29 (5H, s) and 
9.78 (1H, s); 6 c  (CDCI3 ; CHCI3 was the internal standard at 77.7 
ppm) 27.3 (t, CH2CH), 28.8 (q, C(CH3)3), 52.9 (d, CH 2CH), 53.7 (q, 
OCH3), 72.8 (t, OCH2N), 77.1 (t, PhCH20),  81.5 (s, C(CH3)3), 119.2 (d, 
C-4), 128.8 (d, Ph), 129.2 (d, Ph), 129.3 (d, Ph), 130.6 (s, C-5),
136.2 (s, Ph), 136.9 (d, C-2),155.8 (s, NHCO2) and 171.6 (s, CC>2Me);
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m /z  389 (M +, 9%), 202 (26%) and 91 (100%). Found: M +, 
389.1934. C20H27N3O 5 required Af, 389.1950.
1 -B e  n z o x y m e th y l -N  ( a ) - t -b u to x y  c a r b o n y l -3 - m e th y l -L - h i s t id in iu m  
m ethyl ester iodide (43)
1 -B en zo x y m eth y l-A (a )-r-b u to x y carb o n y l-L -h is t id in e  m ethyl e s te r  
hydrochloride (42) (0.21 g, 2 mmol) was dissolved in DMF (2 ml) 
containing triethylam ine (0.20 g, 2 mmol). After a few min 
stirring, trie thylam m onium  chloride was rem oved by filtration. 
Methyl iodide (4.41 g, 31 mmol) was added to the filtrate and the 
solution was heated at reflux (45 °C) for 3 h. The reaction mixture 
was concentrated and the residue was dissolved in acetone. The 
product crystallised on addition of diethyl ether (0.95 g, 89%); 
m .p .134-136 °C; [cc]d20 -13.7° (c, 0.9 in methanol); umax (KBr disc) 
3390, 3090, 2970, 1735, 1710, 1510 and 1500 cm-*; SH (CDCI3 ; 
CHCI3 was the internal standard at 7.25 ppm) 1.44 (9H, s), 3.10- 
3.45 (2H, AB part of an ABX system), 3.80 (3H, s), 3.96 (3H, s), 
4.50-4.60 (1H, X part of an ABX system), 4.85 (2H, s), 5.1 (br s, 
NH), 5.89 (2H, s), 7.17 (1H, s), 7.35 (5H, m) and 10.24 (1H, s); 6C 
(CDCI3 ; CHCI3 was the internal standard at 77.7 ppm) 27.5 (t, 
CHCH2), 28.8 (q, C(CH3)3), 37.5 (q, NCH3), 52.9 (d, CHCH2), 53.8 (q, 
OCH3), 73.3 (t, OCH2N), 77.5 (t, PI1CH2), 81.4 (s, C(CH3)3), 122.6 (d, 
C-4), 128.9 (d, Ph), 129.0 (d, Ph), 129.3 (d, Ph), 132.1 (s, Ph), 136.4 
(s, C-5), 138.4 (d, C-2 ), 156.1 (s, C 0 2C(CH3)3) and 171.5 (s, CO2CH3); 
m/z  283 (3.4%), 226 (4.5%), 183 (1.2%), 166 (26.5%), 124 (15%) 
and 95 (32%).
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General Procedure 8
Base Hydrolysis o f  Methyl Ester Derivatives
The methyl ester derivative (5 mmol) was dissolved in methanol 
(15 ml). Sodium hydroxide solution ( l M ;  5.7 ml) was added and 
the m ixture was stirred at room tem perature for 10 min. The 
solution was then adjusted to pH 4 upon the dropwise addition o f  
hydrochloric  acid ( l M ) .  The solution was then extracted with 
chloroform (3 x 10 ml). The combined chloroform extracts were 
dried, filtered and concentrated at reduced pressure to yield the 
acid.
1 -B e  n zo x y  m e th y l - 3 - m e th y l -N (a ) - t - b u to x y  ca r  b o n y  l -h i s t id in iu m  
io d id e
1 -B e n z o x y  m e th y l-3 -m e th y l-N  ( a ) - / -b u to x y c a rb o n y  l -h is t id in iu m  
m ethyl es te r  iodide (43) (2.65 g, 5 mmol) was treated with 
sodium hydroxide according to the method described in general 
procedure 8 . Concentration of the organic solution yielded 1- 
b e n z o x y m e th y l - 3 - m e th y l - A f ( a ) - / - b u to x y c a r b o n y l  h i s t i d i n i u m  
iodide as an oil (2.05 g, 79%); 5h (D20 ;  acetone was the internal 
standard at 2.28 ppm) 1.30 (9H, s), 3.37-3.62 (2H, AB part of an 
ABX system), 3.87 (3H, s), 4.32-4.40 (1H, s), 4.81 (2H, s), 5.78 (2H, 
s), 7.45 (6 H, aromatic) and 8.85 (1H, s); 6 c  (D20 ;  acetone was the 
internal standard at 32.3 ppm) 26.1 (t, CHCH2), 31.6 (q, C(CH 3)3),
37.9 (q, NCH3), 53.7 (d, CHCH2), 72.0 (s, C(CH3)3), 74.5 (t, OCH2N),
78.3 (t, PhCH2), 125.6 (d, C-4), 130.4 (d, Ph), 130.6 (s, Ph), 130.8 
(d, Ph), 130.9 (d, Ph), 137.5 (s, C-5), 139.6 (d, C-2), 156.7 (s, 
C 0 2C(CH3)3) and 172.6 (s, C0 2H).
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Attempts to Remove the Benzoxym ethyl group
(A ). 1 -B e n z o x y m e th y l-A (a ) - r -b u to x y  c a rb o n y l-3 -m e th y l  
histidinium iodide (2.0 g, 4 mmol) was dissolved in methanol (50 
ml). Ammonium formate (1.6 g, 25 mmol) and palladium  on 
carbon (10%; 3 g) was added and the mixture was heated at 
reflux. Aliquots were removed for TLC. No reaction was observed 
after 24 h. Starting material was recovered on filtration and
evaporation of the solvent.
(B ) . l -B e n z o x y m e th y l -A (a ) - f -b u to x y  c a rb o n y l-3 -m e th y l  
histidinium iodide (2.0 g, 4 mmol) was dissolved in 80% aqueous 
acetic acid (25 ml). Palladium on carbon (10%; 100 mg) was
added  and the suspension  was hydrogenated  at a tm ospher ic  
pressure. Even after 48 h only starting material was recovered.
(C ) . l -B e n z o x y m e th y l-N (a ) - r -b u to x y c a rb o n y  1-3-m e th y l  
histidinium iodide (2.0 g, 4 mmol) was dissolved in 80% aqueous 
acetic acid (25 ml). Palladium on carbon (10%; 100 mg) was
added and the suspension was hydrogenated under pressure  (2  
atm .).
(D ) . l  -Ben zoxy m ethyl-  N (a ) - r -b u to x y  ca rb o n y l-3 -m e th y l  
h is tid in ium  iodide (340 mg, 0.68 mmol) was d isso lv ed  in
methanol (5 ml). Hydrochloric acid (6 m; 10 ml) was added and 
the solution was heated at reflux for 24 h. The mixture was then 
cooled and filtered. The filtrate was concentrated under reduced 
pressure to yield an oil.
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6.3.3 Dipeptides C ontain ing 1-M ethylhistid ine
General procedure 9
N-C arbobenzoxy-pro tected  Am ino Acids
The amino acid (22 mmol) was dissolved in sodium hydroxide 
solution (2m; 11.1 ml) and the mixture was cooled to 0 °C. With 
good stirring and cooling, benzyl chloroformate (4.1 g, 24 mmol) 
was added dropwise over 45 min sim ultaneously w ith sodium 
hydroxide solution (4m; 5.6 ml). Stirring was continued for a 
further 30 min. The reaction mixture was washed several times 
w ith  d ie th y l e th e r  (5 ml) to rem ove u n re a c te d  ben zy l 
chloroformate. The aqueous solution was acidified to Congo Red 
on addition of hydrochloric acid (6 m).
General procedure 10
M ixed Anhydride Coupling o f  N -C arbobenzoxy-pro tected  Am ino  
Acids to L-Histidine Methyl Ester
L-Histidine methyl ester dihydrochloride (1.21 g, 5 mmol) was 
dissolved in methanol ( 1 0  ml) containing triethylamine ( 1 .01  g, 10  
mmol). The solution was stored at 0 °C until it was required. The 
A-carbobenzoxy-protected amino acid (6  mmol) was dissolved in 
acetonitrile (15 ml) containing triethylamine (0.61 g, 6  mmol).
This solution was cooled to -5 °C with the aid of an ice/methanol 
bath. Isobutyl chloroformate (0.82 g, 6  mmol) was added to the 
cooled solution with stirring. Stirring was continued for 5 min. At 
the end of this time the mixture was added to the cooled solution 
containing L-histidine methyl ester with vigorous stirring. The 
combined mixture was set aside for 2 h at 0 °C. The solvent was 
then removed under reduced pressure to yield an oily residue.
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The residue was partitioned between ethyl acetate  (20 ml) and 
w ater (10 ml). The aqueous layer was extracted  with ethyl 
acetate (2  x 1 0  ml) and the combined organic fractions were dried 
and concentrated .
N -C arbobenzoxy-3 -tr ity lhom ocarnosine  m ethy l e s te r  
Triphenylmethylchloride (1.4 g, 5 mmol) was dissolved in toluene 
(5 ml) co n ta in in g  tr ie th y lam in e  (0 .52  g, 5 m m ol). N- 
Carbobenzoxyhom ocarnosine methyl ester (1.9 g, 5 mmol) was 
powdered and added to the solution. The suspension was heated 
at reflux for 1 h. At the end of this time, the mixture was filtered, 
and the f il tra te  was w ashed with w ater (5 ml), dried and 
concentrated. The residue was treated several times with diethyl 
ether (10 ml). Each time the solvent was removed on evaporation 
under reduced pressure until the product was obtained as a crispy 
foam (1.7 g, 54%); 5h (90 MHz) (CDCI3; CHCI3 was the internal 
standard at 7.25 ppm)1.9 (2H, m), 2.4 (2H, t), 3.1-3.3 (4H, m), 3.6 
(3H, s), 5.0 (1H, m), 7.0-7.5 (22H, m).
A t t e m p t e d  N - m e th y  l a t i o n  o f  N - c a r b o b e n z o x y - 3 - t r i t y l  
hom ocarnosine methyl ester
A -C arbobenzoxy-3-trity lhom ocarnosine methyl ester (0.14 g, 0.2 
mmol) was treated with methyl iodide according to the method 
described in general procedure 5. The reaction was monitored by 
TLC (solvent system 1). Even after 48 h, very little product had 
fo rm ed .
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3 -A ce ty l-N -ca rb o b en zo xy -h o m o ca rn o s in e  m ethyl es ter  
N-Carbobenzoxy-L-homocarnosine methyl ester (0.2 g, 0.5 mmol) 
was added to acetic anhydride (0 . 6  ml) and the mixture was 
stirred at room temperature for 10 min. The solvent was then 
removed under reduced pressure at temperatures below 40 °C to 
yield the product as an oil (0.14 g ,  64%); [ cx] d 2 0  +12.3° ( c ,  0.8 in 
CHCI3); 5h  (CDCI3 ; CHCI3 was the internal standard at 7.25 ppm) 
1.84 (2H, m), 2.32 (2H, t), 2.50 (3H, s), 3.13 (2H, t), 3.16-3.23 (2H, 
AB part of an ABX system), 3.69 (3H, s), 4.85-4.89 (1H, X part of  
an ABX system), 5.06 (2H, s), 7.28 (1H, s), 7.34 (5H, s) and 8.31 
(1H, s); 5c (CDCI3 ; CHCI3 was the internal standard at 77.7 ppm)
23.2 (q, COCH 3), 26.0 (t, CHCH2), 29.6 (t, CH2CH2CH2), 33.9 (t, 
COCH2), 40.6 (t, CH2NH), 52.5 (d, CHCH2), 53.3 (q, CO2CH3), 67.3 (t, 
CH2Ph), 116.4 (d, C-4), 128.8 (d, Ph), 129.1 (d, Ph), 129.2 (d, Ph),
134.5 (s, C-5), 137.0 (d, C-2), 137.3 (s, Ph), 157.5 (s, C 0 2CH2), 172.1 
(s, NHCOCH2) and 173.2 (s, CO2CH3).
A ttem p ted  syn thesis  o f  N -carbobenzoxy-1  -m ethy lhom ocarnos ine  
m ethyl ester
3-A cetyl-A -carbobenzoxyhom ocarnosine methyl ester (50 mg, 0.1 
mmol) was treated with methyl iodide according to the method 
described in general procedure 5. On examination of the mixture 
at the end o f  the reaction both the 1- and 3-isomers had been 
fo rm ed .
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General procedure 11
In troduction o f  an N-t-Butoxycarbonyl Group onto the Im idazole  
R ing  o f  ^ -c a rb o b e n z o x y -p ro te c te d  D ipep tides  C on ta in ing  L- 
H is tid in e
T h e  N -c a rb o b e n z o x y -p ro te c te d  d ip e p t id e  (2 .6  m m ol) w as 
d i s s o lv e d  in m e th y le n e  c h lo r id e  ( 2 0  m l) c o n ta in in g  
diazobicyclo[2.2.2]octane (DABCO) (0.29 g, 2.6 mmol). Di-r-butyl 
dicarbonate (1.29 g, 3.5 mmol) was added with stirring. Stirring 
was continued at room temperature for several h. The progress o f  
the reaction was monitored by TLC (solvent system 2). Two 
isomers were formed during the course of the reaction. These 
w ere separated in two batches using positive pressure colum n 
chromatography. The column dimensions were 20 cm by 1.5 cm. 
Ethyl acetate was the solvent used to elute the column.
General Procedure 12
Removal o f  CBZ-Group
(A). The N-CBZ-protected derivative (5 mmol) was dissolved in 
m ethanol (5 ml). Ammonium formate (0.15 g, 2.4 mmol) and
palladium on carbon (10%; 0.17 g) were, added. The mixture was
heated at reflux until TLC (solvent system 1) showed cleavage of 
the CB Z-group was complete. The mixture was filtered and 
concentrated to yield the free dipeptide.
(B). The N-CBZ-protected dipeptide derivative (5 mmol) was 
d isso lved  in methanol ( 1 0  ml) or hydrochloric acid ( 1 0  ml).
Palladium on carbon (10%; 50 mg) was added and the solution was 
hydrogenated until cleavage of the CBZ-group was complete. The 
m ix tu re  was filtered  th rough  ce li te  and the f il t ra te  was
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co n cen tra ted  under reduced  p re ssu re  to y ie ld  the  d ip ep tid e  
d e r iv a t iv e .
(C). The N -CBZ-protected d ipep tide  derivative (5 mmol) was 
dissolved in a small amount o f  methanol. Hydrochloric acid (6 M; 
15 ml) was added and the mixture was heated at reflux for 6  h or 
until TLC (solvent system 1) indicated cleavage was com plete. 
T he  solution was then concentrated  under reduced pressu re  to 
yield the dipeptide derivative as a dihydrochloride salt.
N -Carbobenzoxyglycine (45, n = l)
G lycine  (1.65 g, 22 m m ol) was deriva tised  using  genera l 
procedure 9. On acidification the product separated as an oil. On 
storing at 0 °C for several h crystallisation of the oil occurred. 
Recrystallisation from methanol containing a few drops o f  water 
yielded N-carbobenzoxyglycine (45, n = l)  (3.36 g, 73%); m.p. 123- 
125 °C; U m ax  (KBr disc) 3340, 1730, 1710, 1695, 1680 and 1540 
cm-1; 5h (CD3OD; CD2HOD was the internal standard at 3.5 ppm)
4.03 (2H, s), 5.27 (2H, s), 7.51 (5H, m); 5c (CD3OD; CD2HOD was the 
internal standard at 49 ppm) 43.4 (t, NHCH2), 68.0 (t, CH 2PI1),
129.0 (d, Ph), 129.3 (d, Ph), 129.7 (d, Ph), 138.2 (s, Ph), 159.3 (s, 
NHCO) and 174.0 (s, C 0 2H); m/z 209 (M +, 16%), 108 (100%) and 91 
(8 6 %). Found: M +, 209.0682. Calcd. for C 10H 11NO4 ; M, 209.0688.
N(a)-Carbobenzoxyglycyl-L-histidine m ethyl ester (46, n = l)  
N-Carbobenzoxyglycine (45, n = l)  (1.56 g, 7 mmol) was coupled to 
L-histidine methyl ester according to general procedure 10. The 
residue obtained was extracted with hot diethyl ether. It was 
subsequently  crystallised from chloroform  on the addition o f
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diethyl ether to yield N(a)-carbobenzoxyglycyl-L-histid ine methyl 
ester (46, n= l)  (1.21 g, 67%); m.p. 89-91 °C; [ oc] d 2 0  -2.3° (c, 1.0 in 
83% aqueous ethanol); umax (KBr disc) 3320, 1745, 1700, 1660 
and 1435 cm*1; 5h (CD3OD; CD2HOD was the internal standard at
3.5 ppm) 3.16-3.38 (AB part of an ABX system), 3.86 (3H, s), 3.99 
(2H, s), 4.87-4.93 (X part o f an ABX system), 5.28 (2H, s), 7.11 (1H, 
s), 7.49 (5H, s) and 7.88 (1H, s); 5c (CD3OD; CD2HOD was the internal 
standard at 49.3 ppm) 30.0 (t, CHCH2), 45.0 (t, CH 2NH), 53.2 (q, 
CO2CH3), 54.1 (d, CHCH2), 68.1 (t, CH2Ph), 118.5 (d, C-4), 129.1 (d, 
Ph), 129.3 (d, Ph), 129.8 (d, Ph), 134.1 (s, C-5), 136.5 (d, C-2),
138.3 (s, Ph), 159.2 (s, NHCO2CH2), 172.4 (s, NHCOCH2) and 173.2 
(s, CO2CH3); m/z 360 (M+, 3.4%), 152 (51%), 108 (100%), 91 (79%) 
and 81 (80%). Found: A/+, 360.1422. Calcd. for C 17H 20N4O5 ; M, 
3 6 0 .1 4 3 4 .
1-M ethvlg lycylh istid ine  150)
3 - t-B u to x y c a r b o n y l -N (a ) -c a r b o b e n z o x y g ly c y l-L -h is t id in e  m e th y l  
ester (48, n - l )
G e n e ra l  p ro c e d u re  11 w as fo llo w e d  to  r e a c t  N(a)~  
carbobenzoxyglycyl-L-histidine methyl ester (46, n = l )  (1.79 g, 5 
mmol) with di-r-butyl dicarbonate. The fractions containing the 
more polar product, R f  0.2 (TLC system 2), were pooled and the 
solvent was concentrated to yield the product (48, n = l)  as a 
colourless oil (1.0 g, 44%); [ oc] d 2 0  +12° (c, 0.9 in CHCI3); u m a x  (CHCI3 
solution) 3450, 3040, 1760, 1740, 1690 and 1510 c n r 1; 5H (CDCI3; 
CHCI3 was the internal standard at 7.25 ppm) 1.60 (9H, s), 3.07-
3.15 (2H, AB part of an ABX system), 3.70 (3H, s), 3.93 (2H, m), 
4.81-4.87 (1H, X part of an ABX system), 5.11 (2H, s), 5.61 (1H, br
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s), 7.19 (1H, s), 7.33 (5H, s) and 8.08 (1H, s); 6 c  (CDCI3 ; CHCI3 was 
the internal standard at 77.7 ppm) 28.5 (q, C (C H 3)3), 29.4 (t, 
CHCH2), 45.1 (t, CH2NH), 52.6 (q, C 0 2CH3), 53.3 (d, CHCH2), 67.7 (t, 
CH2Ph), 87.6 (s, C(CH 3)3), 115.8 (d, C-4), 128.7 (d, Ph), 128.8 (d, 
Ph), 129.2 (d, Ph), 136.9 (s, Ph), 137.1 (d, C-2), 137.7 (s, C-5),
146.7 (s, COC(CH3)3), 157.1 (s, COCH2Ph), 169.7 (s, NHCOCH2) and
171.8 (s, C0 2CH3); m/z 460 (M +, 0.3%), 152 (38%), 108 (79%), 91 
(100%) and 81 (50%). Found: M *, 460.1936. Calcd. for C22H2gN407; 
M, 460.1958.
N (a )-C a rb o b e n zo x yg ly cy l- l-m e th y l-L -h is tid in e  m eth y l es te r  (49, 
n = l)
3-t-B u to x y ca rb o n y l-A f(o c)-carb o b en zo x y g ly cy l-L -h istid in e  m ethy l 
ester (48, n = l)  (0.87 g, 1.9 mmol) was m ethylated according to 
general procedure 5. The .V-methylated product (49, n = l)  was 
obtained as an oil (0.46 g, 65%); [a]D20  -3.8° (c, 1.1 in ethanol); 
U m ax (CHCI3 solution) 3010, 2950, 1720, 1680 and 1500 cm-*; 6 H  
(CDCI3 ; CH CI3 was the internal standard at 7.25 ppm) 3.09-3.12 
(2H, AB part o f an ABX system), 3.55 (3H, s), 3.72 (3H, s), 3.85 (2H, 
d), 4.72-4.86 (X part o f an ABX system), 5.08 (2H, s), 5.95 (1H, 
NH), 6.85 (1H, s), 7.31 (5H, s) and 7.68 (1H, s); 6 C (CDCI3; CHCI3 was 
the internal standard at 77.7 ppm) 26.7 (t, CHCFI2), 32.2 (q, NCH3),
44.8 (t, CH2NH), 52.2 (d, CHCH2), 53.3 (q, C0 2CH3), 67.7 (t, CH2Ph),
127.3 (d, C-4), 127.6 (s, Ph), 128.6 (d, Ph), 128.8 (d, Ph), 129.1 (d, 
Ph), 136.8 (s, C-5), 138.5 (d, C-2), 157.3 (s, C 0 2CH2Ph), 170.2 (s, 
NHCOCH2) and 172.0 (s, C 0 2CH3); m/z 374 (M +, 23%), 166 (90%), 
108 (29%), 95(100%) and 91 (87%). Found; M +, 374.1592. Calcd. 
for Ci8H22N40 5; M, 374.1590.
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\-M e th y lg ly cy lh is tid in e  (50) d ih yd ro ch lo rid e
A f(a)-C arbobenzoxyg lycy l-l -m e th y l-L -h istid in e  m ethyl es te r (49, 
n = l)  (0.5 g, 1.3 mmol) was trea ted  w ith  hydroch lo ric  acid  
according to general procedure 6 . The residue obtained at the end 
o f  the reaction was dissolved in ethanol several times. Each tim e 
the  so lu tio n  was concen tra ted  under reduced  p ressure . 1 - 
M e th y lg ly cy lh is tid in e  (50) d ih y d ro ch lo rid e  was obtained  as a 
hygroscopic solid (260 mg, 89%); R f 0.57 ( TLC solvent system 3); 
U m a x  (KBr disc) 3400, 3060, 1740, 1680, 1550 and 1430 c m '1; 5H 
(D 2O; HOD was the internal standard at 4.67 ppm) 3.15-3.37 (2H, 
AB part o f an ABX system), 3.72 (3H, s), 3.73 (2H, s), 4.21-4.28 
(1H, X part o f an ABX system), 7.32 (1H, s) and 8.57 (1H, s); 5c 
(D 2 O; dioxan was the external standard at 67.8 ppm) 24.8 (t, 
CHCH2), 34.7 (q, NCH3), 41.2 (t, CH2NH), 52.3 (d, CHCH2), 120.1 (d, 
C-4), 129.4 (s, C-5), 137.2 (d, C-2), 169.9 (s, NHCO) and 171.3 (s, 
CO 2H); m /z 226 (M +, 2.5%) and 95 (100%). Found: M +, 226.1067. 
Calcd. for C9H 14N4O3 ; M, 226.1066.
N-Carbobenzoxy-& -alanine (45, n - 2 )
(3-A lanine (1 .96  g, 22 m m ol) w as reac ted  w ith  b en zy l 
c h lo ro fo rm a te  as described  in g en era l p ro ced u re  9. On 
a c id if ic a t io n  the  p ro d u c t p re c ip ita te d  as a w h ite  so lid . 
R ecrystallisation  from m ethanol containing a few drops o f w ater 
y ielded  A -carbobenzoxy-p-alanine (45, n=2) (3.97 g, 81%); m.p. 
106-108 °C; umax (KBr disc) 3340, 1690, 1680 and 1535 c m '1; 5H 
(CD3OD; CD2HOD was the internal standard at 3.5 ppm) 2.69 (2H, t), 
3.56 (2H, t), 5.25 (2H, s) and 7.51 (5H, s); 5C (CD3OD; CD2HOD was 
the internal standard at 49.3 ppm) 35.5 (t, NHCH2CH2), 38.0 (t, 
NHCH2CH2 ), 67.7 (t, CH2PH), 129.0 (d, Ph), 129.2 (d, Ph), 129.7 (d,
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Ph), 138.5 (s, Ph), 159.0 (s, NHCO) and 175.8 (s, CO2H); m /z  223 
(M +, 9%), 108 (100%) and 91 (81%). Found: M+, 223.0845. Calcd. 
for C 11H 13NO4 ; M, 223.0845.
'N-Carbobenzoxy-L-carnosine m ethyl ester (46, n=2)
U sing general procedure 10, A -carbobenzoxy-f3-alanine (45, n=2) 
(1.34 g, 6  mmol) was coupled to L-histidine m ethyl ester. The 
resu ltan t residue was heated  w ith diethyl ether. T he d iethy l 
e th e r  was subsequen tly  d ecan ted  off. The oil w as then  
crystallised from ethanol on the addition of diethyl ether to yield  
Af-carbobenzoxy-L-carnosine m ethyl ester (46, n=2) (1.35 g, 72% ); 
m.p. 92-94 °C; [ cx] d 2 0  -4.4° (c, 1.0 in 83% aqueous ethanol); u m a x  
(K B r disc) 3340, 1750, 1695, 1660, 1645 and 1530 c m '1; 5H 
(CD 3OD; CD2HOD was the internal standard at 3.5 ppm) 2.60 (2H, t), 
3.12-3.34 (2H, AB part of an ABX system), 3.54 (2H, t), 3.62-3.72 
(1H, s), 5.25 (2H, s), 7.06 (1H, s), 7.51 (5H, s) and 7.78 (1H, s); 5C 
(CD 3OD; CD2HOD was the internal standard at 49.3 ppm) 30.3 (t, 
CHCH2), 37.1 (t, COCH2), 38.6 (t, CH2NH), 53.1 (q, CO2CH3), 54.3 (d, 
CHCH2), 67.7 (t, CH2Ph), 118.3 (d, C-4), 129.1 (d, Ph), 129.3 (d, Ph),
129.8 (d, Ph), 135.0 (s, C-5), 136.6 (d, C-2), 138.5 (s, Ph), 159.0 (s, 
NHCO2CH2), 173.7 (s, NHCOCH2) and 174.0 (s, CO2CH 3); m /z  374 
(M +, 12%), 152 (58%), 108 (93%), 91 (100%) and 81 (36%). Found: 
M+, 374.1587. Calcd. for C 18H22N4O5 ; M, 374.1590.
1-M ethvlcarnosine (3)
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3 - t-B u to x y c a rb o n y l-N -c a rb o b e n z o x y -L -c a r n o s in e  m e th y l e s te r  
(48, n -2 )
D i-/-b u ty l d ica rb o n a te  w as reac ted  w ith  A -carbobenzoxy-L - 
cam osine m ethyl ester (46, n=2) (1.9 g, 5 m m ol) according to 
general procedure 11. The fractions containing the more po lar 
product, R f 2.3 (TLC solvent system  2), w ere poo led  and the 
s o lv e n t w as rem o v ed  u n d e r  re d u c e d  p re s s u re .  3 -t-  
B u to x y ca rb o n y l-A -ca rb o b en zo x y -L -ca rn o sin e  m ethy l es te r (48, 
n=2) was isolated as a colourless oil (1.26 g ,  53%); [ cx] d 2 0  +17.1° ( c ,  
0.96 in CHCI3); umax (CHCI3 solution) 3325, 2982, 2951, 1755, 
1722, 1672 and 1531 cm -1; 5h (CDCI3 ; CHCI3 was the internal 
standard at 7.25 ppm) 1.59 (9H, s), 2.47 (2H, t), 3.02-3.13 (2H, AB 
part of an ABX system), 3.49 (2H, t), 3.70 (3H, s), 4.74-4.84 (1H, X 
part of an ABX system), 5.09 (2H, s), 5.96 (1H, NH), 7.16 (1H, s), 
7.32 (5H, s) and 8.05 (1H, s); 5c (CDCI3 ; CHCI3 was the internal 
standard at 77.7 ppm) 28.5 (q, C(CH 3)3), 29.5 (t, CH CH 2), 37.0 (t, 
COCH2), 38.0 (t, CH2NH), 52.9 (q, C 0 2CH3), 53.3 (d, CHCH2), 67.1 (t, 
CH2Ph), 86.5 (s, C(CH 3)3), 115.6 (d, C-4), 128.6 (d, Ph), 128.7 (d, 
Ph), 129.2 (d, Ph), 137.3 (s, C-5), 137.8 (d, C-2), 139.0 (s, Ph),
147.3 (s, N H C 0 2C(C H 3)3), 157.2 (s, N HC0 2 CH 2Ph), 172.1 (s, 
NHCOCH2) and 172.3 (s, C 0 2CH3); m/z 474 (M +, 4.5%), 374 (24%), 
168 (19%), 108 (35% ), 91 (100%) and 81 (56% ). Found: M \  
474.2101. Calcd. for C23H3oN4 0 7; M, 474.2114.
N -C arbobenzoxy-\-m ethyl-L -carnosine m ethyl ester (49 n - 2 ) 
3 -f-B u to x y c a rb o n y l-A -c a rb o b e n z o x y -L -c a rn o s in e  m ethy l e s te r  
(48? n=2) (1.2 g, 2.5 mmol) was m ethylated according to the
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method described in general procedure 5. The oil obtained at the 
end o f the reaction was dissolved in ethyl acetate (3 ml) and this 
so lu tion  w as ex tracted  w ith aqueous am m onia. The organic 
p ro tio n  w as d ried , f ilte re d  and e v a p o ra ted  to y ie ld  N- 
C arbobenzoxy-l-m ethy l-L -carnosine m ethyl ester (49, n=2) as an 
oil. (0.5 g, 58% ); [a ] D20 -4.0° (c, 0.7 in ethanol); umax (CHCI3 
solution) 3040, 2985, 1740, 1680 and 1510 cm-1; 6 H (CDCI3 ; CHCI3 
was the internal standard at 7.25 ppm) 2.45 (2H, t), 3.09-3.13 (2H, 
AB part of an ABX system), 3.41 (2H, t), 3.61 (3H, s), 3.73 (3H, s),
4.73-4.83 (1H, X part of an ABX system ), 5.07 (2H, s), 5.51 (1H, 
NH), 6.93 (1H, s), 7.33 (5H, s) and 7.79 (1H, s); 6C (CDCI3 ; CHCI3 was 
the internal standard at 77.7 ppm) 26.8 (t, CHCH2), 33.2 (q, NCH3), 
36.4 (t, COCH2), 37.7 (t, CH2NH), 51.9 (d, CHCH2), 53.5 (q, CO2CH3),
67.3 (t, CH 2Ph), 125.5 (d, C-4), 128.3 (s, C-5), 128.8 (d, Ph), 129.0 
(d, Ph), 129.2 (d, Ph), 137.2 (s, Ph), 137.8 (d, C-2), 157.1 (s, 
NHC0 2 CH2Ph), 171.8 (s, NHCOCH2) and 172.2 (s, CO2CH3); m/z 388 
(M +, 14%), 329 (17%), 166 (54%), 108 (45%), 95 (100%) and 91 
(62%). Found: M \  388.1752. Calcd. for Ci9H24N40 5; M, 388.1747.
\-M eth y lca rn o sin e  (3) d ihydrochloride
A -C arbobenzoxy-l-m ethyl-L -carnosine m ethyl ester (49, n=2) (0.4 
g, 1 mmol) was treated with hydrochloric acid (6 m) according to 
general p rocedure 6 . The residue obtained at the end o f the 
reac tio n  w as trea ted  w ith  e th an o l and the so lu tio n  was 
co n c e n tra ted  severa l tim es to y ie ld  1 -m e th y lca rn o sin e  ( 3 )  
dihydrochloride as a hygroscopic solid (0.2 g, 8 6 %); R f 0.56 (TLC 
solvent system  3); umax (KBr disc) 3420, 3040. 1740, 1660 and 
1550 cm-1; 5h (D2O; HOD was the internal standard at 4.67 ppm) 
2.54 (2H, t), 2.99-3.25 (2H, AB part o f an ABX system), 3.04 (2H,
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t), 3.67 (3H, X part o f an ABX system), 7.14 (1H, s) and 8.47 (1H, 
s); 6 c  26.6 (t, CHCH2), 32.7 (t, COCH2), 34.0 (q, N CH 3), 36.4 (t, 
CH2NH), 54.0 (d, CHCH2), 118.2 (d, C-4), 132.0 (s, C-5), 135.8 (d, C- 
2), 172.5 (s, NHCOCH2) and 177.2 (s, C 0 2H); m/z 240 (M +, 1.4%) and 
95 (100% ). Found: M +, 240.1223. C 10H 16N4O3 requ ired  M,
2 4 0 .1 2 2 2 .
N -C arbobenzoxy-4-am inobutyric acid  (45, n -3 )
G eneral procedure 9 was used to derivatise 4-am inobutyric acid 
(2.27 g, 22 mmol). On acidification the product separated as an
oil. On storing at 0 °C for several h the product crystallised . 
R ecrystallisation from m ethanol containing a few drops o f  w ater 
y ie lded  A -carbobenzoxy-4-am inobutyric acid (45, n=3) (3.97 g, 
76% ); m.p. 61-62 °C; umax (KBr disc) 3340, 1690, 1555 and 1455 
cm ’1; 5h (CD3OD; CD2HOD was the internal standard at 3.5 ppm) 
1.96 (2H, m), 2.50 (2H, t), 3.34 (2H, t), 5.24 (2H, s) and 7.50 (5H, 
m); 6 c  (CD3OD; CE^HOD was the internal standard at 49.3 ppm) 26.5 
(t, NHCH2CH2CH2), 32.3 (t, NHCH2CH2CH2), 41.4 (t, NHCH2CH2CH2),
67.6 (t, CH2Ph), 129.0 (d, Ph), 129.2 (d, Ph), 129.7 (d, Ph), 138.6 (s, 
Ph), 159.1 (s, NHCO) and 177.3 (s, C 0 2H); m/z 237 (M +, 4%), 112 
(4%), 108 (100%) and 91 (89%). Found: M+, 237.0998. Calcd. for 
C i2H i5N 0 4; M, 237.1001.
'N-Carbobenzoxy-L-hom ocarnosine m ethyl ester (46, n=3) 
A -Carbobenzoxy-4-am inobutyric acid (45, n=3) (1.42 g, 6  mmol) 
was coupled to L-histidine m ethyl ester using general procedure
10. The oil was heated with diethyl ether. The diethyl ether was 
decanted off and the oil was dissolved in ethanol. A crystalline 
solid was obtained on the addition of diethyl ether to this solution
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to yield A -carbobenzoxy-L-hom ocarnosine m ethyl este r (46, n=3) 
(1.52 g, 78%); m.p. 103-105 °C; [oc]d20 -7.0° (c, 1.0 in 83% aqueous 
ethanol); umax (KBr disc) 3340, 1750, 1695, 1660, 1645 and 1530 
cm-1; 5H (CD 3OD; CD2HOD was the internal standard at 3.5 ppm)
1.92 (2H, m), 2.41 (2H, t), 3.10-3.35 (2H, AB part o f an ABX 
system), 3.32 (2H, t), 3.89 (3H, s), 4.83-4.90 (1H, X part of an ABX 
system), 5.25 (2H, s), 7.07 (1H, s), 7.52 (5H, s) and 7.82 (1H, s); 6 c  
(CD3OD; CD 2HOD was the internal standard at 49.3 ppm) 27.4 (t, 
CHCH2), 30.2 (t, CH2CH2CH2), 34.2 (t, COCH2), 41.4 (t, CH2NH), 53.0 
(q, CO2CH3), 54.2 (d, CHCH2), 67.7 (t, CH2Ph), 118.4 (d, C-4), 129.1 
(d, Ph), 129.2 (d, Ph), 129.7 (d, Ph), 134.7 (s, C-5), 136.6 (d, C-2),
138.7 (s, Ph), 159.2 (s, NHCO2CH2), 173.7 (s, NHCOCH2) and 175.7 
(s, CO2CH3); m /z 388 (M +, 13%), 152 (23%), 110 (19%), 108 (25%), 
91 (100%) and 81 (47% ). Found: M \  388.1745. Calcd. for 
C 19H24N4O5 ; M, 388.1747.
1-M ethy lhom ocarnosine  (51)
3 - t-B u to x y c a r b o n y l-N -c a r b o b e n z o x y -L -h o m o c a r n o s in e  m e th y l  
ester (48, n - 3 )
A -C arbobenzoxy-L-hom ocarnosine m ethyl este r (46, n=3) (1.2 g,
3.1  mmol) was treated with di-r-butyl d icarbonate according to 
general procedure 11. The fractions containing the more polar 
product R f 0.25 (TLC solvent system  2) w ere pooled . The 
com bined so lu tion  was concentrated under reduced p ressure to 
y ie ld  3 - f -b u to x y  c a rb o n y l-  N- c a rb o b e n z o x y  -L -h o m o c a rn o s in e
methyl ester (48, n=3) as an oil (0.95 g, 63%); [o ]d2^ +14.6° (c, 1.1 
in CHCI3 ); Umax (CHCI3 solution) 3325, 2980, 2951, 1755, 1658. 
1539 and 1390 c n r 1; 5h (CDCI3 ; CHCI3 was the internal standard at
1 9 9
7.25 ppm) 1.58 (9H, s), 1.86 (2H, m), 2.29 (2H, t), 3.02 (2H, t), 
3.09-3.39 (2H, AB part of an ABX system ), 3.68 (3H, s), 4.80-4.90 
(1H, X part o f  an ABX system), 5.08 (2H, s), 5.56 (1H, NH), 7.11 
(1H, s), 7.34 (5H, s) and 7.95 (1H, s); 6 C (CDCI3 ; CHCI3 was the 
internal standard at 77.7 ppm) 26.1 (t, CHCH2), 28.5 (q, C(CH3)3),
30.1 (t, CH 2CH2CH2), 34.1 (t, CH2CH2CH2), 40.7 (t, CH2CH2CH2), 52.7 
(d, CHCH2), 53.1 (q, OCH3), 67.2 (t, CH2Ph), 86.5 (s, C(CH3)3), 115.3 
(d, C-4), 128.7 (d, Ph), 128.9 (d, Ph), 129.1 (d, Ph), 137.3 (s, C-5),
137.7 (d, C-2 ), 139.1 (s, Ph), 147.4 (s, C 0 2C(CH 3)3), 157.3 (s, 
C 0 2CH2Ph), 172.4 (s, NHCOCH2) and 173.0 (s, CO2CH3); m/z 488 (M+, 
0.2% ), 388 (10%), 225 (9%), 108 (65%), 95 (54%) and 91 (100%). 
Found: M +, 488.2282. Calcd. for C24H 32N4O7 ; M, 488.2271.
N -C a rb o b e n zo x y -1  -m e th y l-L -h o m o ca rn o s in e  m e th y l e s te r  (49, 
n=3)
3 -r-B u to x y c a rb o n y l-A -c a rb o b e n z o x y -L -h o m o c a rn o s in e  m e th y l 
ester (48, n= 3 ) (0 .8  g, 1.6  mmol) was treated with methyl iodide 
according to the method described in general procedure 5. The 
residue at the end of the reaction was dissolved in ethyl acetate (2  
ml) and extracted  with aqueous am m onia. The organic portion 
was dried, filtered  and concentrated to y ield  A -carbobenzoxy-1- 
m ethyl-L-hom ocam osine methyl ester (49, n=3) as an oil (0.36 g, 
56%); [ cx] d 2 0  -5.8° ( c ,  0.8 in ethanol); u m a x  (KBr disc) 3280, 3040, 
2960, 1740, 1710, 1660, 1525 and 1450 cm*1; 6 H (CDCI3; CHCI3 was 
the internal standard at 7.25 ppm) 1.76 (2H, m), 2.20 (2H, t), 3.04- 
3.19 (2F1, AB part of an ABX system), 3.59 (3H, s), 3.72 (3H, s),
4.73-4.84 (1H, X part of an ABX system), 5.05 (2H, s), 6.91 (1H, s), 
7.31 (5H, s) and 7.68 (1H, s); 6 c  (CDCI3 ; CHCI3 was the internal 
standard at 77.7 ppm) 26.6 (t, CH2CH2CH2), 27.0 (t, CHCH2) 32.6 (q,
2 0 0
NCH3), 33.8 (t, CH2CH2CH2), 40.7 (t, CH2CH2CH2), 51.9 (d, CHCH2),
53.4 (q, OCH3), 67.3 (t, CH2Ph), 127.0 (d, C-4), 128.7 (d, Ph), 128.8 
(d, Ph), 129.2 (d, Ph), 132.0 (s, C-5), 137.2 (s, Ph), 137.3 (d, C-2),
157.6 (s, N H C 02CH2Ph), 172.1 (s, NHCOCH2) and 173.5 (s, CO2CH3); 
m /z 402 (M +, 2%), 166 (4.4%), 108 (12%) 95 (14%) and 91 (100%). 
Found: M +, 402.1879. Calcd. for C20H26N4O5; M, 402.1903.
l-M ethy lhom ocarnosine  (51) d ihydroch loride
N -C a rb o b e n z o x y -l-m e th y l-L -h o m o c a rn o s in e  m ethy l e s te r  (49 , 
n=3) (0.32 g, 0.8 mmol) was treated  with 6 m hydrochloric acid 
according to general procedure 6 . The residue at the end o f the 
reaction was treated several tim es with ethanol and concentrated 
u n d e r  re d u c e d  p re s s u re . l -M e th y lh o m o c a rn o s in e  (51 ) 
dihydrochloride was obtained as a hygroscopic solid (0.18 g, 87%); 
R f 0.51 (TLC solvent system 3); cmax (KBr disc) 3420, 3040, 1730 
and 1610 c m '1; 5h (D2O; HOD was the internal standard at 4.67 
ppm) 1.76 (2H, m), 2.30 (2H, t), 2.84 (2H, t), 3.16-3.39 (2H, AB 
part o f an ABX system), 3.68 (3H, s), 4.22-4.29 (1H, X part of an 
ABX system), 7.29 (1H, s) and 8.54 (1H, s); 5c (D2O; dioxan was the 
external standard at 67.8 ppm ) 23.1 (t, CH2CH2CH 2 ), 24.9 (t, 
CHCH2), 31.7 (t, COCH2), 34.6 (q, NCH3), 39.9 (t, CH2NH), 52.3 (d, 
CHCH 2), 120.1 (d, C-4), 129.3 (s, C-5), 137.1 (d, C-2), 171.2 (s, 
NHCOCH2) and 178.0 (s, CO2H); m/z 254 (M+, 1.2%) and 95 (100%). 
Found: M \  254.1377. Calcd. for C 11H 18N4O3; M, 254.1379.
201
6.3 .4  D ipeptides C ontain ing 3 -M eth y lh istid in e
3 -M eth y lg ly cv lh istid in e  (53)
1 - l-B u to x y c a rb o n y l-N (a )-c a r b o b e n zo x y g ly c y l-L -h is t id in e  m e th y l  
ester (47, n = l)
7V (a)-C arbobenzoxyglycyl-l-histidine m ethyl ester (46, n = l)  (1.79 
g, 5 mmol) was reacted with di-/-butyl d icarbonate as described 
in general procedure 11. Those fractions containing the less polar 
product, R f 0.46 (TLC solvent system 2), were collected together 
and the so lvent was rem oved under reduced p ressu re . 1 -t- 
B u to x y ca rb o n y l-N -ca rb o b en zo x y -L -h is tid in e  m ethy l e s te r  (47, 
n = l)  was isolated as a colourless oil (0.85 g, 37%); [gc]d20 -29.3° (c,
0.98 in CHCI3); umax (CHCI3 solution) 3040, 3000, 1820, 1760 and 
1745 cm -1; 5h (CDCI3 ; CHCI3 was the internal standard at 7.25 
ppm) 1.58 (9H, s), 3.32-3.54 (2H, AB part of an ABX system), 3.76 
(3H, s), 4.20 (2H, d), 4.66 (2H, s), 5.03-5.14 (1H, X part of an ABX 
system ), 7.17 (1H, s), 7.32 (5H, m) and 7.98 (1H, d); 5C (CDCI3 ; 
CHCI3 was the internal standard at 77.7 ppm) 26.6 (t, CHCH2), 28.5 
(q, C(CH3)3), 49.3 (t, CH2NH), 53.1 d, CHCH2), 53.7 (q, CO2CH3), 65.8 
(t, CH2Ph), 85.1 (s, C(CH3)3), 115.6 (d, C-4), 127.6 (d, Ph), 128.1 (d, 
Ph), 129.15 (d, Ph), 137.4 (d, C-2), 138.5 (s, C-5), 147.2 (s, Ph),
148.9 (s, C02C(CH 3)3), 152.0 (s, C0 2CH2Ph), 167.9 (s, NHCOCH2) and
168.9 (s, CO2CH3); m/z 460 (M +, 1.2%), 252 (30%), 193 (33%), 152 
(100%), 91 (28%) and 81 (40%). Found: M +, 460.1963. Calcd. for 
C22H28N4O7; M, 460.1958.
2 0 2
N (a )-C a rb o b en zo xy g ly c y l-3 -m e th y l-L -h is tid in e  m eth y l e s te r  (52, 
n = l)
1-r-B u toxycarbony l-A -carbobenzoxy-L -h istid ine  m ethyl e s te r (47, 
n = l)  (0.8 g, 1.7 mmol) was m ethylated according to the method 
set out in general procedure 5. The oil obtained at the end of the 
reaction was dissolved in chloroform  (3 ml) and extracted with 
aqueous am m onia. The organic portion was dried, filtered  and 
c o n c e n tr a te d  u n d e r  re d u c e d  p re s s u re  to  y ie ld  N(a)~  
carboben zo x y g ly cy l-3 -m eth y l-L -h is tid in e  m ethyl es te r (52, n = l)  
as an oil (0.3 g, 48%) [a ] D20 -18.0° (c, 1.3 in CHCI3); umax (CHCI3 
solution) 3020, 2990, 1750, 1730 and 1220 c m 1; 5H (CDCI3; CHCI3 
was the internal standard at 7.25 ppm) 3.87-3.94 (2H, AB part of 
an ABX system), 4.65 (3H, s), 4.67 (3H, s), 5.07 (2H, s), 5.71 (1H, 
NH), 7.23 (1H, s), 7.32 (5H, s) and 7.97 (1H, s); 5C (CDCI3 ; CHCI3 was 
the internal standard at 77.7 ppm) 28.5 (t, CHCH2), 37.5 (q, NCH3),
43.2 (t, CH2NH), 53.2 (q, OCH3), 53.7 (d, CHCH2), 67.6 (t, CH2Ph),
117.9 (d, C-4), 127.7 (d, Ph), 128.6 (d, Ph), 129.0 (s, Ph), 129.1 (d, 
Ph), 134.1 (s, C-5), 136.8 (d, C-2), 157.2 (s, C 0 2CH2Ph), 172.3 (s, 
NHCOCH2) and 173.4 (s, C 0 2CH3); m/z 374 (M+, 2%), 283 (14%), 166 
(73%), 108 (20%), 95 (75%) and 91 (71%). Found: M +, 374.1589. 
Calcd. for Ci8H 22N40 5; M, 374.1590.
3 -M eth y lg lycy lh is tid in e  (53) d ihydroch loride
N (a)-C arb o b en zo x y g ly cy l-3 -m eth y l-L -h istid in e  m ethyl e s te r (52, 
n = l)  (0.25g, 0.7 mmol) was treated with 6 m hydrochloric acid 
according to general procedure 6 . The residue obtained at the end
of the reaction was treated several tim es with ethanol and each 
tim e the so lu tion  was concentrated . 1-M ethy lg lycy lh istid ine  
dihydrochloride was obtained as a hygroscopic solid (0.12 g, 79%);
2 0 3
R f 0.63 (TLC solvent system 3); umax (thin film) 3400, 3110, 1720, 
1610 and 1490 c m 1; 5h (D2O; HOD was the internal standard at 
4.67 ppm) 3.18-3.56 (2H, AB part of an ABX system), 3.68 (3H, s), 
3.78 (2H, s), 4.00-4.08 (1H, X part o f an ABX system), 7.18 (1H, s) 
and 8.47 (1H, s); 6c  (D2O; dioxan was the external standard at 67.8 
ppm) 26.6 (t, CHCH2), 31.9 (q, NCH 3), 41.2 (t, CH2NH), 54.5 (d, 
CHCH2), 114.0 (d, C-4), 127.7 (s, C-5), 130.4 (d, C-2), 169.8 (s, 
NHCO) and 171.2 (s, CO2H); m/z 226 (M +, 0.4%) and 95 (100%). 
Found: M \  226.1071. Calcd. for C9H 14N4O 3; M, 226.1066.
3 -M ethv lcarnosine  (4)
\ - t -B u to x y c a r b o n y l-N -c a r b o b e n z o x y -L -c a r n o s in e  m e th y l e s te r  
(47, n=2)
N -C arbobenzoxy-L -carnosine m ethyl es te r (46, n=2) (1.9 g, 5 
m m ol) w as trea ted  w ith d i-r-bu ty l d icarbonate  acco rd ing  to 
general procedure 11. The fractions containing the less po lar 
product, R f 0.32 (TLC solvent system 2) were com bined and the 
so lvent was concentrated to yield 1-f-butoxycarbonyl-L-carnosine 
m ethyl ester (47, n=2) as a colourless oil (0.64 g, 27% ); [cc]d^ 
-10.7° (c, 1.0 in CHCI3); U m ax (CHCI3 solution) 3440, 3020, 3000, 
1755, 1680 and 1400 c m 1; 5 h (CDCI3 ; CHCI3 was the internal 
standard at 7.25 ppm) 1.57 (9H, s), 2.53 (2H, t), 2.90-3.12 (2H, AB 
part of an ABX system), 3.66 (2H, s), 3.93 (2H, t), 4.72-4.82 (1H, X
part o f an ABX system), 5.19 (2H, s), 7.10 (1H, s), 7.32 (5H, m) and
7.93 (1H, s); 6 c  (CDCI3 ; CHCI3 was the internal standard at 77.7
ppm) 28.5 (q, C(CH3)3), 30.0 (t, CHCH2), 36.2 (t, COCH2), 43.5 (t,
CH2NH), 52.5 (d, CHCH2), 53.0 (q, CO2CH3 ), 69.0 (t, CH2Ph), 86.4 (s, 
C(CH3)3), H 5 .2  (d, C-4), 128.8 (d, Ph), 128.9 (d, Ph), 129.1 (d, Ph),
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136.1 (s, C-5), 137.5 (d, C-2), 139.1 (s, Ph), 152.3 (s, C 02C (C H 3)3),
154.2 (s, CO2CH2PI1), 170.6 (s, NHCOCH2) and 172.2 (s, CO2CH 3); m/z 
474 (M +, 6.4%), 374 (17%), 168 (17%), 152 (50%), 108 (36%), 91 
(100%) and 81 (32%). Found: M +, 474.2122. Calcd. for C23H 30N4O7 ; 
M, 474.2114.
N -C arbobenzoxy-3-m ethyl-L-carnosine m ethyl ester (52, n=2) 
1-r-Butoxycarbonyl-L-carnosine m ethyl ester (47, n=2) (0.6 g, 1.3 
mmol) was treated with m ethyl iodide according to the m ethod 
described in general procedure 5. The residue at the end o f the 
reaction was dissolved in chloroform  (3 ml) and extracted with 
aqueous am m onia. The organic portion was dried, filtered  and 
concentrated  under reduced p ressure  to yield Ar-carbobenzoxy-3- 
methyl-L-carnosine methyl ester (52, n=2) as an oil (0.27 g, 54%); 
[ oc] d 2 0  - 3 . 2 0  (C? o.9 in CHCI3); u m a x  (CHCI3 solution) 3440, 3040, 
3000, 1790, 1750, 1690 and 1510 c m 1; 6 H (CDCI3; CHCI3 was the 
internal standard at 7.25 ppm) 2.58 (2H, t), 3.02-3.20 (2H, AB part 
of an ABX system), 3.71 (3H, s), 3.73 (3H, s), 3.91 (2H, t), 4.71-4.81 
(1H, X part o f an ABX system), 7.04 (1H, s), 7.33 (5H, m) and 8.23 
(1H, s); 6c  (CDCI3; CHCI3 was the internal standard at 77.7 ppm)
26.6 (t, CHCH2), 33.5 (q, NCH3), 35.9 (t, COCH2), 43.4 (t, CH2NH),
51.9 (d, CHCH2), 53.5 (q, OCH 3), 69.2 (t, CH2Ph), 122.8 (d, C-4),
128.9 (d, Ph), 129.0 (d, Ph), 129.2 (d, Ph), 129.5 (s, C-5), 136.1 (d, 
C-2), 137.0 (s, Ph), 154.4 (s, NHC0 2CH2Ph), 171.4 (s, NHCOCH2) and
171.7 (s, CO 2CH 3); m/z 388 (M +, 3%), 298 (4%), 280 (13%), 166 
(100%), 108 (38%), 95 (78%) and 91 (61%). Found: M +, 388.1738. 
Calcd. for C 19H24N4O5 ; M, 388.1747.
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3-M ethylcarnosine (4) d ihydrochloride
N -C arb o b en zo x y -3 -m eth y l-L -ca rn o sin e  m ethy l e s te r  (52 , n=2)
(0.23 g, 0.6 m m ol) was trea ted  with 6 M  h y d ro ch lo ric  acid 
according to general procedure 6 . The residue obtained at the end 
o f the reaction was dissolved several times in ethanol. Each time 
the solution was concentrated under reduced pressure  to yield 3 - 
m ethylcarnosine (4) d ihydrochloride as a hygroscopic solid (0.12 
g, 81%); R f 0.60 (TLC solvent system 3); umax (thin film) 3380, 
1730, 1610 and 1560 c m 1; 5h (D 2O; HOD was the in ternal 
standard at 4.67 ppm) 2.63 (2H, t), 3.13 (2H, t), 3.17-3.41 (2H, AB 
part of an ABX system), 3.71 (3H, s), 4.22-4.29 (1H, X part of an 
ABX system), 7.31 (1H, s) and 8.56 (1H, s); 6c  (D2O; dioxan was the 
external standard at 67.8 ppm) 24.9 (t, CHCH2), 32.0 (t, COCH2),
34.6 (q, NCH3), 36.2 (t, CH2NH), 52.4 (d, CHCH2), 120.0 (d, C-4),
129.4 (s, C-5), 137.1 (d, C-2 ), 171.3 (s, NHCOCH2) and 175.5 (s, 
CO2H), m/z 240 (M +, 0.1%) and 95 (100%). Found: M +, 240.1211. 
Calcd. for C 10H 16N4O 3; M, 240.1129.
\-B enzoxym ethyl-N -carbobenzoxy-L -carnosine  m e th y l es te r  (55) 
N -C arbobenzoxy-L -carnosine m ethyl ester (46, n=2) (1.1 g, 3 
mmol) was added to acetic anhydride (3.5 ml). The m ixture was 
stirred at room  tem perature for 10 min. The solution was then 
co n cen tra ted  u n d e r red u ced  p ressu re  to y ie ld  3 -ace ty l-N - 
carbobenzoxy-L -carnosine  m ethyl ester (54). T h is was not 
i s o la te d  b u t d is s o lv e d  in d ic h lo ro m e th a n e  (4 m l). 
B enzylchlorom ethyl e ther was added dropw ise to th is solution 
w ith stirring . The m ixture was stirred  o v ern ig h t at room  
tem perature. The solution was then ex trac ted  w ith aqueous 
ammonia. The organic portion was dried, filtered and evaporated
2 0 6
to  y ie ld  1 -b en zo x y m eth y l-V -ca rb o b en zo x y -L -c a rn o s in e  m ethy l
ester (55) as an oil (1.3 g, 8 6 %); [ oc] d 2 0  -6.0° (c, 1.6 in methanol); 
Umax (CHCI3 solution) 3000, 1740, 1715, 1670 and 1500 c m '1; 6 H 
(CDCI3 ; CHCI3 was the internal standard at 7.25 ppm) 2.50 (2H, t),
3.25 (3H, t), 3.27-3.44 (2H, AB part o f an ABX system), 3.65 (3H, 
s), 4.61-4.63 (1H, X part of an ABX system), 4.68 (2H, s), 5.01 (2H, 
s), 5.69 (2H, s), 7.27 (11H, m) and 9.37 (1H, s); m/z 168 (25%) and 
81 (58%).
A tte m p te d  s y n th e s is  o f  \-b e n z o x y m e th y l-N -c a r b o b e n z o x y -3 -  
m ethyl-L -carnosine  m ethyl ester
1-B enzoxym ethy l-V -carbobenzoxy-L -carnosine  m ethyl este r (55) 
(1.27 g, 2.6 mmol) was dissolved in DMF (5 ml). M ethyl iodide 
(1.45 g, 10.2 mmol) was added and the solution was heated at 
reflux (45 °C). The reaction was m onitored by TLC over a period 
o f 48 h. Very little  product was form ed, the reaction m ixture
consisted m ainly of starting m aterial.
2 0 7
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